Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
67 "Lymph node"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Comparison of Long-term Oncological Outcome of Sentinel Lymph Node Mapping Methods (Dye-Only versus Dye and Radioisotope) in Breast Cancer Patients Following Neoadjuvant Chemotherapy
Jinyoung Byeon, Changjin Lim, Eunhye Kang, Ji-Jung Jung, Hong-Kyu Kim, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han
Received December 30, 2024  Accepted April 13, 2025  Published online April 15, 2025  
DOI: https://doi.org/10.4143/crt.2024.1253    [Accepted]
AbstractAbstract PDF
Purpose
Sentinel lymph node biopsy (SLNB) using dye and isotope (DUAL) is recommended over the dye-only (DYE) method after neoadjuvant chemotherapy (NCT) due to potentially lower false-negative rates. However, the long-term outcome of either method is unclear. We aimed to compare the long-term oncological outcomes of DYE versus DUAL SLNB methods in patients who received NCT.
Materials and Methods
In this retrospective cohort study, 893 patients who underwent SLNB following NCT and had pathologically negative lymph nodes were included. After propensity score matching for cT, cN, and pT stages, 280 patients were in the DYE group and 560 in the DUAL group. Indigo carmine was used for dye and Tc-99m antimony trisulfate for isotope mapping.
Results
Median follow-up was 75.6 months in the DYE group and 83.0 months in the DUAL group. Mean (±SD) number of harvested sentinel nodes was 6.7 (±3.4) and 6.7 (±3.8) in the DYE and DUAL groups (p=0.51). Five-year distant metastasis-free survival was 95.2% in DYE group and 93.3% in DUAL group (HR=1.45; 95% CI, 0.82–2.57; p=0.19). Disease-free survival (HR=0.97; 95% CI, 0.69–1.50; p=0.91) and overall survival (HR=0.98; 95% CI, 0.56–1.69; p=0.95) were not significantly different. Axillary recurrence rate was 1.8% and 2.5% in DYE and DUAL groups(p=0.64).
Conclusion
Long-term oncological outcomes did not significantly differ between DYE and DUAL SLNB methods. The dye-only method can be safely recommended for breast cancer patients who received NCT.
  • 134 View
  • 7 Download
Close layer
Lung and Thoracic cancer
Differences in the Prognostic Impact between Single-Zone and Multi-Zone N2 Node Metastasis in Patients with Station-Based Multiple N2 Non–Small Cell Lung Cancer
Shia Kim, Geun Dong Lee, SeHoon Choi, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Jae Kwang Yun
Cancer Res Treat. 2025;57(1):95-104.   Published online July 22, 2024
DOI: https://doi.org/10.4143/crt.2024.120
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The International Association for the Study of Lung Cancer suggests further subdivision of pathologic N (pN) category in non–small-cell lung cancer (NSCLC) by incorporating the location and number of involved lymph node (LN) stations. We reclassified patients with the station-based N2b disease into single-zone and multi-zone N2b groups and compared survival outcomes between the groups.
Materials and Methods
This retrospective study included patients with pN2 NSCLC who underwent lobectomy from 2006 to 2019. The N2 disease was subdivided into four categories: single-station N2 without N1 (N2a1), single-station N2 with N1 (N2a2), multiple-station N2 with single zone involvement (single-zone N2b), and multiple-station N2 with multiple zone involvement (multi-zone N2b). LN zones included in the subdivision of N2 disease were upper mediastinal, lower mediastinal, aortopulmonary, and subcarinal.
Results
Among 996 eligible patients, 211 (21.2%), 394 (39.6%), and 391 (39.3%) were confirmed to have pN2a1, pN2a2, and pN2b disease, respectively. In multivariable analysis after adjustment for sex, age, pT category, and adjuvant chemotherapy, overall survival was significantly better with single-zone N2b disease (n=125, 12.6%) than with multi-zone N2b disease (n=266, 26.7%) (hazard ratio [HR], 0.67; 95% confidence interval [CI], 0.49 to 0.90; p=0.009) and was comparable to that of N2a2 disease (HR, 1.12; 95% CI, 0.83 to 1.49; p=0.46).
Conclusion
Prognosis of single-zone LN metastasis was better than that of multiple-zone LN metastasis in patients with N2b NSCLC. Along with the station-based N descriptors, zone-based descriptors might ensure optimal staging, enabling the most appropriate decision-making on adjuvant therapy for patients with pN2 NSCLC.
  • 1,473 View
  • 101 Download
Close layer
Gastrointestinal cancer
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
So Heun Lee, Dae Wook Hwang, Changhoon Yoo, Kyu-pyo Kim, Sora Kang, Jae Ho Jeong, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Yejong Park, Bong Jun Kwak, Heung-Moon Chang, Baek-Yeol Ryoo, Song Cheol Kim
Cancer Res Treat. 2023;55(3):956-968.   Published online February 27, 2023
DOI: https://doi.org/10.4143/crt.2022.409
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The benefit of adjuvant chemotherapy following curative-intent surgery in pancreatic ductal adenocarcinoma (PDAC) patients who had received neoadjuvant FOLFIRINOX is unclear. This study aimed to assess the survival benefit of adjuvant chemotherapy in this patient population.
Materials and Methods
This retrospective study included 218 patients with localized non-metastatic PDAC who received neoadjuvant FOLFIRINOX and underwent curative-intent surgery (R0 or R1) between January 2017 and December 2020. The association of adjuvant chemotherapy with disease-free survival (DFS) and overall survival (OS) was evaluated in overall patients and in the propensity score matched (PSM) cohort. Subgroup analysis was conducted according to the pathology-proven lymph node status.
Results
Adjuvant chemotherapy was administered to 149 patients (68.3%). In the overall cohort, the adjuvant chemotherapy group had significantly improved DFS and OS compared to the observation group (DFS: median, 13.8 months [95% confidence interval (CI), 11.0 to 19.1] vs. 8.2 months [95% CI, 6.5 to 12.0]; p < 0.001; and OS: median, 38.0 months [95% CI, 32.2 to not assessable] vs. 25.7 months [95% CI, 18.3 to not assessable]; p=0.005). In the PSM cohort of 57 matched pairs of patients, DFS and OS were better in the adjuvant chemotherapy group than in the observation group (p < 0.001 and p=0.038, respectively). In the multivariate analysis, adjuvant chemotherapy was a significant favorable prognostic factor (vs. observation; DFS: hazard ratio [HR], 0.51 [95% CI, 0.36 to 0.71; p < 0.001]; OS: HR, 0.45 [95% CI, 0.29 to 0.71; p < 0.001]).
Conclusion
Among PDAC patients who underwent surgery following neoadjuvant FOLFIRINOX, adjuvant chemotherapy may be associated with improved survival. Randomized studies should be conducted to validate this finding.

Citations

Citations to this article as recorded by  
  • The survival effect of neoadjuvant therapy and neoadjuvant plus adjuvant therapy on pancreatic ductal adenocarcinoma patients with different TNM stages: a propensity score matching analysis based on the SEER database
    Hao Hu, Yang Xu, Qiang Zhang, Yuan Gao, Zhenyu Wu
    Expert Review of Anticancer Therapy.2024; 24(6): 467.     CrossRef
  • Neoadjuvant treatment of pancreatic ductal adenocarcinoma: Whom, when and how
    Nebojsa Manojlovic, Goran Savic, Stevan Manojlovic
    World Journal of Gastrointestinal Surgery.2024; 16(5): 1223.     CrossRef
  • Case Study on Analysing the Early Disease Detection of Pancreatic Ductal Adenocarcinoma in Korean Association for Clinical Oncology
    Sijithra Ponnarassery Chandran, N. Santhi
    American Journal of Clinical Oncology.2024; 47(10): 475.     CrossRef
  • Evaluating the benefits of adjuvant chemotherapy in patients with pancreatic cancer undergoing radical pancreatectomy after neoadjuvant therapy—a systematic review and meta-analysis
    Jiahao Wu, Yike Zhang, Haodong Wang, Wenyi Guo, Chengqing Li, Yichen Yu, Han Liu, Feng Li, Lei Wang, Jianwei Xu
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Prognostic factors in localized pancreatic ductal adenocarcinoma after neoadjuvant therapy and resection: a systematic review and meta-analysis
    Ammar A Javed, Alyssar Habib, Omar Mahmud, Asad Saulat Fatimi, Mahip Grewal, Nabiha Mughal, Jin He, Christopher L Wolfgang, Lois Daamen, Marc G Besselink
    JNCI: Journal of the National Cancer Institute.2024;[Epub]     CrossRef
  • 5,237 View
  • 161 Download
  • 5 Web of Science
  • 5 Crossref
Close layer
Breast cancer
Retrospective Cohort Study on the Long-term Oncologic Outcomes of Sentinel Lymph Node Mapping Methods (Dye-Only versus Dye and Radioisotope Mapping) in Early Breast Cancer: A Propensity Score-Matched Analysis
Changjin Lim, Eunhye Kang, Ji Gwang Jung, Jong-Ho Cheun, Hong-Kyu Kim, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han
Cancer Res Treat. 2023;55(2):562-569.   Published online September 26, 2022
DOI: https://doi.org/10.4143/crt.2022.871
AbstractAbstract PDFPubReaderePub
Purpose
In sentinel lymph node (SLN) biopsy (SLNB) during breast cancer surgery, SLN mapping using dye and isotope (DUAL) may have lower false-negative rates than the dye-only (DYE) method. However, the long-term outcomes of either method are unclear. We aimed to compare long-term oncological outcomes of DYE and DUAL for SLNB in early breast cancer.
Materials and Methods
This retrospective single-institution cohort study included 5,795 patients (DYE, 2,323; DUAL, 3,472) with clinically node-negative breast cancer who underwent SLNB and no neoadjuvant therapy. Indigo carmine was used for the dye method and Tc99m-antimony trisulfate for the isotope. To compare long-term outcomes, pathologic N0 patients were selected from both groups, and propensity score matching (PSM), considering age, pT category, breast surgery, and adjuvant treatment, was performed (1,441 patients in each group).
Results
The median follow-up duration was 8.7 years. The median number of harvested sentinel nodes was 3.21 and 3.12 in the DYE and DUAL groups, respectively (p=0.112). The lymph node–positive rate was not significantly different between the two groups in subgroups of similar tumor sizes (p > 0.05). Multivariate logistic regression revealed that the mapping method was not significantly associated with the lymph node–positive rate (p=0.758). After PSM, the 5-year axillary recurrence rate (DYE 0.8% vs. DUAL 0.6%, p=0.096), and 5-year disease-free survival (DYE 93.9% vs. DUAL 93.7%, p=0.402) were similar between the two groups.
Conclusion
Dye alone for SLNB was not inferior to dual mapping regarding long-term oncological outcomes in early breast cancer.
  • 4,570 View
  • 112 Download
Close layer
Diagnostic Assessment of Deep Learning Algorithms for Frozen Tissue Section Analysis in Women with Breast Cancer
Young-Gon Kim, In Hye Song, Seung Yeon Cho, Sungchul Kim, Milim Kim, Soomin Ahn, Hyunna Lee, Dong Hyun Yang, Namkug Kim, Sungwan Kim, Taewoo Kim, Daeyoung Kim, Jonghyeon Choi, Ki-Sun Lee, Minuk Ma, Minki Jo, So Yeon Park, Gyungyub Gong
Cancer Res Treat. 2023;55(2):513-522.   Published online September 6, 2022
DOI: https://doi.org/10.4143/crt.2022.055
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Assessing the metastasis status of the sentinel lymph nodes (SLNs) for hematoxylin and eosin–stained frozen tissue sections by pathologists is an essential but tedious and time-consuming task that contributes to accurate breast cancer staging. This study aimed to review a challenge competition (HeLP 2019) for the development of automated solutions for classifying the metastasis status of breast cancer patients.
Materials and Methods
A total of 524 digital slides were obtained from frozen SLN sections: 297 (56.7%) from Asan Medical Center (AMC) and 227 (43.4%) from Seoul National University Bundang Hospital (SNUBH), South Korea. The slides were divided into training, development, and validation sets, where the development set comprised slides from both institutions and training and validation set included slides from only AMC and SNUBH, respectively. The algorithms were assessed for area under the receiver operating characteristic curve (AUC) and measurement of the longest metastatic tumor diameter. The final total scores were calculated as the mean of the two metrics, and the three teams with AUC values greater than 0.500 were selected for review and analysis in this study.
Results
The top three teams showed AUC values of 0.891, 0.809, and 0.736 and major axis prediction scores of 0.525, 0.459, and 0.387 for the validation set. The major factor that lowered the diagnostic accuracy was micro-metastasis.
Conclusion
In this challenge competition, accurate deep learning algorithms were developed that can be helpful for making a diagnosis on intraoperative SLN biopsy. The clinical utility of this approach was evaluated by including an external validation set from SNUBH.

Citations

Citations to this article as recorded by  
  • Detection of metastatic breast carcinoma in sentinel lymph node frozen sections using an artificial intelligence-assisted system
    Chia-Ping Chang, Chih-Yi Hsu, Hsiang Sheng Wang, Peng-Chuna Feng, Wen-Yih Liang
    Pathology - Research and Practice.2025; 267: 155836.     CrossRef
  • Value of frozen section to tailor surgical staging in apparent early-stage epithelial ovarian cancer
    Stefano Di Berardino, Nicolò Bizzarri, Marianna Ciancia, Francesca Moro, Belen Padial Urtueta, Claudia Marchetti, Gian Franco Zannoni, Giovanni Scambia, Anna Fagotti
    International Journal of Gynecological Cancer.2025; : 101746.     CrossRef
  • Comparing the diagnostic efficacy of optical coherence tomography and frozen section for margin assessment in breast-conserving surgery: a meta-analysis
    Shishun Fan, Huirui Zhang, Zhenyu Meng, Ang Li, Yuqing Luo, Yueping Liu
    Journal of Clinical Pathology.2024; 77(8): 517.     CrossRef
  • Intraoperative Margin Assessment in Breast Conservation Surgery: A Necessity or a Luxury?
    Srijan Shukla, Nisha Hariharan
    Annals of Surgical Oncology.2023; 30(9): 5314.     CrossRef
  • 6,777 View
  • 205 Download
  • 3 Web of Science
  • 4 Crossref
Close layer
Genitourinary cancer
The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
Hyehyun Jeong, Kye Jin Park, Yongjune Lee, Hyung-Don Kim, Jwa Hoon Kim, Shinkyo Yoon, Bumsik Hong, Jae Lyun Lee
Cancer Res Treat. 2022;54(1):226-233.   Published online May 6, 2021
DOI: https://doi.org/10.4143/crt.2021.365
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
This study aims to evaluate the prognosis of pathologically node-positive bladder cancer after neoadjuvant chemotherapy, the role of adjuvant chemotherapy in these patients, and the value of preoperative clinical evaluation for lymph node metastases.
Materials and Methods
Patients who received neoadjuvant chemotherapy followed by partial/radical cystectomy and had pathologically confirmed lymph node metastases between January 2007 and December 2019 were identified and analyzed.
Results
A total of 53 patients were included in the study. The median age was 61 years (range, 34 to 81 years) with males comprising 86.8%. Among the 52 patients with post-neoadjuvant/pre-operative computed tomography results, only 33 patients (63.5%) were considered positive for lymph node metastasis. Sixteen patients (30.2%) received adjuvant chemotherapy (AC group), and 37 patients did not (no AC group). With the median follow-up duration of 67.7 months, the median recurrence-free survival (RFS) and the median overall survival (OS) was 8.5 months and 16.2 months, respectively. The 2-year RFS and OS rates were 23.3% and 34.6%, respectively. RFS and OS did not differ between the AC group and no AC group (median RFS, 8.8 months vs. 6.8 months, p=0.772; median OS, 16.1 months vs. 16.3 months, p=0.479). Thirty-eight patients (71.7%) experienced recurrence. Distant metastases were the dominant pattern of failure in both the AC group (91.7%) and no AC group (76.9%).
Conclusion
Patients with lymph node-positive disease after neoadjuvant chemotherapy followed by surgery showed high recurrence rates with limited survival outcomes. Little benefit was observed with the addition of adjuvant chemotherapy.

Citations

Citations to this article as recorded by  
  • A Predictive Nomogram for Development of Lymph Node Metastasis in Muscle-Invasive Bladder Cancer Following Neoadjuvant Therapy
    Garrett K. Harada, Steven N. Seyedin, Olivia Heutlinger, Armon Azizi, Audree Hsu, Arash Rezazadeh, Michael Daneshvar, Greg E. Gin, Edward M. Uchio, Giovanna A. Giannico, Jeremy P. Harris, Aaron B. Simon, Jeffrey V. Kuo, Nataliya Mar
    Advances in Radiation Oncology.2025; 10(1): 101671.     CrossRef
  • Resultados oncológicos de pacientes con afectación ganglionar tras quimioterapia neoadyuvante y cistectomía radical para el cáncer de vejiga músculo-invasivo: estudio observacional multicéntrico del Grupo de Trabajo de Carcinoma Urotelial de la sección de
    G. Marcq, W. Kassouf, M. Roumiguié, B. Pradere, L.S. Mertens, S. Albisinni, A. Cimadamore, J. Yuen-Chun Teoh, M. Moschini, E. Laukhtina, A. Mari, F. Soria, A. Gallioli, F. del Giudice, D. d’Andrea, W. Krajewski, J.B. Beauval, E. Xylinas, D. Pouessel, P. S
    Actas Urológicas Españolas.2025; 49(2): 501701.     CrossRef
  • Oncological outcomes of patients with node positive disease following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: A multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma wor
    G. Marcq, W. Kassouf, M. Roumiguié, B. Pradere, L.S. Mertens, S. Albisinni, A. Cimadamore, J. Yuen-Chun Teoh, M. Moschini, E. Laukhtina, A. Mari, F. Soria, A. Gallioli, F. del Giudice, D. d’Andrea, W. Krajewski, J.B. Beauval, E. Xylinas, D. Pouessel, P. S
    Actas Urológicas Españolas (English Edition).2025; 49(2): 501701.     CrossRef
  • Influence of Neoadjuvant Chemotherapy on Survival Outcomes of Radical Cystectomy in Pathologically Proven Positive and Negative Lymph Nodes
    Krystian Kaczmarek, Bartosz Małkiewicz, Karolina Skonieczna-Żydecka, Artur Lemiński
    Cancers.2023; 15(19): 4901.     CrossRef
  • Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
    Serhat Sekmek, Gökhan Ucar, Irfan Karahan, Dogan Bayram, Selin Aktürk Esen, Ismet Seven, Mehmet Ali Nahit Sendur, Dogan Uncu
    African Journal of Urology.2023;[Epub]     CrossRef
  • 5,800 View
  • 183 Download
  • 4 Web of Science
  • 5 Crossref
Close layer
Gastrointestinal Cancer
LASSO-Based Machine Learning Algorithm for Prediction of Lymph Node Metastasis in T1 Colorectal Cancer
Jeonghyun Kang, Yoon Jung Choi, Im-kyung Kim, Hye Sun Lee, Hogeun Kim, Seung Hyuk Baik, Nam Kyu Kim, Kang Young Lee
Cancer Res Treat. 2021;53(3):773-783.   Published online December 29, 2020
DOI: https://doi.org/10.4143/crt.2020.974
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The role of tumor-infiltrating lymphocytes (TILs) in predicting lymph node metastasis (LNM) in patients with T1 colorectal cancer (CRC) remains unclear. Furthermore, clinical utility of a machine learning–based approach has not been widely studied.
Materials and Methods
Immunohistochemistry for TILs against CD3, CD8, and forkhead box P3 in both center and invasive margin of the tumor were performed using surgically resected T1 CRC slides. Three hundred and sixteen patients were enrolled and categorized into training (n=221) and validation (n=95) sets via random sampling. Using clinicopathologic variables including TILs, the least absolute shrinkage and selection operator (LASSO) regression model was applied for variable selection and predictive signature building in the training set. The predictive accuracy of our model and the Japanese criteria were compared using area under the receiver operating characteristic (AUROC), net reclassification improvement (NRI)/integrated discrimination improvement (IDI), and decision curve analysis (DCA) in the validation set.
Results
LNM was detected in 29 (13.1%) and 12 (12.6%) patients in training and validation sets, respectively. Nine variables were selected and used to generate the LASSO model. Its performance was similar in training and validation sets (AUROC, 0.795 vs. 0.765; p=0.747). In the validation set, the LASSO model showed better outcomes in predicting LNM than Japanese criteria, as measured by AUROC (0.765 vs. 0.518, p=0.003) and NRI (0.447, p=0.039)/IDI (0.121, p=0.034). DCA showed positive net benefits in using our model.
Conclusion
Our LASSO model incorporating histopathologic parameters and TILs showed superior performance compared to conventional Japanese criteria in predicting LNM in patients with T1 CRC.

Citations

Citations to this article as recorded by  
  • Assessing prospective molecular biomarkers and functional pathways in severe asthma based on a machine learning method and bioinformatics analyses
    Ya-Da Zhang, Yi-Ren Chen, Wei Zhang, Bin-Qing Tang
    Journal of Asthma.2025; 62(3): 465.     CrossRef
  • A web-based tool for cancer risk prediction for middle-aged and elderly adults using machine learning algorithms and self-reported questions
    Xingjian Xiao, Xiaohan Yi, Nyi Nyi Soe, Phyu Mon Latt, Luotao Lin, Xuefen Chen, Hualing Song, Bo Sun, Hailei Zhao, Xianglong Xu
    Annals of Epidemiology.2025; 101: 27.     CrossRef
  • Risk stratification scores for lymph node metastases in T1 colorectal cancer—A systematic review
    Rakesh Quinn, Giuleta Jamsari, Ewan MacDermid
    Colorectal Disease.2025;[Epub]     CrossRef
  • Artificial Intelligence in Lymph Node Metastasis Prediction for T1 Colorectal Cancer: Promise and Challenges
    Jung Ho Bae
    Gut and Liver.2025; 19(1): 3.     CrossRef
  • Utilizing Ensemble Learning and Dimension Reduction in Predicting Stock Prices: A Transparent Methodology with Insights from Explainable AI
    Nabanita Das, Bikash Sadhukhan, Chayan Ghosh, Avigyan Chowdhury, Satyajit Chakrabarti
    SN Computer Science.2025;[Epub]     CrossRef
  • Bioinformatics approach reveals the critical role of inflammation-related genes in age-related hearing loss
    Xi Gu, Chenyu Chen, Yuqing Chen, Chaojun Zeng, Yanchun Lin, Ruosi Guo, Shujin Xu, Chang Lin
    Scientific Reports.2025;[Epub]     CrossRef
  • Genome-wide identification and expression analysis of phytochrome gene family in Aikang58 wheat (Triticum aestivum L.)
    Zhu Yang, Wenjie Kan, Ziqi Wang, Caiguo Tang, Yuan Cheng, Dacheng Wang, Yameng Gao, Lifang Wu
    Frontiers in Plant Science.2025;[Epub]     CrossRef
  • Following intravenous thrombolysis, the outcome of diabetes mellitus associated with acute ischemic stroke was predicted via machine learning
    Xiaoqing Liu, Miaoran Wang, Rui Wen, Haoyue Zhu, Ying Xiao, Qian He, Yangdi Shi, Zhe Hong, Bing Xu
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • An early lung cancer diagnosis model for non-smokers incorporating ct imaging analysis and circulating genetically abnormal cells (CACs)
    Ran Ni, Yongjie Huang, Lei Wang, Hongjie Chen, Guorui Zhang, Yali Yu, Yinglan Kuang, Yuyan Tang, Xing Lu, Hong Liu
    BMC Cancer.2025;[Epub]     CrossRef
  • Identification and validation of immune-related biomarkers and polarization types of macrophages in keloid based on bulk RNA-seq and single-cell RNA-seq analysis
    Yuzhu Zhang, Chenglong Fang, Lizhong Zhang, Fengyu Ma, Meihong Sun, Ning Zhang, Nan Bai, Jun Wu
    Burns.2025; 51(3): 107413.     CrossRef
  • Comprehensive analysis of mitochondrial solute carrier family 25 (SLC25) identifies member 19 (SLC25A19) as a regulatory factor in hepatocellular carcinoma
    Xueke Gao, Yangtao Xu, Xinyao Hu, Jiayu Chen, Daoming Zhang, Ximing Xu
    Gene.2025; 944: 149299.     CrossRef
  • A dynamic nomogram predicting nosocomial infections in patients after colon cancer surgery
    Xue Yao, Shuhui Wang, Anning Lu, Yun Xu, Na Li
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Machine learning models to predict 6-month mortality risk in home-based hospice patients with advanced cancer
    Wan Cheng, Jianwei Zheng, Yuanfeng Lu, Guojuan Chen, Zheng Zhu, Hong Wu, Yitao Wei, Huimin Xiao
    Asia-Pacific Journal of Oncology Nursing.2025; 12: 100679.     CrossRef
  • Interpretable Machine Learning Model for Predicting Depression in Middle-aged and Elderly Chinese Arthritis Patients: A Nationwide Prospective Cohort Study
    Xiao Xu, Hai-Yan Huang, Shu-yun Wang, Shen-Yee Tan, Hong-Hui Chen, Min-Min Zhou, Mei-juan Qian
    Archives of Gerontology and Geriatrics.2025; : 105810.     CrossRef
  • Identification of nitric oxide-related key genes in pulmonary hypertension via bioinformatics and in vitro validation for therapeutic target discovery
    Zhuyang Chu, Yiming Li, Jianjun Ge
    Computer Methods in Biomechanics and Biomedical Engineering.2025; : 1.     CrossRef
  • Prediction of Lymph Node Metastasis in Colorectal Cancer Using Intraoperative Fluorescence Multi-Modal Imaging
    Xiaobo Zhu, He Sun, Yuhan Wang, Gang Hu, Lizhi Shao, Song Zhang, Fucheng Liu, Chongwei Chi, Kunshan He, Jianqiang Tang, Yu An, Jie Tian, Zhenyu Liu
    IEEE Transactions on Medical Imaging.2025; 44(3): 1568.     CrossRef
  • Additional staining for lymphovascular invasion is associated with increased estimation of lymph node metastasis in patients with T1 colorectal cancer: Systematic review and meta‐analysis
    Jun Watanabe, Katsuro Ichimasa, Yuki Kataoka, Atsushi Miki, Hidehiro Someko, Munenori Honda, Makiko Tahara, Takeshi Yamashina, Khay Guan Yeoh, Shigeo Kawai, Kazuhiko Kotani, Naohiro Sata
    Digestive Endoscopy.2024; 36(5): 533.     CrossRef
  • Risk assessment in pT1 colorectal cancer
    Emma Jane Norton, Adrian C Bateman
    Journal of Clinical Pathology.2024; 77(4): 225.     CrossRef
  • Identification and Analysis of Immune Microenvironment-Related Genes for Keloid Risk Prediction and Their Effects on Keloid Proliferation and Migration
    Yongyan Pei, Yikai Wu, Mengqi Zhang, Xuemin Su, Hua Cao, Jiaji Zhao
    Biochemical Genetics.2024; 62(4): 3174.     CrossRef
  • Multiple machine-learning tools identifying prognostic biomarkers for acute Myeloid Leukemia
    Yujing Cheng, Xin Yang, Ying Wang, Qi Li, Wanlu Chen, Run Dai, Chan Zhang
    BMC Medical Informatics and Decision Making.2024;[Epub]     CrossRef
  • Artificial Intelligence Applications in the Treatment of Colorectal Cancer: A Narrative Review
    Jiaqing Yang, Jing Huang, Deqian Han, Xuelei Ma
    Clinical Medicine Insights: Oncology.2024;[Epub]     CrossRef
  • Transcriptomic and machine learning analyses identify hub genes of metabolism and host immune response that are associated with the progression of breast capsular contracture
    Yukun Mao, Xueying Hou, Su Fu, Jie Luan
    Genes & Diseases.2024; 11(3): 101087.     CrossRef
  • Bioinformatics and Machine Learning Methods Identified MGST1 and QPCT as Novel Biomarkers for Severe Acute Pancreatitis
    Yang Sun, Jingjun Xie, Jun Zhu, Yadong Yuan
    Molecular Biotechnology.2024; 66(5): 1246.     CrossRef
  • Multi-omics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacy
    Zhixiong Su, Lijie You, Yufang He, Jingbo Chen, Guifeng Zhang, Zhenhua Liu
    Scientific Reports.2024;[Epub]     CrossRef
  • Use of artificial intelligence in the management of T1 colorectal cancer: a new tool in the arsenal or is deep learning out of its depth?
    James Weiquan Li, Lai Mun Wang, Katsuro Ichimasa, Kenneth Weicong Lin, James Chi-Yong Ngu, Tiing Leong Ang
    Clinical Endoscopy.2024; 57(1): 24.     CrossRef
  • SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration
    Shihao Li, Zihao Li, Lan Huang, Zhenyang Geng, Feng Li, Bin Wu, Yinliang Sheng, Yifan Xu, Bowen Li, Yiming Xu, Zhuoyu Gu, Yu Qi
    International Journal of Oncology.2024;[Epub]     CrossRef
  • Overexpression of circulating CD38+ NK cells in colorectal cancer was associated with lymph node metastasis and poor prognosis
    Xueling Wang, Haoran Li, Huixian Chen, Kehua Fang, Xiaotian Chang
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Management after non-curative endoscopic resection of T1 rectal cancer
    Hao Dang, Daan A. Verhoeven, Jurjen J. Boonstra, Monique E. van Leerdam
    Best Practice & Research Clinical Gastroenterology.2024; 68: 101895.     CrossRef
  • Prediction of Lymph Node Metastasis in T1 Colorectal Cancer Using Artificial Intelligence with Hematoxylin and Eosin-Stained Whole-Slide-Images of Endoscopic and Surgical Resection Specimens
    Joo Hye Song, Eun Ran Kim, Yiyu Hong, Insuk Sohn, Soomin Ahn, Seok-Hyung Kim, Kee-Taek Jang
    Cancers.2024; 16(10): 1900.     CrossRef
  • Identification of immune characteristic biomarkers and therapeutic targets in cuproptosis for sepsis by integrated bioinformatics analysis and single-cell RNA sequencing analysis
    Tianfeng Wang, Xiaowei Fang, Ximei Sheng, Meng Li, Yulin Mei, Qing Mei, Aijun Pan
    Heliyon.2024; 10(5): e27379.     CrossRef
  • Possibilities and prospects of artificial intelligence in the treatment of colorectal cancer (review)
    A. Yu. Kravchenko, E. V. Semina, V. V. Kakotkin, M. A. Agapov
    Koloproktologia.2024; 23(2): 184.     CrossRef
  • A risk prediction nomogram for resistant hypertension in patients with obstructive sleep apnea
    Hongze Lin, Chen Zhou, Jiaying Li, Xiuqin Ma, Yan Yang, Taofeng Zhu
    Scientific Reports.2024;[Epub]     CrossRef
  • Unveiling the best predictive models for early‑onset metastatic cancer: Insights and innovations (Review)
    Liqing Yu, Zhenjun Huang, Ziqi Xiao, Xiaofu Tang, Ziqiang Zeng, Xiaoli Tang, Wenhao Ouyang
    Oncology Reports.2024;[Epub]     CrossRef
  • Exploration of the molecular biological mechanisms and review of postoperative radiotherapy cases in tenosynovial giant cell tumors
    Tianwei Zhang, Bin Zeng, Ke Liu, Qin Zeng, Na Wang, Ling Peng, Hongbo Qiu, Xiaomei Chen, Lin Wang
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Radiomics-based machine learning in the differentiation of benign and malignant bowel wall thickening
    Hande Melike Bülbül, Gülen Burakgazi, Uğur Kesimal, Esat Kaba
    Japanese Journal of Radiology.2024; 42(8): 872.     CrossRef
  • Potential Mechanism of Tibetan Medicine Liuwei Muxiang Pills against Colorectal Cancer: Network Pharmacology and Bioinformatics Analyses
    Shaochong Qi, Xinyu Liang, Zijing Wang, Haoran Jin, Liqun Zou, Jinlin Yang
    Pharmaceuticals.2024; 17(4): 429.     CrossRef
  • A new clinical model for predicting lymph node metastasis in T1 colorectal cancer
    Kai Wang, Hui He, Yanyun Lin, Yanhong Zhang, Junguo Chen, Jiancong Hu, Xiaosheng He
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Comprehensive analysis of the interaction of antigen presentation during anti‐tumour immunity and establishment of AIDPS systems in ovarian cancer
    Wenhuizi Sun, Ping Xu, Kefei Gao, Wenqin Lian, Xiang Sun
    Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
  • Use of artificial intelligence for the prediction of lymph node metastases in early-stage colorectal cancer: systematic review
    Nasya Thompson, Arthur Morley-Bunker, Jared McLauchlan, Tamara Glyn, Tim Eglinton
    BJS Open.2024;[Epub]     CrossRef
  • Machine learning for predicting colon cancer recurrence
    Erkan Kayikcioglu, Arif Hakan Onder, Burcu Bacak, Tekin Ahmet Serel
    Surgical Oncology.2024; 54: 102079.     CrossRef
  • A machine learning screening model for identifying the risk of high-frequency hearing impairment in a general population
    Yi Wang, Xinmeng Yao, Dahui Wang, Chengyin Ye, Liangwen Xu
    BMC Public Health.2024;[Epub]     CrossRef
  • Potential clinical value of fibrinogen-like protein 1 as a serum biomarker for the identification of diabetic cardiomyopathy
    Yao Liu, Min Wang, Jia-Bao Su, Xiao Fu, Guan-Li Zheng, Shan Guo, Li-Juan Zhang, Qing-Bo Lu
    Scientific Reports.2024;[Epub]     CrossRef
  • CXCR4-mediated neutrophil dynamics in periodontitis
    Xuanwen Xu, Tiange Li, Jingqi Tang, Danlei Wang, Yi Zhou, Huiqing Gou, Lu Li, Yan Xu
    Cellular Signalling.2024; 120: 111212.     CrossRef
  • Hspb1 and Lgals3 in spinal neurons are closely associated with autophagy following excitotoxicity based on machine learning algorithms
    Lei Yan, Zihao Li, Chuanbo Li, Jingyu Chen, Xun Zhou, Jiaming Cui, Peng Liu, Chong Shen, Chu Chen, Hongxiang Hong, Guanhua Xu, Zhiming Cui, Suyan Tian
    PLOS ONE.2024; 19(5): e0303235.     CrossRef
  • Impact of artificial intelligence in the management of esophageal, gastric and colorectal malignancies
    Ayrton Bangolo, Nikita Wadhwani, Vignesh K Nagesh, Shraboni Dey, Hadrian Hoang-Vu Tran, Izage Kianifar Aguilar, Auda Auda, Aman Sidiqui, Aiswarya Menon, Deborah Daoud, James Liu, Sai Priyanka Pulipaka, Blessy George, Flor Furman, Nareeman Khan, Adewale Pl
    Artificial Intelligence in Gastrointestinal Endoscopy.2024;[Epub]     CrossRef
  • Identification and Validation of Nicotinamide Metabolism-Related Gene Signatures as a Novel Prognostic Model for Hepatocellular Carcinoma
    Sijia Yang, Ang Li, Lihong Lv, Jinxin Duan, Zhihua Zheng, Wenfeng Zhuo, Jun Min, Jinxing Wei
    OncoTargets and Therapy.2024; Volume 17: 423.     CrossRef
  • Machine learning algorithms integrate bulk and single-cell RNA data to unveil oxidative stress following intracerebral hemorrhage
    Chaonan Du, Cong Wang, Zhiwei Liu, Wenxuan Xin, Qizhe Zhang, Alleyar Ali, Xinrui Zeng, Zhenxing Li, Chiyuan Ma
    International Immunopharmacology.2024; 137: 112449.     CrossRef
  • Single-cell analysis and machine learning identify psoriasis-associated CD8+ T cells serve as biomarker for psoriasis
    Sijia He, Lyuye Liu, Xiaoyan Long, Man Ge, Menghan Cai, Junling Zhang
    Frontiers in Genetics.2024;[Epub]     CrossRef
  • DcR3-associated risk score: correlating better prognosis and enhanced predictive power in colorectal cancer
    Ying Duan, Hangrong Fang, Juanhong Wang, Banlai Ruan, Juan Yang, Jie Liu, Siqi Gou, Yijie Li, Zhengyi Cheng
    Discover Oncology.2024;[Epub]     CrossRef
  • Lymph node metastasis detection using artificial intelligence in T1 colorectal cancer: A comprehensive systematic review
    Xiaoyan Yao, Zhiyong Zhou, Shengxun Mao, Jiaqing Cao, Huizi Li
    Journal of Surgical Oncology.2024; 130(3): 637.     CrossRef
  • Development and Validation of an Interpretable Machine Learning Model for Early Prognosis Prediction in ICU Patients with Malignant Tumors and Hyperkalemia
    Zhi-Jun Bu, Nan Jiang, Ke-Cheng Li, Zhi-Lin Lu, Nan Zhang, Shao-Shuai Yan, Zhi-Lin Chen, Yu-Han Hao, Yu-Huan Zhang, Run-Bing Xu, Han-Wei Chi, Zu-Yi Chen, Jian-Ping Liu, Dan Wang, Feng Xu, Zhao-Lan Liu
    Medicine.2024; 103(30): e38747.     CrossRef
  • Machine learning-based model to predict composite thromboembolic events among Chinese elderly patients with atrial fibrillation
    Jiefeng Ren, Haijun Wang, Song Lai, Yi Shao, Hebin Che, Zaiyao Xue, Xinlian Qi, Sha Zhang, Jinkun Dai, Sai Wang, Kunlian Li, Wei Gan, Quanjin Si
    BMC Cardiovascular Disorders.2024;[Epub]     CrossRef
  • Identifying and validating necroptosis‐associated features to predict clinical outcome and immunotherapy response in patients with glioblastoma
    Qinghua Yuan, Weida Gao, Mian Guo, Bo Liu
    Environmental Toxicology.2024; 39(10): 4729.     CrossRef
  • CuPCA: a web server for pan-cancer association analysis of large-scale cuproptosis-related genes
    Yishu Xu, Zhenshu Ma, Yajie Wang, Long Zhang, Jiaming Ye, Yuan Chen, Zhengrong Yuan
    Database.2024;[Epub]     CrossRef
  • Transcriptomic analysis reveals oxidative stress-related signature and molecular subtypes in cholangio carcinoma
    Zichao Wu
    Molecular Genetics and Genomics.2024;[Epub]     CrossRef
  • The application value of support vector machine model based on multimodal MRI in predicting IDH-1mutation and Ki-67 expression in glioma
    He-Xin Liang, Zong-Ying Wang, Yao Li, An-Ning Ren, Zhi-Feng Chen, Xi-Zhen Wang, Xi-Ming Wang, Zhen-Guo Yuan
    BMC Medical Imaging.2024;[Epub]     CrossRef
  • The AC010247.2/miR-125b-5p axis triggers the malignant progression of acute myelocytic leukemia by IL-6R
    Fang Xie, Jialu Xu, Lina Yan, Xia Xiao, Liang Liu
    Heliyon.2024; 10(18): e37715.     CrossRef
  • Application of machine learning for predicting lymph node metastasis in T1 colorectal cancer: a systematic review and meta-analysis
    Chinock Cheong, Na Won Kim, Hye Sun Lee, Jeonghyun Kang
    Langenbeck's Archives of Surgery.2024;[Epub]     CrossRef
  • Short-term PV energy yield predictions within city neighborhoods for optimum grid management
    Stefani Peratikou, Alexandros G. Charalambides
    Energy and Buildings.2024; 323: 114773.     CrossRef
  • Integrating microarray-based spatial transcriptomics and RNA-seq reveals tissue architecture in colorectal cancer
    Zheng Li, Xiaojie Zhang, Chongyuan Sun, Zefeng Li, He Fei, Dongbing Zhao
    Journal of Big Data.2024;[Epub]     CrossRef
  • Construction and validation of a nomogram prediction model for the catheter-related thrombosis risk of central venous access devices in patients with cancer: a prospective machine learning study
    Guiyuan Ma, Shujie Chen, Sha Peng, Nian Yao, Jiaji Hu, Letian Xu, Tingyin Chen, Jiaan Wang, Xin Huang, Jinghui Zhang
    Journal of Thrombosis and Thrombolysis.2024; 58(2): 220.     CrossRef
  • Association of coexposure to perfluoroalkyl and polyfluoroalkyl compounds and heavy metals with pregnancy loss and reproductive lifespan: The mediating role of cholesterol
    Hua Fang, Dai Lin, Ziqi Zhang, Haoting Chen, Zixin Zheng, Dongdong Jiang, Wenxiang Wang
    Ecotoxicology and Environmental Safety.2024; 286: 117160.     CrossRef
  • Identification of novel diagnostic biomarkers associated with liver metastasis in colon adenocarcinoma by machine learning
    Long Yang, Ye Tian, Xiaofei Cao, Jiawei Wang, Baoyang Luo
    Discover Oncology.2024;[Epub]     CrossRef
  • Identification of a disulfidptosis-related genes signature for diagnostic and immune infiltration characteristics in endometriosis
    Xiangyu Chang, Jinwei Miao
    Scientific Reports.2024;[Epub]     CrossRef
  • Machine learning model based on SERPING1, C1QB, and C1QC: A novel diagnostic approach for latent tuberculosis infection
    Linsheng Li, Li Zhuang, Ling Yang, Zhaoyang Ye, Ruizi Ni, Yajing An, Weiguo Zhao, Wenping Gong
    iLABMED.2024; 2(4): 248.     CrossRef
  • Development of machine learning models for predicting depressive symptoms in knee osteoarthritis patients
    Dan Li, Han Lu, Junhui Wu, Hongbo Chen, Meidi Shen, Beibei Tong, Wen Zeng, Weixuan Wang, Shaomei Shang
    Scientific Reports.2024;[Epub]     CrossRef
  • Integrated analysis of single-cell, spatial and bulk RNA-sequencing identifies a cell-death signature for predicting the outcomes of head and neck cancer
    Yue Pan, Lei Fei, Shihua Wang, Hua Chen, Changqing Jiang, Hong Li, Changsong Wang, Yao Yang, Qinggao Zhang, Yongwen Chen
    Frontiers in Immunology.2024;[Epub]     CrossRef
  • Screening the Best Risk Model and Susceptibility SNPs for Chronic Obstructive Pulmonary Disease (COPD) Based on Machine Learning Algorithms
    Zehua Yang, Yamei Zheng, Lei Zhang, Jie Zhao, Wenya Xu, Haihong Wu, Tian Xie, Yipeng Ding
    International Journal of Chronic Obstructive Pulmonary Disease.2024; Volume 19: 2397.     CrossRef
  • Identification of biomarkers related to Escherichia coli infection for the diagnosis of gastrointestinal tumors applying machine learning methods
    Tingting Ge, Wei Wang, Dandan Zhang, Xubo Le, Lumei Shi
    Heliyon.2024; 10(23): e40491.     CrossRef
  • Immune Microenvironment Alterations and Identification of Key Diagnostic Biomarkers in Chronic Kidney Disease Using Integrated Bioinformatics and Machine Learning
    Jinbao Shi, Aliang Xu, Liuying Huang, Shaojie Liu, Binxuan Wu, Zuhong Zhang
    Pharmacogenomics and Personalized Medicine.2024; Volume 17: 497.     CrossRef
  • Identification of alternative lengthening of telomeres-related genes prognosis model in hepatocellular carcinoma
    FanLin Zeng, YuLiang Chen, Jie Lin
    BMC Cancer.2024;[Epub]     CrossRef
  • Bioinformatics Analysis Identifies PLA2G7 as a Key Antigen-Presenting Prognostic Related Gene Promoting Hepatocellular Carcinoma through the STAT1/PD-L1 Axis
    Sihang Guo, Qinhe Yang
    Frontiers in Bioscience-Landmark.2024;[Epub]     CrossRef
  • Risk of intraoperative hemorrhage during cesarean scar ectopic pregnancy surgery: development and validation of an interpretable machine learning prediction model
    Xinli Chen, Huan Zhang, Dongxia Guo, Siyuan Yang, Bao Liu, Yiping Hao, Qingqing Liu, Teng Zhang, Fanrong Meng, Longyun Sun, Xinlin Jiao, Wenjing Zhang, Yanli Ban, Yugang Chi, Guowei Tao, Baoxia Cui
    eClinicalMedicine.2024; 78: 102969.     CrossRef
  • TRIM16 and PRC1 Are Involved in Pancreatic Cancer Progression and Targeted by Delphinidin
    Donghua Wang, Long Lv, Jinghu Du, Kui Tian, Yu Chen, Manyu Chen
    Chemical Biology & Drug Design.2024;[Epub]     CrossRef
  • Identification of Ferroptosis‐Related Gene in Age‐Related Macular Degeneration Using Machine Learning
    Meijiang Zhu, Jing Yu
    Immunity, Inflammation and Disease.2024;[Epub]     CrossRef
  • Integration of bioinformatics analysis reveals ZNF248 as a potential prognostic and immunotherapeutic biomarker for LIHC: machine learning and experimental evidence
    Lifang Weng
    American Journal of Cancer Research.2024; 14(11): 5230.     CrossRef
  • Development and Validation of a Nomogram for Predicting Suicidal Ideation Among Rural Adolescents in China
    Yunjiao Luo, Yuhao Wang, Yingxue Wang, Yihan Wang, Na Yan, Blen Shiferaw, Louisa Mackay, Ziyang Zhang, Caiyi Zhang, Wei Wang
    Psychology Research and Behavior Management.2024; Volume 17: 4413.     CrossRef
  • High serum mannose in colorectal cancer: a novel biomarker of lymph node metastasis and poor prognosis
    Xueling Wang, Haoran Li, Xiaotian Chang, Zibin Tian
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Development of a nomogram for predicting nosocomial infections among patients after cardiac valve replacement surgery
    Xue Yao, Na Li, Ranran Lu, Xujing Wang, Yujun Zhang, Shuhui Wang
    Journal of Clinical Nursing.2023; 32(7-8): 1466.     CrossRef
  • Machine learning-based warning model for chronic kidney disease in individuals over 40 years old in underprivileged areas, Shanxi Province
    Wenzhu Song, Yanfeng Liu, Lixia Qiu, Jianbo Qing, Aizhong Li, Yan Zhao, Yafeng Li, Rongshan Li, Xiaoshuang Zhou
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Artificial intelligence in colorectal surgery: an AI-powered systematic review
    A. Spinelli, F. M. Carrano, M. E. Laino, M. Andreozzi, G. Koleth, C. Hassan, A. Repici, M. Chand, V. Savevski, G. Pellino
    Techniques in Coloproctology.2023; 27(8): 615.     CrossRef
  • Prognostic significance of neutrophil count on in-hospital mortality in patients with acute type A aortic dissection
    Weiqi Feng, Huili Li, Qiuji Wang, Chenxi Li, Jinlin Wu, Jue Yang, Ruixin Fan
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • Machine learning algorithms assisted identification of post-stroke depression associated biological features
    Xintong Zhang, Xiangyu Wang, Shuwei Wang, Yingjie Zhang, Zeyu Wang, Qingyan Yang, Song Wang, Risheng Cao, Binbin Yu, Yu Zheng, Yini Dang
    Frontiers in Neuroscience.2023;[Epub]     CrossRef
  • Risk prediction of bronchopulmonary dysplasia in preterm infants by the nomogram model
    Yang Gao, Dongyun Liu, Yingmeng Guo, Menghan Cao
    Frontiers in Pediatrics.2023;[Epub]     CrossRef
  • LncRNA model predicts liver cancer drug resistance and validate in vitro experiments
    Qiushi Yin, Xiaolong Huang, Qiuxi Yang, Shibu Lin, Qifeng Song, Weiqiang Fan, Wang Li, Zhongyi Li, Lianghui Gao
    Frontiers in Cell and Developmental Biology.2023;[Epub]     CrossRef
  • Artificial intelligence–assisted treatment strategy for T1 colorectal cancer after endoscopic resection
    Katsuro Ichimasa, Shin-ei Kudo, Jonathan Wei Jie Lee, Tetsuo Nemoto, Khay Guan Yeoh
    Gastrointestinal Endoscopy.2023; 97(6): 1148.     CrossRef
  • A risk prediction model for type 2 diabetes mellitus complicated with retinopathy based on machine learning and its application in health management
    Hong Pan, Jijia Sun, Xin Luo, Heling Ai, Jing Zeng, Rong Shi, An Zhang
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • LASSO-based machine learning algorithm to predict the incidence of diabetes in different stages
    Qianying Ou, Wei Jin, Leweihua Lin, Danhong Lin, Kaining Chen, Huibiao Quan
    The Aging Male.2023;[Epub]     CrossRef
  • Prediction model based on radiomics and clinical features for preoperative lymphovascular invasion in gastric cancer patients
    Ping Wang, Kaige Chen, Ying Han, Min Zhao, Nanding Abiyasi, Haiyong Peng, Shaolei Yan, Jiming Shang, Naijian Shang, Wei Meng
    Future Oncology.2023; 19(23): 1613.     CrossRef
  • Liang-Ge-San: a classic traditional Chinese medicine formula, attenuates acute inflammation via targeting GSK3β
    Liling Yang, Lijun Yan, Weifu Tan, Xiangjun Zhou, Guangli Yang, Jingtao Yu, Zibin Lu, Yong Liu, Liyi Zou, Wei Li, Linzhong Yu
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Synergistic inhibition of NUDT21 by secretory S100A11 and exosomal miR‐487a‐5p promotes melanoma oligo‐ to poly‐metastatic progression
    Bin Zeng, Yuting Chen, Hao Chen, Qiting Zhao, Zhiwei Sun, Doudou Liu, Xiaoshuang Li, Yuhan Zhang, Jianyu Wang, H. Rosie Xing
    Molecular Oncology.2023; 17(12): 2743.     CrossRef
  • Identification of immune-related lncRNA in sepsis by construction of ceRNA network and integrating bioinformatic analysis
    Tianfeng Wang, Si Xu, Lei Zhang, Tianjun Yang, Xiaoqin Fan, Chunyan Zhu, Yinzhong Wang, Fei Tong, Qing Mei, Aijun Pan
    BMC Genomics.2023;[Epub]     CrossRef
  • Applying machine learning algorithms to develop a survival prediction model for lung adenocarcinoma based on genes related to fatty acid metabolism
    Dan Cong, Yanan Zhao, Wenlong Zhang, Jun Li, Yuansong Bai
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Identification of raffinose family oligosaccharides in processed Rehmannia glutinosa Libosch using matrix‐assisted laser desorption/ionization mass spectrometry image combined with machine learning
    Huizhi Li, Shishan Zhang, Yanfang Zhao, Jixiang He, Xiangfeng Chen
    Rapid Communications in Mass Spectrometry.2023;[Epub]     CrossRef
  • Development and validation of a LASSO-based prediction model for immunosuppressive medication nonadherence in kidney transplant recipients
    Lei Dong, Xiao Zhu, Hongyu Zhao, Qin Zhao, Shan Liu, Jia Liu, Lina Gong
    Renal Failure.2023;[Epub]     CrossRef
  • An artificial intelligence prediction model outperforms conventional guidelines in predicting lymph node metastasis of T1 colorectal cancer
    Zheng Hua Piao, Rong Ge, Lu Lu
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Silicon versus Superbug: Assessing Machine Learning’s Role in the Fight against Antimicrobial Resistance
    Tallon Coxe, Rajeev K. Azad
    Antibiotics.2023; 12(11): 1604.     CrossRef
  • Predictive model for early death risk in pediatric hemophagocytic lymphohistiocytosis patients based on machine learning
    Li Xiao, Yang Zhang, Ximing Xu, Ying Dou, Xianmin Guan, Yuxia Guo, Xianhao Wen, Yan Meng, Meiling Liao, Qinshi Hu, Jie Yu
    Heliyon.2023; 9(11): e22202.     CrossRef
  • Multimodal and multi-omics-based deep learning model for screening of optic neuropathy
    Ye-ting Lin, Qiong Zhou, Jian Tan, Yulin Tao
    Heliyon.2023; 9(12): e22244.     CrossRef
  • Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning
    Yanyan Liu, Zhenglang Yin, Yao Wang, Haohao Chen
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Current problems and perspectives of pathological risk factors for lymph node metastasis in T1 colorectal cancer: Systematic review
    Katsuro Ichimasa, Shin‐ei Kudo, Hideyuki Miyachi, Yuta Kouyama, Kenichi Mochizuki, Yuki Takashina, Yasuharu Maeda, Yuichi Mori, Toyoki Kudo, Yuki Miyata, Yoshika Akimoto, Yuki Kataoka, Takafumi Kubota, Tetsuo Nemoto, Fumio Ishida, Masashi Misawa
    Digestive Endoscopy.2022; 34(5): 901.     CrossRef
  • Tumor Location as a Prognostic Factor in T1 Colorectal Cancer
    Katsuro Ichimasa, Shin-ei Kudo, Yuta Kouyama, Kenichi Mochizuki, Yuki Takashina, Masashi Misawa, Yuichi Mori, Takemasa Hayashi, Kunihiko Wakamura, Hideyuki Miyachi
    Journal of the Anus, Rectum and Colon.2022; 6(1): 9.     CrossRef
  • The Importance of Being “That” Colorectal pT1: A Combined Clinico-Pathological Predictive Score to Improve Nodal Risk Stratification
    Alessandro Gambella, Enrico Costantino Falco, Giacomo Benazzo, Simona Osella-Abate, Rebecca Senetta, Isabella Castellano, Luca Bertero, Paola Cassoni
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • A Predictive Model for Qualitative Evaluation of PG-SGA in Tumor Patients Through Machine Learning
    Xiangliang Liu, Yuguang Li, Wei Ji, Kaiwen Zheng, Jin Lu, Yixin Zhao, Wenxin Zhang, Mingyang Liu, Jiuwei Cui, Wei Li
    Cancer Management and Research.2022; Volume 14: 1431.     CrossRef
  • Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis
    Liselotte W. Zwager, Barbara A.J. Bastiaansen, Nahid S.M. Montazeri, Roel Hompes, Valeria Barresi, Katsuro Ichimasa, Hiroshi Kawachi, Isidro Machado, Tadahiko Masaki, Weiqi Sheng, Shinji Tanaka, Kazutomo Togashi, Chihiro Yasue, Paul Fockens, Leon M.G. Moo
    Gastroenterology.2022; 163(1): 174.     CrossRef
  • LASSO ‐derived nomogram predicting new‐onset diabetes mellitus in patients with kidney disease receiving immunosuppressive drugs
    Lina Shao, Chuxuan Luo, Chaoyun Yuan, Xiaolan Ye, Yuqun Zeng, Yan Ren, Binxian Ye, Yiwen Li, Juan Jin, Qiang He, Xiaogang Shen
    Journal of Clinical Pharmacy and Therapeutics.2022; 47(10): 1627.     CrossRef
  • Using random forest algorithm for glomerular and tubular injury diagnosis
    Wenzhu Song, Xiaoshuang Zhou, Qi Duan, Qian Wang, Yaheng Li, Aizhong Li, Wenjing Zhou, Lin Sun, Lixia Qiu, Rongshan Li, Yafeng Li
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Identification of diagnostic signatures associated with immune infiltration in Alzheimer’s disease by integrating bioinformatic analysis and machine-learning strategies
    Yu Tian, Yaoheng Lu, Yuze Cao, Chun Dang, Na Wang, Kuo Tian, Qiqi Luo, Erliang Guo, Shanshun Luo, Lihua Wang, Qian Li
    Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
  • Development and validation of a predictive model combining clinical, radiomics, and deep transfer learning features for lymph node metastasis in early gastric cancer
    Qingwen Zeng, Hong Li, Yanyan Zhu, Zongfeng Feng, Xufeng Shu, Ahao Wu, Lianghua Luo, Yi Cao, Yi Tu, Jianbo Xiong, Fuqing Zhou, Zhengrong Li
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Identification of Drug-Induced Liver Injury Biomarkers from Multiple Microarrays Based on Machine Learning and Bioinformatics Analysis
    Kaiyue Wang, Lin Zhang, Lixia Li, Yi Wang, Xinqin Zhong, Chunyu Hou, Yuqi Zhang, Congying Sun, Qian Zhou, Xiaoying Wang
    International Journal of Molecular Sciences.2022; 23(19): 11945.     CrossRef
  • Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma
    Xiaowei Feng, Tao Hong, Wencai Liu, Chan Xu, Wanying Li, Bing Yang, Yang Song, Ting Li, Wenle Li, Hui Zhou, Chengliang Yin
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Preoperative prediction of lymph node status in patients with colorectal cancer. Developing a predictive model using machine learning
    Morten Hartwig, Karoline Bendix Bräuner, Rasmus Vogelsang, Ismail Gögenur
    International Journal of Colorectal Disease.2022; 37(12): 2517.     CrossRef
  • A retrospective analysis based on multiple machine learning models to predict lymph node metastasis in early gastric cancer
    Tao Yang, Javier Martinez-Useros, JingWen Liu, Isaias Alarcón, Chao Li, WeiYao Li, Yuanxun Xiao, Xiang Ji, YanDong Zhao, Lei Wang, Salvador Morales-Conde, Zuli Yang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Challenges and opportunities in the application of artificial intelligence in gastroenterology and hepatology
    Chrysanthos D Christou, Georgios Tsoulfas
    World Journal of Gastroenterology.2021; 27(37): 6191.     CrossRef
  • 13,461 View
  • 372 Download
  • 120 Web of Science
  • 114 Crossref
Close layer
Breast cancer
Challenge for Diagnostic Assessment of Deep Learning Algorithm for Metastases Classification in Sentinel Lymph Nodes on Frozen Tissue Section Digital Slides in Women with Breast Cancer
Young-Gon Kim, In Hye Song, Hyunna Lee, Sungchul Kim, Dong Hyun Yang, Namkug Kim, Dongho Shin, Yeonsoo Yoo, Kyowoon Lee, Dahye Kim, Hwejin Jung, Hyunbin Cho, Hyungyu Lee, Taeu Kim, Jong Hyun Choi, Changwon Seo, Seong il Han, Young Je Lee, Young Seo Lee, Hyung-Ryun Yoo, Yongju Lee, Jeong Hwan Park, Sohee Oh, Gyungyub Gong
Cancer Res Treat. 2020;52(4):1103-1111.   Published online June 30, 2020
DOI: https://doi.org/10.4143/crt.2020.337
AbstractAbstract PDFPubReaderePub
Purpose
Assessing the status of metastasis in sentinel lymph nodes (SLNs) by pathologists is an essential task for the accurate staging of breast cancer. However, histopathological evaluation of sentinel lymph nodes by a pathologist is not easy and is a tedious and time-consuming task. The purpose of this study is to review a challenge competition (HeLP 2018) to develop automated solutions for the classification of metastases in hematoxylin and eosin–stained frozen tissue sections of SLNs in breast cancer patients.
Materials and Methods
A total of 297 digital slides were obtained from frozen SLN sections, which include post–neoadjuvant cases (n = 144, 48.5%) in Asan Medical Center, South Korea. The slides were divided into training, development, and validation sets. All of the imaging datasets have been manually segmented by expert pathologists. A total of 10 participants were allowed to use the Kakao challenge platform for six weeks with two P40 GPUs. The algorithms were assessed in terms of the AUC (area under receiver operating characteristic curve).
Results
The top three teams showed 0.986, 0.985, and 0.945 AUCs for the development set and 0.805, 0.776, and 0.765 AUCs for the validation set. Micrometastatic tumors, neoadjuvant systemic therapy, invasive lobular carcinoma, and histologic grade 3 were associated with lower diagnostic accuracy.
Conclusion
In a challenge competition, accurate deep learning algorithms have been developed, which can be helpful in making frozen diagnosis of intraoperative sentinel lymph node biopsy. Whether this approach has clinical utility will require evaluation in a clinical setting

Citations

Citations to this article as recorded by  
  • Detection of metastatic breast carcinoma in sentinel lymph node frozen sections using an artificial intelligence-assisted system
    Chia-Ping Chang, Chih-Yi Hsu, Hsiang Sheng Wang, Peng-Chuna Feng, Wen-Yih Liang
    Pathology - Research and Practice.2025; 267: 155836.     CrossRef
  • Diagnostic Assessment of Deep Learning Algorithms for Frozen Tissue Section Analysis in Women with Breast Cancer
    Young-Gon Kim, In Hye Song, Seung Yeon Cho, Sungchul Kim, Milim Kim, Soomin Ahn, Hyunna Lee, Dong Hyun Yang, Namkug Kim, Sungwan Kim, Taewoo Kim, Daeyoung Kim, Jonghyeon Choi, Ki-Sun Lee, Minuk Ma, Minki Jo, So Yeon Park, Gyungyub Gong
    Cancer Research and Treatment.2023; 55(2): 513.     CrossRef
  • Artificial intelligence and frozen section histopathology: A systematic review
    Benjamin G. Gorman, Mark A. Lifson, Nahid Y. Vidal
    Journal of Cutaneous Pathology.2023; 50(9): 852.     CrossRef
  • Effectiveness of transfer learning for enhancing tumor classification with a convolutional neural network on frozen sections
    Young-Gon Kim, Sungchul Kim, Cristina Eunbee Cho, In Hye Song, Hee Jin Lee, Soomin Ahn, So Yeon Park, Gyungyub Gong, Namkug Kim
    Scientific Reports.2020;[Epub]     CrossRef
  • 8,525 View
  • 207 Download
  • 14 Web of Science
  • 4 Crossref
Close layer
Head/neck cancer
Nomogram for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Retrospective Cohort Study of Two Clinical Centers
Zheyu Yang, Yu Heng, Jianwei Lin, Chenghao Lu, Dingye Yu, Lei Tao, Wei Cai
Cancer Res Treat. 2020;52(4):1010-1018.   Published online June 9, 2020
DOI: https://doi.org/10.4143/crt.2020.254
AbstractAbstract PDFPubReaderePub
Purpose
Central lymph node metastasis (CNM) are highly prevalent but hard to detect preoperatively in papillary thyroid carcinoma (PTC) patients, while the significance of prophylactic compartment central lymph node dissection (CLND) remains controversial as a treatment option. We aim to establish a nomogram assessing risks of CNM in PTC patients, and explore whether prophylactic CLND should be recommended.
Materials and Methods
One thousand four hundred thirty-eight patients from two clinical centers that underwent thyroidectomy with CLND for PTC within the period 2016–2019 were retrospectively analyzed. Univariate and multivariate analysis were performed to examine risk factors associated with CNM. A nomogram for predicting CNM was established, thereafter internally and externally validated.
Results
Seven variables were found to be significantly associated with CNM and were used to construct the model. These were as follows: thyroid capsular invasion, multifocality, creatinine > 70 μmol/L, age < 40, tumor size > 1 cm, body mass index < 22, and carcinoembryonic antigen > 1 ng/mL. The nomogram had good discrimination with a concordance index of 0.854 (95% confidence interval [CI], 0.843 to 0.867), supported by an external validation point estimate of 0.825 (95% CI, 0.793 to 0.857). A decision curve analysis was made to evaluate nomogram and ultrasonography for predicting CNM.
Conclusion
A validated nomogram utilizing readily available preoperative variables was developed to predict the probability of central lymph node metastases in patients presenting with PTC. This nomogram may help surgeons make appropriate surgical decisions in the management of PTC, especially in terms of whether prophylactic CLND is warranted.

Citations

Citations to this article as recorded by  
  • Risk nomogram for papillary thyroid microcarcinoma with central lymph node metastasis and postoperative thyroid function follow-up
    Yuting Huang, Pengwei Lou, Hui Li, Yinhui Li, Li Ma, Kai Wang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Ultrasonic Feature Prediction of Large-Number Central Lymph Node Metastasis in Clinically Node-Negative Solitary Papillary Thyroid Carcinoma
    Weihan Xiao, Xiaomin Hu, Chaoxue Zhang, Xiachuan Qin
    Endocrine Research.2023; 48(4): 112.     CrossRef
  • Nomogram for predicting central lymph node metastasis in T1-T2 papillary thyroid cancer with no lateral lymph node metastasis
    Yubo Sun, Wei Sun, Jingzhe Xiang, Hao Zhang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • An integrated nomogram combining deep learning, clinical characteristics and ultrasound features for predicting central lymph node metastasis in papillary thyroid cancer: A multicenter study
    Luchen Chang, Yanqiu Zhang, Jialin Zhu, Linfei Hu, Xiaoqing Wang, Haozhi Zhang, Qing Gu, Xiaoyu Chen, Sheng Zhang, Ming Gao, Xi Wei
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Central and lateral neck involvement in papillary thyroid carcinoma patients with or without thyroid capsular invasion: A multi-center analysis
    Zheyu Yang, Yu Heng, Jian Zhou, Lei Tao, Wei Cai
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Development and validation of nomograms for predicting the risk of central lymph node metastasis of solitary papillary thyroid carcinoma of the isthmus
    Yonghao Li, Xuefei Gao, Tiantian Guo, Jing Liu
    Journal of Cancer Research and Clinical Oncology.2023; 149(16): 14853.     CrossRef
  • Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma
    X. Wei, Y. Min, Y. Feng, D. He, X. Zeng, Y. Huang, S. Fan, H. Chen, J. Chen, K. Xiang, H. Luo, G. Yin, D. Hu
    Journal of Endocrinological Investigation.2022; 45(3): 507.     CrossRef
  • Preoperative Prediction of Central Cervical Lymph Node Metastasis in Fine-Needle Aspiration Reporting Suspicious Papillary Thyroid Cancer or Papillary Thyroid Cancer Without Lateral Neck Metastasis
    Kai Zhang, Lang Qian, Jieying Chen, Qian Zhu, Cai Chang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma
    Jing Zhou, Da-Xue Li, Han Gao, Xin-Liang Su
    World Journal of Clinical Cases.2022; 10(12): 3709.     CrossRef
  • Hashimoto’s Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience
    Bin Zeng, Yu Min, Yang Feng, Ke Xiang, Hang Chen, Zijing Lin
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis
    Qungang Chang, Jieming Zhang, Yaqian Wang, Hongqiang Li, Xin Du, Daohong Zuo, Detao Yin
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Ultrasound-based radiomics nomogram combined with clinical features for the prediction of central lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto’s thyroiditis
    Peile Jin, Jifan Chen, Yiping Dong, Chengyue Zhang, Yajun Chen, Cong Zhang, Fuqiang Qiu, Chao Zhang, Pintong Huang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Lateral Involvement in Different Sized Papillary Thyroid Carcinomas Patients with Central Lymph Node Metastasis: A Multi-Center Analysis
    Yu Heng, Zheyu Yang, Pengyu Cao, Xi Cheng, Lei Tao
    Journal of Clinical Medicine.2022; 11(17): 4975.     CrossRef
  • Risk factors and prediction models of lymph node metastasis in papillary thyroid carcinoma based on clinical and imaging characteristics
    Yanyuan Deng, Jie Zhang, Jiao Wang, Jinying Wang, Junping Zhang, Lulu Guan, Shasha He, Xiudan Han, Wei Cai, Jixiong Xu
    Postgraduate Medicine.2022;[Epub]     CrossRef
  • A prognostic nomogram for papillary thyroid cancer lymph node metastasis based on immune score
    Yihua Lu, Kai Qian, Mengjia Fei, Kai Guo, Yuan Shi, Zhuoying Wang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Risk factors for central and lateral lymph node metastasis in papillary thyroid carcinoma
    Ji Hyun Ahn, Hee Kyung Chang
    Kosin Medical Journal.2022; 37(4): 311.     CrossRef
  • Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma
    Y. Feng, Y. Min, H. Chen, K. Xiang, X. Wang, G. Yin
    Journal of Endocrinological Investigation.2021; 44(10): 2203.     CrossRef
  • Application of Machine Learning Algorithms to Predict Central Lymph Node Metastasis in T1-T2, Non-invasive, and Clinically Node Negative Papillary Thyroid Carcinoma
    Jiang Zhu, Jinxin Zheng, Longfei Li, Rui Huang, Haoyu Ren, Denghui Wang, Zhijun Dai, Xinliang Su
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Preoperative Predictors of Lymph Node Metastasis in Colon Cancer
    Yansong Xu, Yi Chen, Chenyan Long, Huage Zhong, Fangfang Liang, Ling-xu Huang, Chuanyi Wei, Shaolong Lu, Weizhong Tang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto’s Thyroiditis
    Yu Min, Yizhou Huang, Minjie Wei, Xiaoyuan Wei, Hang Chen, Xing Wang, Jialin Chen, Ke Xiang, Yang Feng, Guobing Yin
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Reevaluation of Criteria and Establishment of Models for Total Thyroidectomy in Differentiated Thyroid Cancer
    Zhenghao Wu, Yunxiao Xiao, Jie Ming, Yiquan Xiong, Shuntao Wang, Shengnan Ruan, Tao Huang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Influencing Factors and Cumulative Risk Analysis of Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma
    Yirong Yin, Xiang Xu, Liyan Shen, Wenjuan Zhao, Hongcui Diao, Chengqian Li
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer
    Zheyu Yang, Yu Heng, Qiwu Zhao, Zichao Cao, Lei Tao, Weihua Qiu, Wei Cai
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study
    Jingjing Li, Xinxin Wu, Ning Mao, Guibin Zheng, Haicheng Zhang, Yakui Mou, Chuanliang Jia, Jia Mi, Xicheng Song
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Nomogram Including Elastography for Prediction of Contralateral Central Lymph Node Metastasis in Solitary Papillary Thyroid Carcinoma Preoperatively


    Ning Li, Ju-hua He, Chao Song, Li-chun Yang, Hong-jiang Zhang, Zhi-hai Li
    Cancer Management and Research.2020; Volume 12: 10789.     CrossRef
  • 10,108 View
  • 244 Download
  • 45 Web of Science
  • 25 Crossref
Close layer
Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases
Chao Lin, Xue-Song Sun, Sai-Lan Liu, Xiao-Yun Li, Nian Lu, Xin-Ling Li, Lin-Quan Tang, Ling Guo
Cancer Res Treat. 2020;52(3):855-866.   Published online March 10, 2020
DOI: https://doi.org/10.4143/crt.2019.772
AbstractAbstract PDFPubReaderePub
Purpose
The prognosis of nasopharyngeal carcinoma (NPC) patients with parotid lymph node (PLN) metastasis remains unclear. This study was performed to investigate the prognostic significance and optimal staging category of PLN metastasis and develop a nomogram for estimating individual risk.
Materials and Methods
Clinical data of 7,084 non-metastatic NPC patients were retrospectively reviewed. Overall survival (OS) was the primary endpoint. A nomogram was established based on the Cox proportional hazards regression model. The accuracy and calibration ability of this nomogram was evaluated by C-index and calibration curves with bootstrap validation.
Result
Totally, 164/7,084 NPC patients (2.3%) presented with PLNs. Multivariate analyses showed that PLN metastasis was a negative prognostic factor for OS, progression-free survival (PFS), distant metastasis-free survival (DMFS), and locoregional relapse-free survival (LRFS). Patients with PLN metastasis had a worse prognosis than N3 disease. Five independent prognostic factors were included in the nomogram, which showed a C-index of 0.743. The calibration curves for probability of 3- and 5-year OS indicated satisfactory agreement between nomogram-based prediction and actual observation. All results were confirmed in the validation cohort.
Conclusion
NPC patient with PLN metastasis had poorer survival outcome (OS, PFS, DMFS, and LRFS) than N3 disease. We developed a nomogram to provide individual prediction of OS for patients with PLN metastasis.

Citations

Citations to this article as recorded by  
  • Risk factors analysis and nomogram for predicting recurrence in periocular basal cell carcinoma
    Xincen Hou, Alexander C. Rokohl, Katharina Berndt, Senmao Li, Xiaojun Ju, Philomena A. Wawer Matos, Wanlin Fan, Ludwig M. Heindl
    Canadian Journal of Ophthalmology.2025;[Epub]     CrossRef
  • Advances in Nasopharyngeal Carcinoma Staging: from the 7th to the 9th Edition of the TNM System and Future Outlook
    Binhao Wu, Xiaozhong Chen, Caineng Cao
    Current Oncology Reports.2025; 27(3): 322.     CrossRef
  • Analysis of patients with parotid recurrence after parotid-sparing IMRT for nasopharyngeal carcinoma: case series and review of the literature
    Sezin Yuce Sari, Melek Tugce Yilmaz, Gozde Yazici, Sepideh Mohammadipour, Gokhan Ozyigit, Ibrahim Gullu, Mustafa Cengiz
    Strahlentherapie und Onkologie.2024; 200(12): 1057.     CrossRef
  • Nomogram Based on Liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving PD-1 Inhibitor Therapy
    Lixia Liang, Yan Li, Yansui Hong, Tianxing Ji, Hao Chen, Zhifang Lin
    Current Oncology.2023; 30(8): 7189.     CrossRef
  • A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma
    Wen Liu, Huilan Li, Hui Sheng, Xiaohua Liu, Peidong Chi, Xueping Wang, Minjie Mao
    Advances in Therapy.2020; 37(10): 4280.     CrossRef
  • Prognosis prediction signature of seven immune genes based on HPV status in cervical cancer
    Qianqian Xia, Hua Jin, Xing Zhang, Wenjing Yan, Dan Meng, Bo Ding, Jian Cao, Dake Li, Shizhi Wang
    International Immunopharmacology.2020; 88: 106935.     CrossRef
  • 15,221 View
  • 127 Download
  • 4 Web of Science
  • 6 Crossref
Close layer
Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status
Soo Young Jeong, Hyea Park, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae Joong Kim, Jeong Won Lee, Byoung-Gie Kim, Duk Soo Bae, Chel Hun Choi
Cancer Res Treat. 2020;52(2):516-523.   Published online October 29, 2019
DOI: https://doi.org/10.4143/crt.2019.328
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Lymph node metastasis (LNM) is the most significant prognostic factor in cervical cancer that was recently incorporated into the International Federation of Gynecology and Obstetrics (FIGO) staging system. This study was performed to evaluate whether the prognostic significance of LNM differs according to disease status.
Materials and Methods
Patients with FIGO stage IB or higher cervical cancer who had pretreatment computed tomography and/or magnetic resonance imaging studies as well as long-term follow-up were enrolled in this retrospective study. The hazard ratio (HR) of Cox regression was used to determine the prognostic significance of LNM. The HRs were compared between the different tumor groups (based on stage, histology, tumor size, primary treatment, age, parametrium involvement, and lymphovascular space invasion).
Results
A total of 970 patients treated between January 1999 and December 2007 were included. The pretreatment LNM had prognostic significance in patients with stage IB1/IIA (HR for progression-free survival 2.10, p=0.001; HR for overall survival 1.99, p=0.005). However, the significance gradually decreased or disappeared with advancing stages. Similarly, the prognostic significance of the pretreatment LNM decreased with advancing disease status, including old age, parametrial involvement or lymphovascular space involvement. In contrast, the tumor size was associated with the prognostic significance of LNM with advancing status. The significance of the clinical LNM did not reflect the significance of the clinical stage. In contrast, the tumor size, parametrial involvement, and significance of the pathologic LNM reflected the clinical stage.
Conclusion
In patients with cervical cancer, pretreatment LNM on imaging has different clinical significance depending on the tumor status.

Citations

Citations to this article as recorded by  
  • Development of cervical intraepithelial neoplasia and invasive cervical cancer due to oxidative stress
    Amir Asotić, Memić Asotić, Muhamed Memić, Kerim Asotić, Amra Asotić
    Sanamed.2024; 19(1): 39.     CrossRef
  • Investigating and Analyzing Prognostic Factors and Their Impact on Recurrent Cervical Cancers
    Ashish Uke, Shweta B Dahake, Anurag Luharia, Monika Luharia, Gaurav V Mishra, Chanrashekhar Mahakalkar
    Cureus.2024;[Epub]     CrossRef
  • Based on 3D-PDU and clinical characteristics nomogram for prediction of lymph node metastasis and lymph-vascular space invasion of early cervical cancer preoperatively
    Shuang Dong, Yan-Qing Peng, Ya-Nan Feng, Xiao-Ying Li, Li-Ping Gong, Shuang Zhang, Xiao-Shan Du, Li-Tao Sun
    BMC Women's Health.2024;[Epub]     CrossRef
  • Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors
    Angela Santoro, Frediano Inzani, Giuseppe Angelico, Damiano Arciuolo, Emma Bragantini, Antonio Travaglino, Michele Valente, Nicoletta D’Alessandris, Giulia Scaglione, Stefania Sfregola, Alessia Piermattei, Federica Cianfrini, Paola Roberti, Gian Franco Za
    Cancers.2023; 15(4): 1137.     CrossRef
  • Identification of lymph node metastasis in pre‐operation cervical cancer patients by weakly supervised deep learning from histopathological whole‐slide biopsy images
    Qingqing Liu, Nan Jiang, Yiping Hao, Chunyan Hao, Wei Wang, Tingting Bian, Xiaohong Wang, Hua Li, Yan zhang, Yanjun Kang, Fengxiang Xie, Yawen Li, XuJi Jiang, Yuan Feng, Zhonghao Mao, Qi Wang, Qun Gao, Wenjing Zhang, Baoxia Cui, Taotao Dong
    Cancer Medicine.2023; 12(17): 17952.     CrossRef
  • Roles of DWI and T2-weighted MRI volumetry in the evaluation of lymph node metastasis and lymphovascular invasion of stage IB–IIA cervical cancer
    Y. Wang, X. Chen, H. Pu, Y. Yuan, S. Li, G. Chen, Y. Liu, H. Li
    Clinical Radiology.2022; 77(3): 224.     CrossRef
  • Risk Factor Assessment of Lymph Node Metastasis in Patients With FIGO Stage IB1 Cervical Cancer
    Mu Xu, Xiaoyan Xie, Liangzhi Cai, Yongjin Xie, Qiao Gao, Pengming Sun
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Intravoxel Incoherent Motion (IVIM) MR Quantification in Locally Advanced Cervical Cancer (LACC): Preliminary Study on Assessment of Tumor Aggressiveness and Response to Neoadjuvant Chemotherapy
    Miriam Dolciami, Silvia Capuani, Veronica Celli, Alessandra Maiuro, Angelina Pernazza, Innocenza Palaia, Violante Di Donato, Giusi Santangelo, Stefania Maria Rita Rizzo, Paolo Ricci, Carlo Della Rocca, Carlo Catalano, Lucia Manganaro
    Journal of Personalized Medicine.2022; 12(4): 638.     CrossRef
  • The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric
    Yuan-Kai Cheng, Shih-Hsun Kuo, Heng-Hsuan Yen, Jing-Hu Wu, Yu-Chieh Chen, Ming-Yii Huang
    Radiation Oncology.2022;[Epub]     CrossRef
  • What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?
    Njål Lura, Kari S. Wagner-Larsen, David Forsse, Jone Trovik, Mari K. Halle, Bjørn I. Bertelsen, Øyvind Salvesen, Kathrine Woie, Camilla Krakstad, Ingfrid S. Haldorsen
    Insights into Imaging.2022;[Epub]     CrossRef
  • Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer
    Chao Ran, Jian Sun, Yunhui Qu, Na Long
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer
    Jun Wang, Hua Zheng, Yatian Han, Geng Wang, Yanbin Li, Cuida Meng
    International Journal of Genomics.2020; 2020: 1.     CrossRef
  • 10,425 View
  • 223 Download
  • 14 Web of Science
  • 12 Crossref
Close layer
Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14)
Kyubo Kim, Yuri Jeong, Kyung Hwan Shin, Jin Ho Kim, Seung Do Ahn, Su Ssan Kim, Chang-Ok Suh, Yong Bae Kim, Doo Ho Choi, Won Park, Jihye Cha, Mison Chun, Dong Soo Lee, Sun Young Lee, Jin Hee Kim, Hae Jin Park, Wonguen Jung
Cancer Res Treat. 2019;51(4):1500-1508.   Published online March 15, 2019
DOI: https://doi.org/10.4143/crt.2018.575
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The purpose of this study was to evaluate the treatment outcomes of radiotherapy (RT) for breast cancer with ipsilateral supraclavicular (SCL) and/or internal mammary (IMN) lymph node involvement.
Materials and Methods
A total of 353 patients from 11 institutions were included. One hundred and thirty-six patients had SCL involvement, 148 had IMN involvement, and 69 had both. All patients received neoadjuvant systemic therapy followed by breast-conserving surgery or mastectomy, and postoperative RT to whole breast/chest wall. As for regional lymph node irradiation, SCL RT was given to 344 patients, and IMN RT to 236 patients. The median RT dose was 50.4 Gy.
Results
The median follow-up duration was 61 months (range, 7 to 173 months). In-field progression was present in SCL (n=20) and/or IMN (n=7). The 5-year disease-free survival (DFS) and overall survival rates were 57.8% and 75.1%, respectively. On multivariate analysis, both SCL/IMN involvement, number of axillary lymph node ≥ 4, triple-negative subtype, and mastectomy were significant adverse prognosticators for DFS (p=0.022, p=0.001, p=0.001, and p=0.004, respectively). Regarding the impact of regional nodal irradiation, SCL RT dose ≥ 54 Gy was not associated with DFS (5-year rate, 52.9% vs. 50.9%; p=0.696) in SCL-involved patients, and the receipt of IMN RT was not associated with DFS (5-year rate, 56.1% vs. 78.1%; p=0.099) in IMN-involved patients.
Conclusion
Neoadjuvant chemotherapy followed by surgery and postoperative RT achieved an acceptable in-field regional control rate in patients with SCL and/or IMN involvement. However, a higher RT dose to SCL or IMN RT was not associated with the improved DFS in these patients.

Citations

Citations to this article as recorded by  
  • Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation field
    Xiaofang Wang, Xiaomeng Zhang, Li Zhang, Jin Meng, Wei Shi, Xingxing Chen, Zhaozhi Yang, Xin Mei, Xiaoli Yu, Zhen Zhang, Zhimin Shao, Xiaomao Guo, Jinli Ma
    Breast Cancer.2025; 32(1): 144.     CrossRef
  • Outcomes and Trends in Axillary Management of Stage cN3b Breast Cancer Patients
    Julia M. Selfridge, Zachary Schrank, Chris B. Agala, David W. Ollila, Kristalyn K. Gallagher, Dana L. Casey, Philip M. Spanheimer
    Annals of Surgical Oncology.2025; 32(3): 2070.     CrossRef
  • Internal mammary regional management after neoadjuvant therapy in breast cancer
    Zhao Bi, Chun-Hui Zheng, Tong-Yue Ren, Yong-Sheng Wang
    International Journal of Surgery.2024;[Epub]     CrossRef
  • Oncological outcomes in patients with residual triple-negative breast cancer after preoperative chemotherapy
    Hyunki Park, Haeyoung Kim, Won Park, Won Kyung Cho, Nalee Kim, Tae Gyu Kim, Young-Hyuck Im, Jin Seok Ahn, Yeon Hee Park, Ji-Yeon Kim, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Byung Joo Chae, Sei Kyung Lee, Jai-Min Ryu
    Radiation Oncology Journal.2024; 42(3): 210.     CrossRef
  • Clinical audit of breast cancer patients treated with helical tomotherapy for irradiation of the internal mammary chain
    Garima Shrivastav, Debanjali Datta, Tabassum Wadasadawala, Pallavi Rane, Subhajit Panda, Rima Pathak, Libin Scaria, Revathy Krishnamurthy, Rajiv Sarin
    Journal of Radiotherapy in Practice.2023;[Epub]     CrossRef
  • The optimal regional irradiation volume for breast cancer patients: A comprehensive systematic review and network meta-analysis of published studies
    Wei-Xiang Qi, Lu Cao, Cheng Xu, Gang Cai, Jiayi Chen
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Contemporary Outcomes After Multimodality Therapy in Patients With Breast Cancer Presenting With Ipsilateral Supraclavicular Node Involvement
    Kevin Diao, Lauren M. Andring, Carlos H. Barcenas, Puneet Singh, Huong (Carisa) Le-Petross, Valerie K. Reed, Jay P. Reddy, Elizabeth S. Bloom, Neelofur R. Ahmad, Lauren L. Mayo, George H. Perkins, Melissa P. Mitchell, Kevin T. Nead, Welela Tereffe, Benjam
    International Journal of Radiation Oncology*Biology*Physics.2022; 112(1): 66.     CrossRef
  • Locoregional Management and Prognostic Factors in Breast Cancer With Ipsilateral Internal Mammary and Axillary Lymph Node Involvement
    Lauren M. Andring, Kevin Diao, Susie Sun, Miral Patel, Gary J. Whitman, Pamela Schlembach, Isadora Arzu, Melissa M. Joyner, Simona F. Shaitelman, Karen Hoffman, Michael C. Stauder, Benjamin D. Smith, Wendy A. Woodward
    International Journal of Radiation Oncology*Biology*Physics.2022; 113(3): 552.     CrossRef
  • Yesterday, Today and Tomorrow – Are We Any Closer to Knowing Which Patients Will Benefit from Adjuvant Internal Mammary Nodal Irradiation?
    C.A. Johnson, J. Evans
    Clinical Oncology.2022; 34(8): 534.     CrossRef
  • Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study
    Haeyoung Kim, Yeon Jeong Kim, Donghyun Park, Woong-Yang Park, Doo Ho Choi, Won Park, Won kyung Cho, Nalee Kim
    Breast Cancer Research and Treatment.2021; 189(1): 167.     CrossRef
  • Cervical Lymph Node Involvement above the Supraclavicular Fossa in Breast Cancer: Comparison with Stage IIIC (KROG 18-02)
    Jae Sik Kim, Kyubo Kim, Kyung Hwan Shin, Jin Ho Kim, Seung Do Ahn, Su Ssan Kim, Yong Bae Kim, Jee Suk Chang, Doo Ho Choi, Won Park, Tae Hyun Kim, Mison Chun, Jihye Cha, Jin Hee Kim, Dong Soo Lee, Sun Young Lee, Hae Jin Park
    Journal of Breast Cancer.2020; 23(2): 194.     CrossRef
  • Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14)
    Kyubo Kim, Su Ssan Kim, Kyung Hwan Shin, Jin Ho Kim, Seung Do Ahn, Doo Ho Choi, Won Park, Sun Young Lee, Mison Chun, Jin Hee Kim, Yong Bae Kim, Jihye Cha, Hae Jin Park, Dong Soo Lee, Wonguen Jung
    Clinical Breast Cancer.2020; 20(1): 51.     CrossRef
  • Combined Therapy Can Improve the Outcomes of Breast Cancer with Isolated Supraclavicular Lymph Node Involvement


    Tianyi Ma, Yan Mao, Haibo Wang
    Cancer Management and Research.2020; Volume 12: 11857.     CrossRef
  • 8,728 View
  • 331 Download
  • 16 Web of Science
  • 13 Crossref
Close layer
Nomogram Development and External Validation for Predicting the Risk of Lymph Node Metastasis in T1 Colorectal Cancer
Jung Ryul Oh, Boram Park, Seongdae Lee, Kyung Su Han, Eui-Gon Youk, Doo-Han Lee, Do-Sun Kim, Doo-Seok Lee, Chang Won Hong, Byung Chang Kim, Bun Kim, Min Jung Kim, Sung Chan Park, Dae Kyung Sohn, Hee Jin Chang, Jae Hwan Oh
Cancer Res Treat. 2019;51(4):1275-1284.   Published online January 17, 2019
DOI: https://doi.org/10.4143/crt.2018.569
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Predicting lymph node metastasis (LNM) risk is crucial in determining further treatment strategies following endoscopic resection of T1 colorectal cancer (CRC). This study aimed to establish a new prediction model for the risk of LNM in T1 CRC patients.
Materials and Methods
The development set included 833 patients with T1 CRC who had undergone endoscopic (n=154) or surgical (n=679) resection at the National Cancer Center. The validation set included 722 T1 CRC patients who had undergone endoscopic (n=249) or surgical (n=473) resection at Daehang Hospital. A logistic regression model was used to construct the prediction model. To assess the performance of prediction model, discrimination was evaluated using the receiver operating characteristic (ROC) curves with area under the ROC curve (AUC), and calibration was assessed using the Hosmer-Lemeshow (HL) goodness-of-fit test.
Results
Five independent risk factors were determined in the multivariable model, including vascular invasion, high-grade histology, submucosal invasion, budding, and background adenoma. In final prediction model, the performance of the model was good that the AUC was 0.812 (95% confidence interval [CI], 0.770 to 0.855) and the HL chi-squared test statistic was 1.266 (p=0.737). In external validation, the performance was still good that the AUC was 0.771 (95% CI, 0.708 to 0.834) and the p-value of the HL chi-squared test was 0.040. We constructed the nomogram with the final prediction model.
Conclusion
We presented an externally validated new prediction model for LNM risk in T1 CRC patients, guiding decision making in determining whether additional surgery is required after endoscopic resection of T1 CRC.

Citations

Citations to this article as recorded by  
  • Risk stratification scores for lymph node metastases in T1 colorectal cancer—A systematic review
    Rakesh Quinn, Giuleta Jamsari, Ewan MacDermid
    Colorectal Disease.2025;[Epub]     CrossRef
  • The critical role of tumor size in predicting lymph node metastasis in early-stage colorectal cancer
    Attila Ulkucu, Metincan Erkaya, Ekin Inal, Emre Gorgun
    The American Journal of Surgery.2025; 241: 116152.     CrossRef
  • Pitfalls during histological assessment in locally resected pT1 colorectal cancer
    Emma J Norton, Adrian C Bateman
    Histopathology.2025;[Epub]     CrossRef
  • Artificial intelligence-based model to predict recurrence after local excision in T1 rectal cancer
    Jiarui Su, Zhiyuan Liu, Haiming Li, Li Kang, Kaihong Huang, Jiawei Wu, Han Huang, Fei Ling, Xueqing Yao, Chengzhi Huang
    European Journal of Surgical Oncology.2025; 51(6): 109717.     CrossRef
  • Prediction of lymph node metastasis in stage I–III colon cancer patients younger than 40 years
    Wei-Hao Zhang, Meng-Di Huang, Yan-Ling Tu, Kun-Zhai Huang, Chao-Jun Wang, Zhao-Hui Liu, Rui-Sheng Ke
    Clinical and Translational Oncology.2025;[Epub]     CrossRef
  • Risk assessment in pT1 colorectal cancer
    Emma Jane Norton, Adrian C Bateman
    Journal of Clinical Pathology.2024; 77(4): 225.     CrossRef
  • Curative criteria for endoscopic treatment of colorectal cancer
    Lucille Quénéhervé, Mathieu Pioche, Jérémie Jacques
    Best Practice & Research Clinical Gastroenterology.2024; 68: 101883.     CrossRef
  • Commentary: An artificial intelligence prediction model outperforms conventional guidelines in predicting lymph node metastasis of T1 colorectal cancer
    Katsuro Ichimasa, Shin-ei Kudo, Khay Guan Yeoh
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Management after non-curative endoscopic resection of T1 rectal cancer
    Hao Dang, Daan A. Verhoeven, Jurjen J. Boonstra, Monique E. van Leerdam
    Best Practice & Research Clinical Gastroenterology.2024; 68: 101895.     CrossRef
  • A clinical-radiomics nomogram based on spectral CT multi-parameter images for preoperative prediction of lymph node metastasis in colorectal cancer
    Qian Li, Rui Hong, Ping Zhang, Liting Hou, Hailun Bao, Lin Bai, Jian Zhao
    Clinical & Experimental Metastasis.2024; 41(5): 639.     CrossRef
  • A new clinical model for predicting lymph node metastasis in T1 colorectal cancer
    Kai Wang, Hui He, Yanyun Lin, Yanhong Zhang, Junguo Chen, Jiancong Hu, Xiaosheng He
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Predictors of early colorectal cancer metastasis to lymph nodes: providing rationale for therapy decisions
    Xu Song, Jun Li, Jiang Zhu, Yun-Fei Kong, Yu-Hang Zhou, Zi-Kun Wang, Jin Zhang
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Approaches and considerations in the endoscopic treatment of T1 colorectal cancer
    Yunho Jung
    The Korean Journal of Internal Medicine.2024; 39(4): 563.     CrossRef
  • A Nomogram for Predicting Unplanned Intraoperative Hypothermia in Patients With Colorectal Cancer Undergoing Laparoscopic Colorectal Procedures
    Lupei Yan, Jingxing Tan, Hao Chen, Han Xiao, Yi Zhang, Qin Yao, Yuerong Li
    AORN Journal.2023;[Epub]     CrossRef
  • A proposal for grading the risk of lymph node metastasis after endoscopic resection of T1 colorectal cancer
    Zhenghua Piao, Rong Ge, Chunnian Wang
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Nomogram as a novel predictive tool for lymph node metastasis in T1 colorectal cancer treated with endoscopic resection: a nationwide, multicenter study
    Yoshiki Kajiwara, Shiro Oka, Shinji Tanaka, Takahiro Nakamura, Shoichi Saito, Yosuke Fukunaga, Manabu Takamatsu, Hiroshi Kawachi, Kinichi Hotta, Hiroaki Ikematsu, Motohiro Kojima, Yutaka Saito, Masayoshi Yamada, Yukihide Kanemitsu, Shigeki Sekine, Shinji
    Gastrointestinal Endoscopy.2023; 97(6): 1119.     CrossRef
  • CT morphological features for predicting the risk of lymph node metastasis in T1 colorectal cancer
    Suyun Li, Zhenhui Li, Li Wang, Mimi Wu, Xiaobo Chen, Chutong He, Yao Xu, Mengyi Dong, Yanting Liang, Xin Chen, Zaiyi Liu
    European Radiology.2023; 33(10): 6861.     CrossRef
  • Prediction model for lymph node metastasis in superficial colorectal cancer: a better choice than computed tomography
    Chao-Tao Tang, Jun Li, Peng Wang, You-Xiang Chen, Chun-Yan Zeng
    Surgical Endoscopy.2023; 37(10): 7444.     CrossRef
  • Lymph Node Molecular Analysis with OSNA Enables the Identification of pT1 CRC Patients at Risk of Recurrence: A Multicentre Study
    Karmele Saez de Gordoa, Maria Teresa Rodrigo-Calvo, Ivan Archilla, Sandra Lopez-Prades, Alba Diaz, Jordi Tarragona, Isidro Machado, Juan Ruiz Martín, Diana Zaffalon, Maria Daca-Alvarez, Maria Pellisé, Jordi Camps, Miriam Cuatrecasas
    Cancers.2023; 15(22): 5481.     CrossRef
  • Prediction of disease recurrence or residual disease after primary endoscopic resection of pT1 colorectal cancer—results from a large nationwide Danish study
    Ilze Ose, Katarina Levic, Lau Caspar Thygesen, Orhan Bulut, Thue Bisgaard, Ismail Gögenur, Tine Plato Kuhlmann
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Endoscopic resection alone as a potential treatment method for low-risk deep invasive T1 colorectal cancer
    Yuta Kouyama, Shin-ei Kudo, Katsuro Ichimasa, Shingo Matsudaira, Yushi Ogawa, Kenichi Mochizuki, Yuki Takashina, Yuta Sato, Tatsuya Sakurai, Yasuharu Maeda, Hiroki Nakamura, Masashi Misawa, Yuichi Mori, Toyoki Kudo, Takemasa Hayashi, Kunihiko Wakamura, Te
    iGIE.2023; 2(4): 503.     CrossRef
  • A Retrospective Multicenter Study of Risk Factors, Stratification, and Prognosis of Lymph Node Metastasis in T1 and T2 Colorectal Cancer
    Eui Myung Kim, Il Tae Son, Byung Chun Kim, Jun Ho Park, Byung Mo Kang, Jong Wan Kim
    Journal of Clinical Medicine.2023; 12(24): 7744.     CrossRef
  • Risk and Time Pattern of Recurrences After Local Endoscopic Resection of T1 Colorectal Cancer: A Meta-analysis
    Hao Dang, Nik Dekkers, Saskia le Cessie, Jeanin E. van Hooft, Monique E. van Leerdam, Philip P. Oldenburg, Louis Flothuis, Jan W. Schoones, Alexandra M.J. Langers, James C.H. Hardwick, Jolein van der Kraan, Jurjen J. Boonstra
    Clinical Gastroenterology and Hepatology.2022; 20(2): e298.     CrossRef
  • Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection
    Xinxin Cheng, Yaxin Lu, Sai Chen, Weilin Yang, Bo Xu, Jianyong Zou, Zhenguang Chen
    Annals of Surgical Oncology.2022; 29(1): 598.     CrossRef
  • Current problems and perspectives of pathological risk factors for lymph node metastasis in T1 colorectal cancer: Systematic review
    Katsuro Ichimasa, Shin‐ei Kudo, Hideyuki Miyachi, Yuta Kouyama, Kenichi Mochizuki, Yuki Takashina, Yasuharu Maeda, Yuichi Mori, Toyoki Kudo, Yuki Miyata, Yoshika Akimoto, Yuki Kataoka, Takafumi Kubota, Tetsuo Nemoto, Fumio Ishida, Masashi Misawa
    Digestive Endoscopy.2022; 34(5): 901.     CrossRef
  • Tumor Location as a Prognostic Factor in T1 Colorectal Cancer
    Katsuro Ichimasa, Shin-ei Kudo, Yuta Kouyama, Kenichi Mochizuki, Yuki Takashina, Masashi Misawa, Yuichi Mori, Takemasa Hayashi, Kunihiko Wakamura, Hideyuki Miyachi
    Journal of the Anus, Rectum and Colon.2022; 6(1): 9.     CrossRef
  • Identification of Predictive Factors for Lymph Node Metastasis in pT1 Stage Colorectal Cancer Patients: A Retrospective Analysis Based on the Population Database
    Jiawei Song, Huanhuan Yin, Yong Zhu, Shengqi Fei
    Pathology and Oncology Research.2022;[Epub]     CrossRef
  • Establishment of a Dynamic Nomogram for Predicting the Risk of Lymph Node Metastasis in T1 Stage Colorectal Cancer
    Zitao Liu, Chao Huang, Huakai Tian, Yu Liu, Yongshan Huang, Zhengming Zhu
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis
    Liselotte W. Zwager, Barbara A.J. Bastiaansen, Nahid S.M. Montazeri, Roel Hompes, Valeria Barresi, Katsuro Ichimasa, Hiroshi Kawachi, Isidro Machado, Tadahiko Masaki, Weiqi Sheng, Shinji Tanaka, Kazutomo Togashi, Chihiro Yasue, Paul Fockens, Leon M.G. Moo
    Gastroenterology.2022; 163(1): 174.     CrossRef
  • Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer
    Jeong-ki Kim, Ye-Young Rhee, Jeong Mo Bae, Jung Ho Kim, Seong-Joon Koh, Hyun Jung Lee, Jong Pil Im, Min Jung Kim, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park, Ji Won Park, Gyeong Hoon Kang
    BMC Cancer.2022;[Epub]     CrossRef
  • Lymph node metastasis in T1 colorectal cancer with the only high-risk histology of submucosal invasion depth ≥ 1000 μm
    Yusuke Yamaoka, Akio Shiomi, Hiroyasu Kagawa, Hitoshi Hino, Shoichi Manabe, Kai Chen, Kenji Nanishi, Akifumi Notsu
    International Journal of Colorectal Disease.2022; 37(11): 2387.     CrossRef
  • Subpopulation analysis of survival in high-risk T1 colorectal cancer: surgery versus endoscopic resection only
    Ryun Kyong Ha, Boram Park, Kyung Su Han, Dae Kyung Sohn, Chang Won Hong, Byung Chang Kim, Bun Kim, Sung Chan Park, Hee Jin Chang, Jae Hwan Oh
    Gastrointestinal Endoscopy.2022; 96(6): 1036.     CrossRef
  • Preoperative prediction of lymph node status in patients with colorectal cancer. Developing a predictive model using machine learning
    Morten Hartwig, Karoline Bendix Bräuner, Rasmus Vogelsang, Ismail Gögenur
    International Journal of Colorectal Disease.2022; 37(12): 2517.     CrossRef
  • Preoperative Predictors of Lymph Node Metastasis in Colon Cancer
    Yansong Xu, Yi Chen, Chenyan Long, Huage Zhong, Fangfang Liang, Ling-xu Huang, Chuanyi Wei, Shaolong Lu, Weizhong Tang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • LASSO-Based Machine Learning Algorithm for Prediction of Lymph Node Metastasis in T1 Colorectal Cancer
    Jeonghyun Kang, Yoon Jung Choi, Im-kyung Kim, Hye Sun Lee, Hogeun Kim, Seung Hyuk Baik, Nam Kyu Kim, Kang Young Lee
    Cancer Research and Treatment.2021; 53(3): 773.     CrossRef
  • Risk Stratification of T1 Colorectal Cancer Metastasis to Lymph Nodes: Current Status and Perspective
    Katsuro Ichimasa, Shin-ei Kudo, Hideyuki Miyachi, Yuta Kouyama, Masashi Misawa, Yuichi Mori
    Gut and Liver.2021; 15(6): 818.     CrossRef
  • Supervised Learning Based Systemic Inflammatory Markers Enable Accurate Additional Surgery for pT1NxM0 Colorectal Cancer: A Comparative Analysis of Two Practical Prediction Models for Lymph Node Metastasis
    Jinlian Jin, Haiyan Zhou, Shulin Sun, Zhe Tian, Haibing Ren, Jinwu Feng
    Cancer Management and Research.2021; Volume 13: 8967.     CrossRef
  • Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer
    Kaibo Guo, Yuqian Feng, Li Yuan, Harpreet S. Wasan, Leitao Sun, Minhe Shen, Shanming Ruan
    Cancer Medicine.2020; 9(14): 5095.     CrossRef
  • Development and external validation of a predictive scoring system associated with metastasis of T1‐2 colorectal tumors to lymph nodes
    Shaobo Mo, Zheng Zhou, Weixing Dai, Wenqiang Xiang, Lingyu Han, Long Zhang, Renjie Wang, Sanjun Cai, Qingguo Li, Guoxiang Cai
    Clinical and Translational Medicine.2020; 10(1): 275.     CrossRef
  • Inverse Association of Age with Risk of Lymph Node Metastasis in Superficial Colorectal Cancer: A Large Population-Based Study
    Qing-Wei Zhang, Long-Ci Sun, Chao-Tao Tang, Qian Liang, Yang-Yang Zhou, Hui-Min Chen, Yun-Jie Gao, Zhi-Zheng Ge
    The Oncologist.2020; 25(6): e920.     CrossRef
  • T1 colorectal cancers: The impact of screening programs on a curable disease
    Adriana Vaz Safatle-Ribeiro
    Digestive and Liver Disease.2020; 52(8): 918.     CrossRef
  • Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies
    Wei Xu, Yazhou He, Yuming Wang, Xue Li, Jane Young, John P. A. Ioannidis, Malcolm G. Dunlop, Evropi Theodoratou
    BMC Medicine.2020;[Epub]     CrossRef
  • 10,439 View
  • 386 Download
  • 44 Web of Science
  • 42 Crossref
Close layer
Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
Yanru Feng, Caineng Cao, Qiaoying Hu, Xiaozhong Chen
Cancer Res Treat. 2019;51(3):1222-1230.   Published online December 27, 2018
DOI: https://doi.org/10.4143/crt.2018.595
AbstractAbstract PDFPubReaderePub
Purpose
The aim of the present study was to evaluate the prognostic value of magnetic resonance imaging (MRI)‒determined lymph nodal necrosis (LNN) in nasopharyngeal carcinoma (NPC) and explore the feasibility of an N-classification system based on the 8th edition of the American Joint Committee on Cancer (AJCC) system.
Materials and Methods
The MRI scans of 616 patients with newly diagnosed stage T1-4N1-3M0 NPC who were treated with definitive intensity-modulated radiotherapy (IMRT) were reviewed.
Results
Multivariate analysis showed that LNN was an independent negative prognostic predictor of distant metastasis free survival (hazard ratio, 1.634; 95% confidence interval, 1.023 to 2.609; p=0.040) and overall survival (hazard ratio, 2.154; 95% confidence interval, 1.282 to 3.620; p=0.004). Patients of classification N1 disease with LNN were reclassified as classification N2, and classification N2 disease with LNN as classification N3 in the proposed N-classification system. Correlation with death and distant failure was significant, and the total difference between N1 and N3 was wider with the proposed system.
Conclusion
MRI-determined LNN is an independent negative prognostic factor for NPC. The proposed N classification system is powerfully predictive.

Citations

Citations to this article as recorded by  
  • Identifying adverse nodal features associated with poor prognosis in stage IB nasopharyngeal carcinoma patients based on the 9th AJCC/UICC staging system: Implications for treatment intensification
    Jing Zhong, Hongye Chen, Xinlan Chen, Ning Ma, Yuan Huang, Shaojun Lin, Jianji Pan, Yunbin Chen, Tianzhu Lu, Youping Xiao, Peng Shi, Hanchuan Xu, Qiaojuan Guo
    Radiotherapy and Oncology.2025; 205: 110747.     CrossRef
  • Advanced image-identified extranodal extension of retropharyngeal lymph nodes in the refinement of N classification for nasopharyngeal carcinoma
    Wei Jiang, Gao-Yuan Wang, Guan-Jie Qin, Wu-Qi Zhang, Xiao-Dong Zhu, Ya-Qian Han, Feng Lei, Liang-Fang Shen, Kun-Yu Yang, Chun-Yan Cui, Ling-Long Tang, Yan-Ping Mao, Lei Chen, Rui Guo, Ling Li, Zheng Wu, Gui-Qiong Xu, Qin Zhou, Jing Huang, Shao-Hui Huang,
    Cell Reports Medicine.2025; 6(2): 101942.     CrossRef
  • Advances in Nasopharyngeal Carcinoma Staging: from the 7th to the 9th Edition of the TNM System and Future Outlook
    Binhao Wu, Xiaozhong Chen, Caineng Cao
    Current Oncology Reports.2025; 27(3): 322.     CrossRef
  • Development and Validation of a Nomogram Based on the Different Grades of Cervical Lymph Node Necrosis to Predict Overall Survival in Patients with Lymph Node-Positive Locally Advanced Nasopharyngeal Carcinoma
    Run-Zhi Wang, Li-Ru Zhu, Yao-Can Xu, Mei-Wen Chen, Zhong-Guo Liang, Kai-Hua Chen, Ling Li, Xiao-Dong Zhu
    Academic Radiology.2025;[Epub]     CrossRef
  • Matted Lymph Nodes on MRI in Nasopharyngeal Carcinoma: Prognostic Factor and Potential Indication for Induction Chemotherapy Benefits
    Annan Dong, Siyu Zhu, Huali Ma, Xiaoyu Wei, Wenjie Huang, Guangying Ruan, Lizhi Liu, Yunxian Mo, Fei Ai
    Journal of Magnetic Resonance Imaging.2024; 59(6): 1976.     CrossRef
  • Statistical and machine learning methods for cancer research and clinical practice: A systematic review
    Laura Lopez-Perez, Eleni Georga, Carlo Conti, Victor Vicente, Rebeca García, Leandro Pecchia, Dimitris Fotiadis, Lisa Licitra, Maria Fernanda Cabrera, Maria Teresa Arredondo, Giuseppe Fico
    Biomedical Signal Processing and Control.2024; 92: 106067.     CrossRef
  • The Prognostic Value of Serum Sialic Acid in Patients with Nasopharyngeal Carcinoma: A Propensity Score Matching Study
    Zetan Chen, Gang Wu, Xiangying Lin, Xiaopeng Huang, Shuai Zhang, Kaihua Chen, Zhongguo Liang, Xiaodong Zhu
    Cancer Management and Research.2024; Volume 16: 215.     CrossRef
  • A prognostic nomogram incorporating tumor size and lymph node size for patients with nasopharyngeal carcinoma
    Qi Yi, Jiazuo Cai, Yunen Lin, Zimei Hu, Jie Lin, Zhong Huang, Wei Liu, Ronghui Zheng, YaWei Yuan, Chengcong Chen
    American Journal of Otolaryngology.2023; 44(2): 103717.     CrossRef
  • Intra- and peritumoral MRI radiomics assisted in predicting radiochemotherapy response in metastatic cervical lymph nodes of nasopharyngeal cancer
    Hao Xu, Ai Wang, Chi Zhang, Jing Ren, Peng Zhou, Jieke Liu
    BMC Medical Imaging.2023;[Epub]     CrossRef
  • Construction of Prognostic Nomogram in Patients with N3-Stage Nasopharyngeal Carcinoma
    Wenmiao Cao, Xiaoxin Li, Jianqi Yang, Enming Xing, Wenjuan Wu, Yizhi Ge, Buhai Wang
    ORL.2023; 85(4): 195.     CrossRef
  • Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR
    Yongfeng Piao, Caineng Cao, Yuanfan Xu, Shuang Huang, Feng Jiang, Ting Jin, Qifeng Jin, Yonghong Hua, Qiaoying Hu, Xiaozhong Chen
    European Archives of Oto-Rhino-Laryngology.2022; 279(1): 353.     CrossRef
  • A nonendemic analysis of the patterns and prognosis of de novo metastatic nasopharyngeal carcinomas in older patients aged ≥ 65 years
    Baoqiu Liu, Mingxing Zhang, Yanqing Cao, Zhe Wang, Xicheng Wang
    Scientific Reports.2022;[Epub]     CrossRef
  • Prognostic value of cervical nodal necrosis on staging imaging of nasopharyngeal carcinoma in era of intensity-modulated radiotherapy: a systematic review and meta-analysis
    Qi-Yong H. Ai, Kuo Feng Hung, Tiffany Y. So, Frankie K. F. Mo, Wing Tsung Anthony Chin, Edwin P. Hui, Brigette B. Y. Ma, Michael Ying, Ann D. King
    Cancer Imaging.2022;[Epub]     CrossRef
  • Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
    Yuanxiu Yin, Ziyan Zhou, Zhiru Li, Mingjun Shen, Yating Qin, Chaolin Yang, Rensheng Wang, Min Kang
    Radiation Oncology.2022;[Epub]     CrossRef
  • FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer
    Martin Dolezel, Marek Slavik, Tomas Blazek, Tomas Kazda, Pavel Koranda, Lucia Veverkova, Petr Burkon, Jakub Cvek
    Journal of Personalized Medicine.2022; 12(8): 1245.     CrossRef
  • Prognostic value of the cervical lymph node necrosis ratio in nasopharyngeal carcinoma
    Ying Bin, Zhen Meng, Lu-Lu Huang, Xue-Ying Hu, Jun-Mei Song, Yi-Ting Xie, Min Kang, Ren-Sheng Wang
    Radiotherapy and Oncology.2022; 177: 185.     CrossRef
  • Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma
    Shao-Bo Liang, Lu-Si Chen, Xing-Li Yang, Dan-Ming Chen, Dong-Hui Wang, Chun-Yan Cui, Chuan-Bo Xie, Li-Zhi Liu, Xiang-Ying Xu
    Radiotherapy and Oncology.2021; 155: 219.     CrossRef
  • Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis
    Wanpeng Li, Hanyu Lu, Huan Wang, Li Hu, Xicai Sun, Hongmeng Yu, Dehui Wang
    Head & Neck.2021; 43(8): 2353.     CrossRef
  • Contemporary management of the neck in nasopharyngeal carcinoma
    Wai Tong Ng, Raymond K. Y. Tsang, Jonathan J. Beitler, Remco de Bree, Andrés Coca‐Pelaz, Avraham Eisbruch, Orlando Guntinas‐Lichius, Anne W. M. Lee, Antti A. Mäkitie, William M. Mendenhall, Sandra Nuyts, Alessandra Rinaldo, K. Thomas Robbins, Juan P. Rodr
    Head & Neck.2021; 43(6): 1949.     CrossRef
  • MRI-based radiomics as response predictor to radiochemotherapy for metastatic cervical lymph node in nasopharyngeal carcinoma
    Hao Xu, Jieke Liu, Ying Huang, Peng Zhou, Jing Ren
    The British Journal of Radiology.2021;[Epub]     CrossRef
  • Long-term survival outcomes and adverse effects of nasopharyngeal carcinoma patients treated with IMRT in a non-endemic region: a population-based retrospective study
    Man Xu, Jian Zang, Shanquan Luo, Jianhua Wang, Xuqi Li
    BMJ Open.2021; 11(8): e045417.     CrossRef
  • Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature
    Chi Leung Chiang, Qiaojuan Guo, Wai Tong Ng, Shaojun Lin, Tiffany Sze Wai Ma, Zhiyuan Xu, Youping Xiao, Jishi Li, Tianzhu Lu, Horace Cheuk Wai Choi, Wenqi Chen, Eric Sze Chun Chau, Peter Ho Yin Luk, Shao Hui Huang, Brian O’Sullivan, Jianji Pan, Anne Wing
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Long-term outcomes of induction chemotherapy followed by intensity-modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease
    Xiaoshuang Niu, Fen Xue, Peiyao Liu, Chaosu Hu, Xiayun He
    Translational Oncology.2021; 14(12): 101216.     CrossRef
  • Prognostic value and the potential role of treatment options for cervical lymph node necrosis in nasopharyngeal carcinoma
    Kuiyuan Liu, Siting Lin, Liangru Ke, Weixiong Xia, Chun Zhang, Jianpeng Li, Mingyong Gao, Mengyun Qiang, Xi Chen, Jia Liu, Chuanmiao Xie, Xiang Guo, Xing Lv
    Oral Oncology.2020; 109: 104864.     CrossRef
  • The evolution of the nasopharyngeal carcinoma staging system over a 10-year period: implications for future revisions
    Si-Qi Tang, Yan-Ping Mao, Cheng Xu, Rui Guo, Wen-Fei Li, Ling-Long Tang, Ying Sun, Jun Ma
    Chinese Medical Journal.2020; 133(17): 2044.     CrossRef
  • Prognostic and Treatment Guiding Significance of MRI-Based Tumor Burden Features and Nodal Necrosis in Nasopharyngeal Carcinoma
    Xi Chen, Xun Cao, Bingzhong Jing, Weixiong Xia, Liangru Ke, Yanqun Xiang, Kuiyuan Liu, Mengyun Qiang, Chixiong Liang, Jianpeng Li, Mingyong Gao, Wangzhong Li, Jingjing Miao, Guoying Liu, Zhuochen Cai, Shuhui Lv, Xiang Guo, Chaofeng Li, Xing Lv
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Patterns and Prognostic Value of Lymph Node Metastasis on Distant Metastasis and Survival in Nasopharyngeal Carcinoma: A Surveillance, Epidemiology, and End Results Study, 2006–2015
    Yali Xu, Taoyuan Huang, Liqin Fan, Wei Jin, Xiaoming Chen, Jinhai Chen
    Journal of Oncology.2019; 2019: 1.     CrossRef
  • Screening of key miRNAs and evaluation of their diagnostic and prognostic values in nasopharyngeal carcinoma
    Xianlu Zhuo, Wei Zhou, Huiping Ye, Dairong Li, Aoshuang Chang, Yongzhong Wu, Qi Zhou
    Oncology Letters.2019;[Epub]     CrossRef
  • 8,413 View
  • 171 Download
  • 29 Web of Science
  • 28 Crossref
Close layer
Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1-3 Positive Nodes
Ji Hyeon Joo, Su Ssan Kim, Byung Ho Son, Seung Do Ahn, Jin Hong Jung, Eun Kyung Choi, Sei Hyun Ahn, Jong Won Lee, Hee Jeong Kim, Beom Seok Ko
Cancer Res Treat. 2019;51(3):1011-1021.   Published online October 16, 2018
DOI: https://doi.org/10.4143/crt.2018.438
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Axillary lymph node dissection (ALND) may be avoidable for breast cancer patients with 1-2 positive lymph nodes (LN) after breast-conserving therapy. However, the effects of ALND after mastectomy remain unclear because radiation is not routinely used. Herein, we compared the benefits of post-mastectomy ALND versus sentinel node biopsy (SNB) alone for breast cancer patients with 1-3 metastatic LNs.
Materials and Methods
A total of 1,697 patients with pN1 disease who underwent mastectomy during 2000-2015 were identified from an institutional database. Outcomes were compared using the inverse probability of treatment weighted method.
Results
Patients who underwent SNB tended to have smaller tumors, a lower histology grade, a lower number of positive LNs, and better immunohistochemical findings. After correcting all confounding factors regarding patient, tumor, and adjuvant treatment, the SNB and ALND groups did not differ in terms of overall survival (OS) and disease-free survival (DFS), distant metastasis and locoregional recurrence. The 10-year DFS and OS rates were 83% and 84%, respectively, during a median follow-up period of 93 months.
Conclusion
ALND did not improve post-mastectomy survival outcomes among patients with N1 breast cancer, even after adjusting for all histopathologic and treatment-related factors.

Citations

Citations to this article as recorded by  
  • The Impact of Sentinel Lymph Node Biopsy on Female Patients With T3-4c Breast Cancer and 1-2 Positive Lymph Nodes: A Population-Based Cohort Study
    Hanzhao Yang, Yadong Sun, Peili Wang, Jianghua Qiao, Chengzheng Wang, Zhenzhen Liu
    Clinical Breast Cancer.2024; 24(3): e126.     CrossRef
  • Axillary management in patients with clinical node-negative early breast cancer and positive sentinel lymph node: a systematic review and meta-analysis
    Changzai Li, Pan Zhang, Jie Lv, Wei Dong, Baoshan Hu, Jinji Zhang, Hongcheng Zhu
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Reevaluating Axillary Lymph Node Dissection in Total Mastectomy for Low Axillary Burden Breast Cancer: Insights from a Meta-Analysis including the SINODAR-ONE Trial
    Munaser Alamoodi, Neill Patani, Kinan Mokbel, Umar Wazir, Kefah Mokbel
    Cancers.2024; 16(4): 742.     CrossRef
  • RecurIndex-Guided postoperative radiotherapy with or without Avoidance of Irradiation of regional Nodes in 1–3 node-positive breast cancer (RIGAIN): a study protocol for a multicentre, open-label, randomised controlled prospective, phase III trial
    Jing Liu, Yuting Tan, Zhuofei Bi, Suning Huang, Na Zhang, An-du Zhang, Lina Zhao, Yu Wang, Zibin Liang, Yu Hou, Xiangying Xu, Jianying Chen, Fei Wang, Xiaowen Lan, Xiao Lin, Xiaoxue Zhang, Wenyi Zhou, Xuting Ye, Jian-gui Guo, Xiaohong Wang, Ran Ding, Jiay
    BMJ Open.2024; 14(7): e078049.     CrossRef
  • The prognostic analysis of further axillary dissection in breast cancer with 1-2 positive sentinel lymph nodes undergoing mastectomy
    Xueyi Zhao, Liu Yang, Congbo Cao, Zhenchuan Song
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy
    Damiano GENTILE, Corrado TINTERRI
    Minerva Surgery.2024;[Epub]     CrossRef
  • Can Axillary Lymph Node Dissection be Omitted in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes Undergoing Mastectomy? A Systematic Review and Meta‐Analysis of Real‐World Evidence
    Fulong Chen, Xiaowen Li, Xianjun Lin, Lijia Chen, Zhaoling Lin, Hao Wu, Jishang Chen
    World Journal of Surgery.2023; 47(10): 2446.     CrossRef
  • De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer
    Laura D. Leonard, Thiago B. de Araujo, Christopher Quinn, Madeline B. Thomas, Laurel Beaty, Nicole M. Mott, Kathryn Colborn, Alicia A. Heelan, Sarah E. A. Tevis, Nicole Christian, Gretchen Arhendt, Ana L. Gleisner
    Annals of Surgical Oncology.2023; 30(9): 5692.     CrossRef
  • A multi-dimensional nomogram to predict non-sentinel lymph node metastases in T1–2HR+ breast cancer
    Ke Xiang, Jialin Chen, Yu Min, Hang Chen, Jiaxin Yang, Daixing Hu, Yuling Han, Guobing Yin, Yang Feng
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolm
    Corrado Tinterri, Giuseppe Canavese, Wolfgang Gatzemeier, Erika Barbieri, Alberto Bottini, Andrea Sagona, Giulia Caraceni, Alberto Testori, Simone Di Maria Grimaldi, Carla Dani, Luca Boni, Paolo Bruzzi, Bethania Fernandes, Marta Scorsetti, Alberto Zambell
    British Journal of Surgery.2023; 110(9): 1143.     CrossRef
  • Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis
    Yu-Jia Fan, Jin-Cheng Li, De-Miao Zhu, Hai-Long Zhu, Yi Zhao, Xin-Bing Zhu, Gang Wu, Ting-ting Bai
    BMC Surgery.2023;[Epub]     CrossRef
  • Factores predictivos de metástasis en ganglios no centinela en el cáncer de mama con ganglio centinela positivo
    Mariana Peyroteo, Rita Canotilho, Ana Margarida Correia, Catarina Baía, Cátia Ribeiro, Paulo Reis, Abreu de Sousa
    Cirugía Española.2022; 100(2): 81.     CrossRef
  • Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes
    Olga Kantor, Jessica Means, Samantha Grossmith, Tanujit Dey, Jennifer R. Bellon, Elizabeth A. Mittendorf, Tari A. King
    Annals of Surgical Oncology.2022; 29(2): 972.     CrossRef
  • Predictive factors of non-sentinel lymph node disease in breast cancer patients with positive sentinel lymph node
    Mariana Peyroteo, Rita Canotilho, Ana Margarida Correia, Catarina Baía, Cátia Ribeiro, Paulo Reis, Abreu de Sousa
    Cirugía Española (English Edition).2022; 100(2): 81.     CrossRef
  • Axilla lymph node dissection can be safely omitted in patients with 1–2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis
    Weiqi Gao, Shuangshuang Lu, Yufei Zeng, Xiaosong Chen, Kunwei Shen
    Breast Cancer Research and Treatment.2022; 196(1): 129.     CrossRef
  • Comparison of survival outcomes between axillary conservation and axillary lymph node dissections in N1 early breast cancer: a propensity-matched SEER analysis
    Nisha Wu, Xiaohan Su, Qiao Tan, Jing Luo, Yewei Yuan, Lingmi Hou, Junyan Li
    Clinical and Translational Oncology.2022; 25(4): 1091.     CrossRef
  • Surgeon Bias in the Management of Positive Sentinel Lymph Nodes
    Brittany J. Mathias, James Sun, Weihong Sun, Jun-Min Zhou, William J. Fulp, Christine Laronga, M. Catherine Lee, John V. Kiluk
    Clinical Breast Cancer.2021; 21(1): 74.     CrossRef
  • Impact of Axillary Dissection Among Patients With Sentinel Node–Positive Breast Cancer Undergoing Mastectomy
    James Sun, Brittany J. Mathias, Christine Laronga, Weihong Sun, Jun-Min Zhou, William J. Fulp, John V. Kiluk, M. Catherine Lee
    Journal of the National Comprehensive Cancer Network.2021; 19(1): 40.     CrossRef
  • Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study
    André Hennigs, Fabian Riedel, Manuel Feißt, Melitta Köpke, Mahdi Rezai, Ulrike Nitz, Mareike Moderow, Michael Golatta, Christof Sohn, Jörg Heil
    Annals of Surgical Oncology.2019; 26(8): 2435.     CrossRef
  • 9,403 View
  • 327 Download
  • 19 Web of Science
  • 19 Crossref
Close layer
The Lymphatic Drainage Pattern of Internal Mammary Sentinel Lymph Node Identified by Small Particle Radiotracer (99mTc-Dextran 40) in Breast
Xiao-Shan Cao, Guo-Ren Yang, Bin-Bin Cong, Peng-Fei Qiu, Yong-Sheng Wang
Cancer Res Treat. 2019;51(2):483-492.   Published online June 11, 2018
DOI: https://doi.org/10.4143/crt.2018.062
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to detect the lymphatic drainage pattern of internal mammary area and verify the concept of internal mammary sentinel lymph node (IM-SLN) in breast.
Materials and Methods
A small particle radiotracer (99mTc-Dextran 40) was prepared and tested. 99mTc-Dextran 40 was injected into intraparenchyma at the sound breast by a modified radiotracer injection technique. Subsequently, dynamic single-photon emission computed tomography (SPECT), computed tomography (CT), and SPECT/CT combination images were performed to identify the radioactive lymph vessels and internal mammary lymph nodes (IMLNs). The direction of lymph drainage and the location of the IMLNs were identified in the SPECT/CT imaging.
Results
The radiochemical purity of 99mTc-Dextran 40 was > 95%. 99mTc-Dextran 40 could drainage into first, second, and third lymph node and the radioactive lymph node could be detected by the γ detector in the animal experiment. After 99mTc-Dextran 40 injecting into intraparenchyma, 50.0% cases (15/30) were identified the drainage lymphatic vessels and radioactive IMLNs by SPECT. The drainage lymphatic vessel was found from injection point to the first IMLN (IM-SLN) after 10.5±0.35 minutes radiotracer injection, and then 99mTc-Dextran 40 was accumulated into the IM-SLN. The combination imaging of SPECT/CT showed the second IMLN received the lymph drainage from the IM-SLN. The lymphatic drainage was step by step in the internal mammary area.
Conclusion
The lymph was identified to drain from different regions of the breast to IM-SLN, and then outward from IM-SLN to other IMLN consecutively. It demonstrated the concept of the IM-SLN and provided more evidences for the application of internal mammary sentinel lymph node biopsy.

Citations

Citations to this article as recorded by  
  • 99mTc-rituximab tracer injection for guiding internal mammary sentinel lymph nodes biopsy in primary breast cancer: A prospective observational study
    Wenxin Chen, Yaodong Su, Hui Zhang, Yu Zhang, Lin Zhu, Mengbo Lin, Zhiyi Lin, Mingdian Yu, Shengping Yang, Yanmin Zhang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Internal mammary lymph node metastasis in breast cancer patients based on anatomical imaging and functional imaging
    Wei Wang, Pengfei Qiu, Jianbin Li
    Breast Cancer.2022; 29(6): 933.     CrossRef
  • The hypothesis of internal mammary lymph node drainage chain in breast cancer
    Zhao Bi, Peng Chen, Xian-Rang Song, Yong-Sheng Wang
    Future Oncology.2020; 16(21): 1489.     CrossRef
  • Comparative research on 99mTc-Rituximab and 99mTc-sulfur colloid in sentinel lymph node imaging of breast cancer
    Jing-Jie Zhang, Wan-Chun Zhang, Cai-Xia An, Xiao-Min Li, Le Ma
    BMC Cancer.2019;[Epub]     CrossRef
  • 11,217 View
  • 177 Download
  • 5 Web of Science
  • 4 Crossref
Close layer
Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
Seho Park, Ja Seung Koo, Gun Min Kim, Joohyuk Sohn, Seung Il Kim, Young Up Cho, Byeong-Woo Park, Vivian Youngjean Park, Jung Hyun Yoon, Hee Jung Moon, Min Jung Kim, Eun-Kyung Kim
Cancer Res Treat. 2018;50(3):801-812.   Published online August 17, 2017
DOI: https://doi.org/10.4143/crt.2017.210
AbstractAbstract PDFPubReaderePub
Purpose
Sentinel lymph node biopsy (SLNB) can be performed when node-positive disease is converted to node-negative status after neoadjuvant chemotherapy (NCT). Tattooing nodes might improve accuracy but supportive data are limited. This study aimed to investigate the feasibility of charcoal tattooing metastatic axillary lymph node (ALN) at presentation followed by SLNB after NCT in breast cancers.
Materials and Methods
Twenty patientswith cytology-proven node metastases prospectively underwent charcoal tattooing at diagnosis. SLNB using dual tracers and axillary surgery after NCT were then performed. The detection rate of tattooed node and diagnostic performance of SLNB were analyzed.
Results
All patients underwent charcoal tattooingwithout significant morbidity. Sentinel and tattooed nodes could be detected during surgery after NCT. Nodal pathologic complete response was achieved in 10 patients. Overall sensitivity, false-negative rate (FNR), negative predictive value, and accuracy of hot/blue SLNB were 80.0%, 20.0%, 83.3%, and 90.0%, respectively. Retrieving more nodes and favorable nodal response were associated with improved performance. The best accuracy was observed when excised tattooed node was calculated together (FNR, 0.0%). Cold/non-blue tattooed nodes of five patients were removed during non-sentinel axillary surgery but clinicopathological parameters did not differ compared to patients with hot/blue tattooed node detected during SLNB, suggesting the importance of the tattooing procedure itself to improve performance.
Conclusion
Charcoal tattooing of cytology-confirmed metastatic ALN at presentation is technically feasible and does not limit SLNB after NCT. The tattooing procedure without additional preoperative localization is advantageous for improving the diagnostic performance of SLNB in this setting.

Citations

Citations to this article as recorded by  
  • Indocyanine Green Fluorescence Plus Blue Dye for Sentinel Lymph Node Biopsy in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer: A Multicenter, Prospective Cohort Study
    Miao Liu, Yang Yang, Bin Hua, Rui Feng, Tianyu Xu, Mengyuan Wang, Xiaowei Qi, Yingming Cao, Bo Zhou, Fuzhong Tong, Peng Liu, Hongjun Liu, Lin Cheng, Houpu Yang, Fei Xie, Siyuan Wang, Chaobin Wang, Yuan Peng, Danhua Shen, Lei Chen, Jun Jiang, Shu Wang
    Thoracic Cancer.2025;[Epub]     CrossRef
  • The efficacy and oncological safety of minimally invasive axillary procedures in patients with node-positive breast cancer receiving neoadjuvant chemotherapy: A network meta-regression and trial sequential analysis
    James Lucocq, Hassan Baig, Esther McNeill, J Michael Dixon
    European Journal of Surgical Oncology.2025; 51(7): 109689.     CrossRef
  • Targeted Axillary Dissection for Clinically Node-Positive Breast Cancer Cases that Turn Negative After Neoadjuvant Systemic Therapy Using Charcoal Tattooing
    Mohamed Yousri, Ashraf Khater, Waleed Elnahas, Osama Eldamshety, Eman Alnaghy, Mohamed Ezzat
    Indian Journal of Surgical Oncology.2025;[Epub]     CrossRef
  • Radiographic identification of a positive clipped axillary lymph node in a mastectomy specimen following neoadjuvant chemotherapy
    Andrew Seto, Cynthia Lin, Samantha Norden, Jamie Stratton, Moira O'Riordan, Helen Pass
    Radiology Case Reports.2024; 19(1): 435.     CrossRef
  • Peut-on surseoir au curage axillaire en cas de carcinome mammaire invasif avec envahissement ganglionnaire ?
    Susie Brousse, Clémentine Lafond, Martin Schmitt, Sophie Guillermet, Sébastien Molière, Carole Mathelin
    Gynécologie Obstétrique Fertilité & Sénologie .2024; 52(3): 132.     CrossRef
  • The Role of Level III Dissection in Locally Advanced Breast Cancer following Neoadjuvant Chemotherapy—A Prospective Study
    Rexeena V. Bhargavan, Nisha Prasannan, K.M. Jagathnath Krishna, Paul Augustine, Kurian Cherian
    South Asian Journal of Cancer.2024; 13(03): 170.     CrossRef
  • Melanin-Based Nanoparticles for Lymph Node Tattooing: Experimental, Histopathological and Ultrastructural Study
    Marta Baselga, Antonio Güemes, Cristina Yus, Teresa Alejo, Víctor Sebastián, Dolores Arribas, Gracia Mendoza, Eva Monleón, Manuel Arruebo
    Nanomaterials.2024; 14(13): 1149.     CrossRef
  • Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy
    Yuka Endo, Haruru Kotani, Nobuko Tamura, Kiyo Tanaka, Chiho Kudo, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Ayumi Kataoka, Kazuki Nozawa, Yuri Ozaki, Ayaka Isogai, Rie Komaki, Akira Nakakami, Nari Kureyama, Maho Kusudo, Waki Hosoda, Hidetaka Kawab
    Breast Cancer.2024; 31(6): 1130.     CrossRef
  • Oncological outcomes of selective axillary dissection with 4% carbon marking
    LUCAS ROSKAMP BUDEL, CLEVERTON CÉSAR SPAUTZ, MARIA HELENA LOUVEIRA, TERESA CRISTINA SANTOS CAVALCANTI, ALESSANDRA CORDEIRO FORNAZARI, PLINIO GASPERIN JUNIOR, LEONARDO NISSEN, VINICIUS MILANI BUDEL
    Revista do Colégio Brasileiro de Cirurgiões.2024;[Epub]     CrossRef
  • Desfechos oncológicos da dissecção axilar seletiva utilizando carvão a 4% como marcador
    LUCAS ROSKAMP BUDEL, CLEVERTON CÉSAR SPAUTZ, MARIA HELENA LOUVEIRA, TERESA CRISTINA SANTOS CAVALCANTI, ALESSANDRA CORDEIRO FORNAZARI, PLINIO GASPERIN JUNIOR, LEONARDO NISSEN, VINICIUS MILANI BUDEL
    Revista do Colégio Brasileiro de Cirurgiões.2024;[Epub]     CrossRef
  • Preclinical evaluation of polymer encapsulated carbon-based nano and microparticles for sentinel lymph node tattooing
    Marta Baselga, Antonio Güemes, Manuel Arruebo, Cristina Yus, Teresa Alejo, Víctor Sebastián, Gema Martínez, Dolores Arribas, Gracia Mendoza, Concepción Junquera, Eva Monleón
    Scientific Reports.2024;[Epub]     CrossRef
  • Biopsia del ganglio centinela y disección axilar dirigida en mujeres con cáncer de mama y axila positiva en el momento del diagnóstico: caminando hacia el futuro
    Paula Moral Rubio, Silvia Delgado García, Hortensia Ballester Galiana, Jose Ponce Lorenzo, Tina Martín Bayón, Gloria Peiró
    Revista de Senología y Patología Mamaria.2023; 36(1): 100402.     CrossRef
  • Estadificación ganglionar tras terapia sistémica primaria en mujeres con cáncer de mama y afectación ganglionar al diagnóstico
    Eva Acea-Figueira, Alejandra García-Novoa, Carlota Díaz Carballada, Alberto Bouzón Alejandro, Carmen Conde, Paz Santiago Freijanes, Joaquín Mosquera Oses, Benigno Acea-Nebril
    Cirugía Española.2023; 101(6): 417.     CrossRef
  • Lymph node staging after primary systemic therapy in women with breast cancer and lymph node involvement at diagnosis
    Eva Acea-Figueira, Alejandra García-Novoa, Carlota Díaz Carballada, Alberto Bouzón Alejandro, Carmen Conde, Paz Santiago Freijanes, Joaquín Mosquera Oses, Benigno Acea-Nebril
    Cirugía Española (English Edition).2023; 101(6): 417.     CrossRef
  • Carbon tattooing of axillary lymph nodes in breast cancer patients before neoadjuvant chemotherapy: A retrospective analysis
    Mauro Porpiglia, Fulvio Borella, Pierluigi Chieppa, Carola Brino, Ada Ala, Vincenzo Marra, Isabella Castellano, Chiara Benedetto
    Tumori Journal.2023; 109(3): 301.     CrossRef
  • Concomitant Use of Biopsy Clips and Wire Localization in Invasive Breast Cancer is Associated With Successful Clip Retrieval
    Jennifer H. Chen, Joe K. Canner, Kelly Myers, Melissa Camp
    Clinical Breast Cancer.2023; 23(3): e163.     CrossRef
  • Carbon nanoparticles localized clipped node dissection combined with sentinel lymph node biopsy with indocyanine green and methylene blue after neoadjuvant therapy in node positive breast cancer in China: initial results of a prospective study
    Xin Yang, Yao Li, Xiao-tian Ren, Lei Fan, Bin Hua
    World Journal of Surgical Oncology.2023;[Epub]     CrossRef
  • Outcomes of Sentinel Node Biopsy for Women with Breast Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis of Real-World Data
    Shi-Qian Lin, Nguyen-Phong Vo, Yu-Chun Yen, Ka-Wai Tam
    Annals of Surgical Oncology.2022; 29(5): 3038.     CrossRef
  • Nanoparticle-assisted axillary staging: an alternative approach after neoadjuvant chemotherapy in patients with pretreatment node-positive breast cancers
    Jiqiao Yang, Tao He, Yunhao Wu, Zhoukai Fu, Qing Lv, Shan Lu, Xiaodong Wang, Hongjiang Li, Jing Wang, Jie Chen
    Breast Cancer Research and Treatment.2022; 192(3): 573.     CrossRef
  • Axillary Management: How Has Neoadjuvant Chemotherapy Changed Our Surgical Approach?
    Mara A. Piltin, Judy C. Boughey
    Current Breast Cancer Reports.2022; 14(1): 1.     CrossRef
  • Gezielte Entfernung axillärer Lymphknoten nach Kohlenstoffmarkierung bei Patientinnen mit primär systemisch behandeltem Mammakarzinom
    Steffi Hartmann, Angrit Stachs, Thorsten Kühn, Jana de Boniface, Maggie Banys-Paluchowski, Toralf Reimer
    Senologie - Zeitschrift für Mammadiagnostik und -therapie.2022; 19(01): 49.     CrossRef
  • Gezielte Entfernung axillärer Lymphknoten nach Kohlenstoffmarkierung bei Patientinnen mit primär systemisch behandeltem Mammakarzinom
    Steffi Hartmann, Angrit Stachs, Thorsten Kühn, Jana de Boniface, Maggie Banys-Paluchowski, Toralf Reimer
    TumorDiagnostik & Therapie.2022; 43(03): 197.     CrossRef
  • False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy
    Jana de Boniface, Jan Frisell, Thorsten Kühn, Ingrid Wiklander-Bråkenhielm, Karin Dembrower, Per Nyman, Athanasios Zouzos, Bernd Gerber, Toralf Reimer, Steffi Hartmann
    Breast Cancer Research and Treatment.2022; 193(3): 589.     CrossRef
  • Diagnostic accuracy of de‐escalated surgical procedure in axilla for node‐positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic review and meta‐analysis
    Yu‐xin Song, Zheng Xu, Ming‐xing Liang, Zhen Liu, Jun‐chen Hou, Xiu Chen, Di Xu, Yin‐jiao Fei, Jin‐hai Tang
    Cancer Medicine.2022; 11(22): 4085.     CrossRef
  • Multidisciplinary considerations in the management of breast cancer patients receiving neoadjuvant chemotherapy
    Faina Nakhlis, Leah Portnow, Eva Gombos, Ayse Ece Cali Daylan, Jose Pablo Leone, Olga Kantor, Edward T. Richardson, Alice Ho, Samantha Armstrong Dunn, Nisha Ohri
    Current Problems in Surgery.2022; 59(9): 101191.     CrossRef
  • Combining Wire Localization of Clipped Nodes with Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: Preliminary Results from a Prospective Study
    Alejandra García-Novoa, Benigno Acea-Nebril, Carlota Díaz Carballada, Alberto Bouzón Alejandro, Carmen Conde, Carmen Cereijo Garea, José Ramón Varela, Paz Santiago Freijanes, Silvia Antolín Novoa, Lourdes Calvo Martínez, Inma Díaz, Sofia Rodríguez Martíne
    Annals of Surgical Oncology.2021; 28(2): 958.     CrossRef
  • A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients
    Amit Goyal, Shama Puri, Andrea Marshall, Kalliope Valassiadou, Moin M. Hoosein, Amtul R. Carmichael, Gabriella Erdelyi, Nisha Sharma, Janet Dunn, Joanne York
    Breast Cancer Research and Treatment.2021; 185(2): 433.     CrossRef
  • Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial
    S Hartmann, T Kühn, J de Boniface, A Stachs, A Winckelmann, J Frisell, I Wiklander-Bråkenhielm, J Stubert, B Gerber, T Reimer
    British Journal of Surgery.2021; 108(3): 302.     CrossRef
  • Different strategies in marking axillary lymph nodes in breast cancer patients undergoing neoadjuvant medical treatment: a systematic review
    Vivian Man, Ava Kwong
    Breast Cancer Research and Treatment.2021; 186(3): 607.     CrossRef
  • Sentinel lymph node BIOPSY after neoadjuvant therapy in breast cancer patients with lymph node involvement at diagnosis. Could wire localization of clipped node improve our results?
    Marina Alarcón, Elvira Buch, Ana Julve, Marta Hernandorena, Marcos Tajahuerce, Héctor Rodríguez, Begoña Bermejo, Judith Ramírez, Octavio Burgués, Sandra Díaz, Gara M. Alcalá, Joaquín Ortega
    The Surgeon.2021; 19(6): 344.     CrossRef
  • The Evolving Role of Marked Lymph Node Biopsy (MLNB) and Targeted Axillary Dissection (TAD) after Neoadjuvant Chemotherapy (NACT) for Node-Positive Breast Cancer: Systematic Review and Pooled Analysis
    Parinita K. Swarnkar, Salim Tayeh, Michael J. Michell, Kefah Mokbel
    Cancers.2021; 13(7): 1539.     CrossRef
  • New horizons in imaging and surgical assessment of breast cancer lymph node metastasis
    Firouzeh Arjmandi, Ann Mootz, Deborah Farr, Sangeetha Reddy, Basak Dogan
    Breast Cancer Research and Treatment.2021; 187(2): 311.     CrossRef
  • Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node-positive breast cancer according to breast cancer subtype
    Yurina Maeshima, Takehiko Sakai, Akiko Ogiya, Yoko Takahashi, Yumi Miyagi, Yumi Kokubu, Tomo Osako, Yoshinori Ito, Shunji Takahashi, Shinji Ohno, Takayuki Ueno
    Scientific Reports.2021;[Epub]     CrossRef
  • Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
    Gunay Gurleyik, Sibel Aydin Aksu, Fügen Aker, Kubra Kaytaz Tekyol, Eda Tanrikulu, Emin Gurleyik
    Annals of Surgical Treatment and Research.2021; 100(6): 305.     CrossRef
  • Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer
    Vijayashree Murthy, Jessica Young, Yoshihisa Tokumaru, Marie Quinn, Stephen B. Edge, Kazuaki Takabe
    Cancers.2021; 13(16): 4167.     CrossRef
  • Influence of Imaging Features and Technique on US-guided Tattoo Ink Marking of Axillary Lymph Nodes Removed at Sentinel Lymph Node Biopsy in Women With Breast Cancer
    Marlen Pajcini, Irene Wapnir, Jacqueline Tsai, Joanne Edquilang, Wendy DeMartini, Debra Ikeda
    Journal of Breast Imaging.2021; 3(5): 583.     CrossRef
  • Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy
    Steffi Hartmann, Angrit Stachs, Thorsten Kühn, Jana de Boniface, Maggie Banys-Paluchowski, Toralf Reimer
    Geburtshilfe und Frauenheilkunde.2021; 81(10): 1121.     CrossRef
  • Axillary Imaging Following a New Invasive Breast Cancer Diagnosis—A Radiologist’s Dilemma
    Vandana Dialani, Basak Dogan, Katerina Dodelzon, Brian N Dontchos, Neha Modi, Lars Grimm
    Journal of Breast Imaging.2021; 3(6): 645.     CrossRef
  • Selective Extirpation of Tattooed Lymph Node in Combination with Sentinel Lymph Node Biopsy in the Management of Node-Positive Breast Cancer Patients after Neoadjuvant Systemic Therapy
    Lukas Dostalek, Andrej Cerny, Petra Saskova, David Pavlista
    Breast Care.2021; 16(6): 623.     CrossRef
  • False Negativity of Targeted Axillary Dissection in Breast Cancer
    George Kirkilesis, Anastasia Constantinidou, Michalis Kontos
    Breast Care.2021; 16(5): 532.     CrossRef
  • Synchronous early‑stage breast cancer and axillary follicular lymphoma diagnosed by core needle biopsy: A case report
    Ryotaro Eto, Rikiya Nakamura, Naohito Yamamoto, Toshiko Miyaki, Shoko Hayama, Itaru Sonoda, Makiko Itami, Hideki Tsujimura, Hideyuki Hashimoto, Masayuki Otsuka
    Molecular and Clinical Oncology.2021;[Epub]     CrossRef
  • Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019
    Nina Ditsch, Isabel T. Rubio, Maria L. Gasparri, Jana de Boniface, Thorsten Kuehn
    Current Opinion in Obstetrics & Gynecology.2020; 32(1): 91.     CrossRef
  • Targeted axillary dissection after neoadjuvant systemic therapy in patients with node‐positive breast cancer
    Kavitha Kanesalingam, Nina Sriram, Ghaith Heilat, E ‐Ern Ng, Farid Meybodi, Elisabeth Elder, Meagan Brennan, James French
    ANZ Journal of Surgery.2020; 90(3): 332.     CrossRef
  • Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial)
    Geok Hoon Lim, Sze Yiun Teo, Mihir Gudi, Ruey Pyng Ng, Jinnie Pang, Yia Swam Tan, Yien Sien Lee, John C. Allen, Lester Chee Hao Leong
    Cancer Medicine.2020; 9(6): 1978.     CrossRef
  • Targeted axillary dissection of carbon‐tattooed metastatic lymph nodes in combination with post–neo‐adjuvant sentinel lymph node biopsy using 1% methylene blue in breast cancer patients
    Emad Khallaf, Rasha Wessam, Mohamed Abdoon
    The Breast Journal.2020; 26(5): 1061.     CrossRef
  • Marking axillary nodes with 4% carbon microparticle suspension before neoadjuvant chemotherapy improves sentinel node identification rate and axillary staging
    Cleverton Cesar Spautz, Eduardo Schunemann Junior, Lucas Roskamp Budel, Tereza Cristina Santos Cavalcanti, Maria Helena Louveira, Plinio Gasperin Junior, Leonardo Paese Nissen, Bernardo Passos Sobreiro, Maíra Teixeira Dória, Cicero Andrade Urban, Vinicius
    Journal of Surgical Oncology.2020; 122(2): 164.     CrossRef
  • Targeted Axillary Dissection for Patients Who Convert to Clinically Node Negative After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer
    Kandice Ludwig, Amanda L. Kong
    Current Breast Cancer Reports.2020; 12(4): 391.     CrossRef
  • Clinical Practice Status of Sentinel Lymph Node Biopsy for Early-Stage Breast Cancer Patients in China: A Multicenter Study


    Juliang Zhang, Ting Wang, Changjiao Yan, Meiling Huang, Zhimin Fan, Rui Ling
    Clinical Epidemiology.2020; Volume 12: 917.     CrossRef
  • Feasibility of preoperative tattooing of percutaneously biopsied axillary lymph node: an experimental pilot study
    Abida K. Sattar, Basim Ali, Imrana Masroor, Shaista Afzal, Mohammad Usman Tariq, Romana Idrees, Maseeh Uzzaman, Wardah Khalid
    Pilot and Feasibility Studies.2020;[Epub]     CrossRef
  • Effectiveness of preoperative ultrasound-guided charcoal tattooing for localization of metastatic melanoma
    Ji Hyun Lee, Hyun Su Kim, Young Cheol Yoon, Min Je Kim, Min Jae Cha, Jung-Han Kim
    Ultrasonography.2020; 39(4): 376.     CrossRef
  • To Evaluate the Accuracy of Axillary Staging Using Ultrasound and Ultrasound-Guided Fine-Needle Aspiration Cytology (USG-FNAC) in Early Breast Cancer Patients—a Prospective Study
    Rashpal Singh, S. V. S. Deo, Ekta Dhamija, Sandeep Mathur, Sanjay Thulkar
    Indian Journal of Surgical Oncology.2020; 11(4): 726.     CrossRef
  • Leveraging Neoadjuvant Chemotherapy to Minimize the Burden of Axillary Surgery: a Review of Current Strategies and Surgical Techniques
    Alison Laws, Michelle C. Specht
    Current Breast Cancer Reports.2020; 12(4): 317.     CrossRef
  • Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer
    Janine M. Simons, Thiemo J. A. van Nijnatten, Carmen C. van der Pol, Ernest J. T. Luiten, Linetta B. Koppert, Marjolein L. Smidt
    Annals of Surgery.2019; 269(3): 432.     CrossRef
  • Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment
    Ioannis Natsiopoulos, Stavros Intzes, Triantafyllos Liappis, Konstantinos Zarampoukas, Thomas Zarampoukas, Vasiliki Zacharopoulou, Konstantinos Papazisis
    Clinical Breast Cancer.2019; 19(3): 208.     CrossRef
  • Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node
    Rupa Patel, Wendy MacKerricher, Jacqueline Tsai, Nicole Choy, Jafi Lipson, Debra Ikeda, Sunita Pal, Wendy De Martini, Kimberly H. Allison, Irene L. Wapnir
    Annals of Surgical Oncology.2019; 26(8): 2452.     CrossRef
  • Node positive breast cancer: Concordance between baseline PET/CT and sentinel node assessment after neoadjuvant therapy
    Oscar Leopoldo Christin, Jonathan Kuten, Einat Even-Sapir, Joseph Klausner, Tehillah S. Menes
    Surgical Oncology.2019; 30: 1.     CrossRef
  • Sentinel Node Lymph Node Surgery After Neoadjuvant Therapy: Principles and Techniques
    Jennifer M. Racz, Abigail S. Caudle
    Annals of Surgical Oncology.2019; 26(10): 3040.     CrossRef
  • Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer
    J M Simons, M L M A van Pelt, A W K S Marinelli, M E Straver, A M Zeillemaker, L M Pereira Arias-Bouda, T J A van Nijnatten, L B Koppert, K K Hunt, M L Smidt, E J T Luiten, C C van der Pol
    British Journal of Surgery.2019; 106(12): 1632.     CrossRef
  • Ultrasound-guided dual-localization for axillary nodes before and after neoadjuvant chemotherapy with clip and activated charcoal in breast cancer patients: a feasibility study
    Won Hwa Kim, Hye Jung Kim, See Hyung Kim, Jin Hyang Jung, Ho Yong Park, Jeeyeon Lee, Wan Wook Kim, Ji Young Park, Yee Soo Chae, Soo Jung Lee
    BMC Cancer.2019;[Epub]     CrossRef
  • Conservative Management of Positive Axilla After Neoadjuvant Systemic Therapy—The Need for, and Review of, Techniques Used for Lymph Node Localization
    Matthew Green, Foteini Neamonitou, Raghavan Vidya
    Clinical Breast Cancer.2018; 18(5): e739.     CrossRef
  • Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint
    Judy C. Boughey, Michael D. Alvarado, Rachael B. Lancaster, W. Fraser Symmans, Rita Mukhtar, Jasmine M. Wong, Cheryl A. Ewing, David A. Potter, Todd M. Tuttle, Tina J. Hieken, Jodi M. Carter, James W. Jakub, Henry G. Kaplan, Claire L. Buchanan, Nora T. Ja
    npj Breast Cancer.2018;[Epub]     CrossRef
  • 12,904 View
  • 361 Download
  • 61 Web of Science
  • 61 Crossref
Close layer
Risk Factors for a False-Negative Result of Sentinel Node Biopsy in Patients with Clinically Node-Negative Breast Cancer
Seung Ah Lee, Hak Min Lee, Hak Woo Lee, Ban Seok Yang, Jong Tae Park, Sung Gwe Ahn, Joon Jeong, Seung Il Kim
Cancer Res Treat. 2018;50(3):625-633.   Published online July 31, 2017
DOI: https://doi.org/10.4143/crt.2017.089
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Although sentinel lymph node biopsy (SLNB) can accurately represent the axillary lymph node (ALN) status, the false-negative rate (FNR) of SLNB is the main concern in the patients who receive SLNB alone instead of ALN dissection (ALND).
Materials and Methods
We analyzed 1,886 patientswho underwent ALNDafter negative results of SLNB,retrospectively. A logistic regression analysis was used to identify risk factors associated with a falsenegative (FN) result. Cox regression model was used to estimate the hazard ratio of factors affecting disease-free survival (DFS).
Results
Tumor located in the upper outer portion of the breast, lymphovascular invasion, suspicious node in imaging assessment and less than three sentinel lymph nodes (SLNs) were significant independent risk factors for FN in SLNB conferring an adjusted odds ratio of 2.10 (95% confidence interval [CI], 1.30 to 3.39), 2.69 (95% CI, 1.47 to 4.91), 2.59 (95% CI, 1.62 to 4.14), and 2.39 (95% CI, 1.45 to 3.95), respectively. The prognostic factors affecting DFS were tumor size larger than 2 cm (hazard ratio [HR], 1.86; 95% CI, 1.17 to 2.96) and FN of SLNB (HR, 2.51; 95% CI, 1.42 to 4.42) in SLN-negative group (FN and true-negative), but in ALN-positive group (FN and true-positive), FN of SLNB (HR, 0.64; 95% CI, 0.33 to 1.25) did not affect DFS.
Conclusion
In patients with risk factors for a FN such as suspicious node in imaging assessment, upper outer breast cancer, less than three harvested nodes, we need attention to find another metastatic focus in non-SLNs during the operation. It may contribute to provide an exact prognosis and optimizing adjuvant treatments.

Citations

Citations to this article as recorded by  
  • Detection of presence or absence of metastasis in WSI patches of breast cancer using the dual-enhanced convolutional ensemble neural network
    Ruigang Ge, Guoyue Chen, Kazuki Saruta, Yuki Terata
    Machine Learning with Applications.2024; 17: 100579.     CrossRef
  • Ultrasound radiomics based on axillary lymph nodes images for predicting lymph node metastasis in breast cancer
    Yu-Long Tang, Bin Wang, Tao Ou-Yang, Wen-Zhi Lv, Shi-Chu Tang, An Wei, Xin-Wu Cui, Jiang-Sheng Huang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer
    Filippo Pesapane, Luciano Mariano, Francesca Magnoni, Anna Rotili, Davide Pupo, Luca Nicosia, Anna Carla Bozzini, Silvia Penco, Antuono Latronico, Maria Pizzamiglio, Giovanni Corso, Enrico Cassano
    Medicina.2023; 59(9): 1544.     CrossRef
  • Axillary Lymph Node Dissection Can Be Omitted in Breast Cancer Patients With Mastectomy and False-Negative Frozen Section in Sentinel Lymph Node Biopsy
    Jing Si, Rong Guo, Huan Pan, Xiang Lu, Zhiqin Guo, Chao Han, Li Xue, Dan Xing, Wanxin Wu, Caiping Chen
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • False-negative frozen section of sentinel nodes in early breast cancer (cT1-2N0) patients
    Zhu-Jun Loh, Kuo-Ting Lee, Ya-Ping Chen, Yao-Lung Kuo, Wei-Pang Chung, Ya-Ting Hsu, Chien-Chang Huang, Hui-Ping Hsu
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • What Is High-risk Breast Cancer With Pathologically Negative Lymph Nodes for Regional Recurrence?
    Sang-Won Kim, Won Kyung Cho, Doo Ho Choi, Haeyoung Kim, Oyeon Cho, Won Park, Mison Chun
    International Journal of Radiation Oncology*Biology*Physics.2021; 111(4): 992.     CrossRef
  • Validating the ACOSOG Z0011 Trial Result: A Population-Based Study Using the SEER Database
    Jiwoong Jung, Byoung Hyuck Kim, Jongjin Kim, Sohee Oh, Su-jin Kim, Chang-Sup Lim, In Sil Choi, Ki-Tae Hwang
    Cancers.2020; 12(4): 950.     CrossRef
  • Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort
    Jiwoong Jung, Wonshik Han, Eun Sook Lee, So-Youn Jung, Jai Hong Han, Dong-Young Noh, Yumi Kim, Hee Jun Choi, Jeong Eon Lee, Seok Jin Nam, Jong Won Lee, Hee Jeong Kim, Eunhae Um, Joo Heung Kim, Seho Park, Young Up Cho
    Breast Cancer Research and Treatment.2019; 175(1): 203.     CrossRef
  • Preliminary study of contrast-enhanced ultrasound in combination with blue dye vs. indocyanine green fluorescence, in combination with blue dye for sentinel lymph node biopsy in breast cancer
    Yidong Zhou, Yan Li, Feng Mao, Jing Zhang, Qingli Zhu, Songjie Shen, Yan Lin, Xiaohui Zhang, He Liu, Mengsu Xiao, Yuxin Jiang, Qiang Sun
    BMC Cancer.2019;[Epub]     CrossRef
  • 12,831 View
  • 350 Download
  • 10 Web of Science
  • 9 Crossref
Close layer
Which Patients with Isolated Para-aortic Lymph Node Metastasis Will Truly Benefit from Extended Lymph Node Dissection for Colon Cancer?
Sung Uk Bae, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Nam Kyu Kim
Cancer Res Treat. 2018;50(3):712-719.   Published online July 14, 2017
DOI: https://doi.org/10.4143/crt.2017.100
AbstractAbstract PDFPubReaderePub
Purpose
The prognosis of patientswith colon cancer and para-aortic lymph node metastasis (PALNM) is poor. We analyzed the prognostic factors of extramesenteric lymphadenectomy for colon cancer patients with isolated PALNM.
Materials and Methods
We retrospectively reviewed 49 patients with PALNM who underwent curative resection between October 1988 and December 2009.
Results
In univariate analyses, the 5-year overall survival (OS) and disease-free survival (DFS) rates were higher in patients with ≤ 7 positive para-aortic lymph node (PALN) (36.5% and 27.5%) than in those with > 7 PALN (14.3% and 14.3%; p=0.010 and p=0.027, respectively), and preoperative carcinoembryonic antigen (CEA) level > 5 was also correlated with a lower 5-year OS and DFS rate of 21.5% and 11.7% compared with those with CEA ≤ 5 (46.3% and 41.4%; p=0.122 and 0.039, respectively). Multivariate analysis found that the number of positive PALN (hazard ratio [HR], 3.291; 95% confidence interval [CI], 1.309 to 8.275; p=0.011) was an independent prognostic factor for OS and the number of positive PALN (HR, 2.484; 95% CI, 0.993 to 6.211; p=0.052) and preoperative CEA level (HR, 1.953; 95% CI, 0.940 to 4.057; p=0.073) were marginally independent prognostic factors for DFS. According to our prognostic model, the 5-year OS and DFS rate increased to 59.3% and 53.3%, respectively, in patients with ≤ 7 positive PALN and CEA level ≤ 5.
Conclusion
PALN dissection might be beneficial in carefully selected patients with a low CEA level and less extensive PALNM.

Citations

Citations to this article as recorded by  
  • Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer—A Multicenter Retrospective Study
    Hiroaki Nozawa, Sono Ito, Kazuhito Sasaki, Koji Murono, Shigenobu Emoto, Yuichiro Yokoyama, Shinichi Yamauchi, Yusuke Kinugasa, Yoichi Ajioka, Soichiro Ishihara
    Annals of Surgical Oncology.2025; 32(4): 2282.     CrossRef
  • Clinical Significance of Surgical Resection for Isolated Para-aortic Lymph Node Metastasis from Colorectal Cancer in the Multidisciplinary Treatment Strategy
    Satoru Akaza, Akira Ouchi, Aina Kunitomo, Yusuke Sato, Takashi Kinoshita, Koji Komori
    Nihon Daicho Komonbyo Gakkai Zasshi.2025; 78(2): 39.     CrossRef
  • Does surgical intervention contribute to survival for patients with para‐aortic lymph node metastasis from colorectal cancer?
    Akira Ouchi, Koji Komori, Sono Ito, Yusuke Kinugasa, Soichiro Ishihara, Akio Shiomi, Yukihide Kanemitsu, Takeshi Suto, Hiroki Takahashi, Yoichi Ajioka
    Annals of Gastroenterological Surgery.2025;[Epub]     CrossRef
  • Prognostic factors of para-aortic lymph node metastasis from colorectal cancer in highly selected patients undergoing para-aortic lymph node dissection
    Shin Emoto, Yosuke Fukunaga, Manabu Takamatsu, Hiroshi Kawachi, Shuhei Sano, Tetsuro Tominaga, Toshiki Mukai, Tomohiro Yamaguchi, Toshiya Nagasaki, Takashi Akiyoshi, Tsuyoshi Konishi, Satoshi Nagayama, Masashi Ueno
    Surgery Today.2024; 54(4): 356.     CrossRef
  • Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence
    Rémi Grange, Pascal Rousset, Nicolas Williet, Mathias Guesnon, Laurent Milot, Guillaume Passot, Jean-Marc Phelip, Bertrand Le Roy, Olivier Glehen, Vahan Kepenekian
    Annals of Surgical Oncology.2024; 31(4): 2378.     CrossRef
  • Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes
    Neal Bhutiani, Kentaro Ochiai, Muhammad O. Awiwi, Miguel A. Rodriguez-Bigas, Abhineet Uppal, Oliver Peacock, Craig Messick, Michael G. White, John M. Skibber, Brian K. Bednarski, Y. Nancy You, George J. Chang, Harmeet Kaur, Tsuyoshi Konishi
    Annals of Surgical Oncology.2024; 31(9): 5962.     CrossRef
  • Surgery for Infrarenal Retroperitoneal Node Metastases from Colon Cancer
    Anne-Sophie Dulac, Pietro Genova, Olivier Benoit, Cindy Neuzillet, Mostapha El Hajjam, Jean-François Emile, Frédérique Peschaud, Renato Micelli Lupinacci
    Journal of Gastrointestinal Cancer.2024; 55(3): 1306.     CrossRef
  • Long-term Outcome After Surgical Resection of Para-aortic Lymph Node Metastasis of Colorectal Cancer: A Multicenter Retrospective Study
    Sono Ito, Yusuke Kinugasa, Shinichi Yamauchi, Hiroyuki Sato, Akihiro Hirakawa, Soichiro Ishihara, Akio Shiomi, Yukihide Kanemitsu, Takeshi Suto, Hiroki Takahashi, Michio Itabashi, Manabu Shiozawa, Masaya Hiyoshi, Takaya Kobatake, Koji Komori, Hiroyuki Egi
    Diseases of the Colon & Rectum.2024; 67(11): 1423.     CrossRef
  • Long-Term Outcome After Resection of Hepatic and Pulmonary Metastases in Multivisceral Colorectal Cancer
    Christopher Berlin, Geoffroy Andrieux, Magdalena Menzel, Gabriel J. Stöger, Andreas Gengenbach, Luisa Schäfer, Hans C. Hillebrecht, Rebecca Kesselring, Uyen-Thao Le, Stefan Fichtner-Feigl, Philipp A. Holzner
    Cancers.2024; 16(22): 3741.     CrossRef
  • Survival outcomes after synchronous para‐aortic lymph node metastasis in colorectal cancer: A systematic review
    Conor Aylward, Jawed Noori, Jack Tyrrell, Niall O'sullivan, Dara O. Kavanagh, John O. Larkin, Brian J. Mehigan, Paul H. McCormick, Michael E. Kelly
    Journal of Surgical Oncology.2023; 127(4): 645.     CrossRef
  • Retroperitoneal Lymph Node Dissection in Colorectal Cancer with Lymph Node Metastasis: A Systematic Review
    Michael G. Fadel, Mosab Ahmed, Gianluca Pellino, Shahnawaz Rasheed, Paris Tekkis, David Nicol, Christos Kontovounisios, Erik Mayer
    Cancers.2023; 15(2): 455.     CrossRef
  • The management of clinically suspicious para‐aortic lymph node metastasis in colorectal cancer: A systematic review
    Michelle Zhiyun Chen, Yeng Kwang Tay, Swetha Prabhakaran, Joseph C Kong
    Asia-Pacific Journal of Clinical Oncology.2023; 19(6): 596.     CrossRef
  • Survival benefits of para-aortic lymphadenectomy in colorectal cancer with clinically suspected para-aortic lymph node metastasis: a meta-analysis and systematic review
    Rong-Chang Wang, Jian-Qi Wang, Xiao-Yu Zhou, Chu-lin Zhong, Jin-Xu Chen, Jing-Song Chen
    World Journal of Surgical Oncology.2023;[Epub]     CrossRef
  • Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases
    Frédéric Schell, Amaniel Kefleyesus, Nazim Benzerdjeb, Guillaume Passot, Pascal Rousset, Alhadeedi Omar, Laurent Villeneuve, Julien Péron, Olivier Glehen, Vahan Kepenekian
    Annals of Surgical Oncology.2023; 30(7): 4444.     CrossRef
  • Lymph nodes primary staging of colorectal cancer in 18F-FDG PET/MRI: a systematic review and meta-analysis
    Qingwei Ren, Yanyan Chen, Xuejun Shao, Lanzhong Guo, Xinxin Xu
    European Journal of Medical Research.2023;[Epub]     CrossRef
  • Oncologic Outcomes after Surgical Resection for Para-aortic Lymph Node Metastasis in Colorectal Cancer
    Takayuki Okuno, Masaya Hiyoshi, Yuusuke Kyoden, Junji Yamamoto
    Nippon Daicho Komonbyo Gakkai Zasshi.2023; 76(7): 460.     CrossRef
  • Multicenter study of prognostic factors in paraaortic lymph node dissection for metastatic colorectal cancer
    Jun Woo Bong, Sanghee Kang, Pyoungjae Park
    Annals of Surgical Treatment and Research.2023; 105(5): 271.     CrossRef
  • Outcomes of metachronous para-aortic lymphadenectomy in colorectal cancer: a systematic review of the literature
    Oluwatobi O. Onafowokan, Jennifer Redfern, Agastya Patel, Thomas Satyadas, Minas Baltatzis
    Langenbeck's Archives of Surgery.2023;[Epub]     CrossRef
  • Predictive factors of survival of colorectal cancer patients after para-aortic lymph node metastasis
    Hiroaki Nozawa, Kazushige Kawai, Kazuhito Sasaki, Shigenobu Emoto, Shinya Abe, Hirofumi Sonoda, Koji Murono, Junko Kishikawa, Yuzo Nagai, Yuichiro Yokoyama, Hiroyuki Anzai, Soichiro Ishihara
    International Journal of Clinical Oncology.2022; 27(3): 520.     CrossRef
  • Long-Term Outcomes of Surgical Resection of Pathologically Confirmed Isolated Para-Aortic Lymph Node Metastases in Colorectal Cancer: A Systematic Review
    Maurizio Zizzo, Maria Pia Federica Dorma, Magda Zanelli, Francesca Sanguedolce, Maria Chiara Bassi, Andrea Palicelli, Stefano Ascani, Alessandro Giunta
    Cancers.2022; 14(3): 661.     CrossRef
  • Effect of radical lymphadenectomy in colorectal cancer with para-aortic lymph node metastasis: a systematic review and meta-analysis
    Pengyue Zhao, Xingpeng Yang, Yang Yan, Jiaqi Yang, Songyan Li, Xiaohui Du
    BMC Surgery.2022;[Epub]     CrossRef
  • Prognostic significance of enlarged paraaortic lymph nodes detected during left-sided colorectal cancer surgery: a single-center retrospective cohort study
    Jaram Lee, Hyeong-min Park, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • Risk factors for local recurrence and long term survival after minimally invasive intersphincteric resection for very low rectal cancer: Multivariate analysis in 161 patients
    G.N. Piozzi, H. Park, T.H. Lee, J.S. Kim, H.B. Choi, S.J. Baek, J.M. Kwak, J. Kim, S.H. Kim
    European Journal of Surgical Oncology.2021; 47(8): 2069.     CrossRef
  • Effect of lymphadenectomy in colorectal cancer with isolated synchronous para‐aortic lymph node metastasis
    Sung Chul Lee, Hee Cheol Kim, Woo Yong Lee, Seong Hyeon Yun, Yong Beom Cho, Jung Wook Huh, Yoon Ah Park, Jung Kyong Shin
    Colorectal Disease.2021; 23(10): 2584.     CrossRef
  • Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes
    Guglielmo Niccolò Piozzi, Seon Hahn Kim
    Annals of Coloproctology.2021; 37(6): 351.     CrossRef
  • Is 18F-FDG PET/CT an Accurate Way to Detect Lymph Node Metastasis in Colorectal Cancer: A Systematic Review and Meta-Analysis
    Hamid Dahmarde, Fateme Parooie, Morteza Salarzaei
    Contrast Media & Molecular Imaging.2020; 2020: 1.     CrossRef
  • Oncologic outcomes after resection of para-aortic lymph node metastasis in left-sided colon and rectal cancer
    Junichi Sakamoto, Heita Ozawa, Hiroki Nakanishi, Shin Fujita, Norikatsu Miyoshi
    PLOS ONE.2020; 15(11): e0241815.     CrossRef
  • Long-term outcome and prognostic factors for patients with para-aortic lymph node dissection in left-sided colorectal cancer
    Kota Sahara, Jun Watanabe, Atsushi Ishibe, Yusuke Suwa, Hirokazu Suwa, Mitsuyoshi Ota, Chikara Kunisaki, Itaru Endo
    International Journal of Colorectal Disease.2019; 34(6): 1121.     CrossRef
  • 16,670 View
  • 336 Download
  • 26 Web of Science
  • 28 Crossref
Close layer
Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer Surgery
Soo Kyung Ahn, Min Kyoon Kim, Jongjin Kim, Eunshin Lee, Tae-Kyung Yoo, Han-Byoel Lee, Young Joon Kang, Jisun Kim, Hyeong-Gon Moon, Jung Min Chang, Nariya Cho, Woo Kyung Moon, In Ae Park, Dong-Young Noh, Wonshik Han
Cancer Res Treat. 2017;49(4):1088-1096.   Published online January 25, 2017
DOI: https://doi.org/10.4143/crt.2016.473
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The American College of Surgeons Oncology Group Z0011 trial reported that complete dissection of axillary lymph nodes (ALNs) may not be warranted in women with clinical T1-T2 tumors and one or two involved ALNs who were undergoing lumpectomy plus radiation followed by systemic therapy. The present study was conducted to identify preoperative imaging predictors of ≥ 3 ALNs.
Materials and Methods
The training set consisted of 1,917 patients with clinical T1-T2 and node negative invasive breast cancer. Factors associated with ≥ 3 involved ALNs were evaluated by logistic regression analysis. The validation set consisted of 378 independent patients. The nomogram was applied prospectively to 512 patients who met the Z0011 criteria.
Results
Of the 1,917 patients, 204 (10.6%) had ≥ 3 positive nodes. Multivariate analysis showed that involvement of ≥ 3 nodes was significantly associated with ultrasonographic and chest computed tomography findings of suspicious ALNs (p < 0.001 each). These two imaging criteria, plus patient age, were used to develop a nomogram calculating the probability of involvement of ≥ 3 ALNs. The areas under the receiver operating characteristic curve of the nomogram were 0.852 (95% confidence interval [CI], 0.820 to 0.883) for the training set and 0.896 (95% CI, 0.836 to 0.957) for the validation set. Prospective application of the nomogram showed that 60 of 512 patients (11.7%) had scores above the cut-off. Application of the nomogram reduced operation time and cost, with a very low re-operation rate (1.6%).
Conclusion
Patients likely to have ≥ 3 positive ALNs could be identified by preoperative imaging. The nomogram was helpful in selective intraoperative examination of sentinel lymph nodes.

Citations

Citations to this article as recorded by  
  • Predicting three or more metastatic nodes using contrast-enhanced lymphatic US findings in early breast cancer
    Zihan Niu, Yunxia Hao, Yuanjing Gao, Jing Zhang, Mengsu Xiao, Feng Mao, Yidong Zhou, Ligang Cui, Yuxin Jiang, Qingli Zhu
    Insights into Imaging.2024;[Epub]     CrossRef
  • Individualized prediction of non-sentinel lymph node metastasis in Chinese breast cancer patients with ≥ 3 positive sentinel lymph nodes based on machine-learning algorithms
    Xiangli Xie, Yutong Fang, Lifang He, Zexiao Chen, Chunfa Chen, Huancheng Zeng, Bingfeng Chen, Guangsheng Huang, Cuiping Guo, Qunchen Zhang, Jundong Wu
    BMC Cancer.2024;[Epub]     CrossRef
  • Gail model and fifth edition of ultrasound BI‐RADS help predict axillary lymph node metastasis in breast cancer—A multicenter prospective study
    Lu‐Ying Gao, Hai‐Tao Ran, You‐Bin Deng, Bao‐Ming Luo, Ping Zhou, Wu Chen, Yu‐Hong Zhang, Jian‐Chu Li, Hong‐Yan Wang, Yu‐Xin Jiang
    Asia-Pacific Journal of Clinical Oncology.2023;[Epub]     CrossRef
  • Nomogram based on multiparametric analysis of early‐stage breast cancer: Prediction of high burden metastatic axillary lymph nodes
    Ling Li, Jing Zhao, Yu Zhang, Zhanyu Pan, Jin Zhang
    Thoracic Cancer.2023; 14(35): 3465.     CrossRef
  • Stratification of Axillary Lymph Node Metastasis Risk with Breast MRI in Breast Cancer
    Jieying Chen, Xiaolian Su, Tingting Xu, Qifeng Luo, Lin Zhang, Guangyu Tang
    Future Oncology.2022; 18(15): 1849.     CrossRef
  • ACR Appropriateness Criteria® Imaging of the Axilla
    Huong T. Le-Petross, Priscilla J. Slanetz, Alana A. Lewin, Jean Bao, Elizabeth H. Dibble, Mehra Golshan, Jessica H. Hayward, Charlotte D. Kubicky, A. Marilyn Leitch, Mary S. Newell, Christine Prifti, Matthew F. Sanford, John R. Scheel, Richard E. Sharpe,
    Journal of the American College of Radiology.2022; 19(5): S87.     CrossRef
  • Avoiding unnecessary intraoperative sentinel lymph node frozen section biopsy of patients with early breast cancer
    Jongwon Kang, Tae-Kyung Yoo, Ahwon Lee, Jun Kang, Chang Ik Yoon, Bong Joo Kang, Sung Hun Kim, Woo Chan Park
    Annals of Surgical Treatment and Research.2022; 102(5): 241.     CrossRef
  • A nomogram for predicting three or more axillary lymph node involvement before breast cancer surgery
    Young-Joon Kang, Jung Hyun Park, Young Wook Ju, Kyoung-Eun Kim, Yumi Kim, Eunshin Lee, Han-Byoel Lee, Dong-Young Noh, Wonshik Han
    Scientific Reports.2022;[Epub]     CrossRef
  • Accurate Evaluation of Feature Contributions for Sentinel Lymph Node Status Classification in Breast Cancer
    Angela Lombardi, Nicola Amoroso, Loredana Bellantuono, Samantha Bove, Maria Colomba Comes, Annarita Fanizzi, Daniele La Forgia, Vito Lorusso, Alfonso Monaco, Sabina Tangaro, Francesco Alfredo Zito, Roberto Bellotti, Raffaella Massafra
    Applied Sciences.2022; 12(14): 7227.     CrossRef
  • Is Routine Intraoperative Frozen Section Analysis of Sentinel Lymph Nodes Necessary in Every Early-Stage Breast Cancer?
    Bhoowit Lerttiendamrong, Nattanan Treeratanapun, Voranaddha Vacharathit, Kasaya Tantiphlachiva, Phuphat Vongwattanakit, Sopark Manasnayakorn, Mawin Vongsaisuwon
    Breast Cancer: Targets and Therapy.2022; Volume 14: 281.     CrossRef
  • Predictive nomogram based on serum tumor markers and clinicopathological features for stratifying lymph node metastasis in breast cancer
    Sheng-Kai Geng, Shao-Mei Fu, Hong-Wei Zhang, Yi-Peng Fu
    BMC Cancer.2022;[Epub]     CrossRef
  • Prediction of axillary nodal burden in patients with invasive lobular carcinoma using MRI
    Su Min Ha, Jung Min Chang, Soo-Yeon Kim, Su Hyun Lee, Eun Sil Kim, Yeon Soo Kim, Nariya Cho, Woo Kyung Moon
    Breast Cancer Research and Treatment.2021; 186(2): 463.     CrossRef
  • Predicting of Sentinel Lymph Node Status in Breast Cancer Patients with Clinically Negative Nodes: A Validation Study
    Annarita Fanizzi, Domenico Pomarico, Angelo Paradiso, Samantha Bove, Sergio Diotaiuti, Vittorio Didonna, Francesco Giotta, Daniele La Forgia, Agnese Latorre, Maria Irene Pastena, Pasquale Tamborra, Alfredo Zito, Vito Lorusso, Raffaella Massafra
    Cancers.2021; 13(2): 352.     CrossRef
  • Sentinel Lymph Node Metastasis on Clinically Negative Patients: Preliminary Results of a Machine Learning Model Based on Histopathological Features
    Annarita Fanizzi, Vito Lorusso, Albino Biafora, Samantha Bove, Maria Colomba Comes, Cristian Cristofaro, Maria Digennaro, Vittorio Didonna, Daniele La Forgia, Annalisa Nardone, Domenico Pomarico, Pasquale Tamborra, Alfredo Zito, Angelo Virgilio Paradiso,
    Applied Sciences.2021; 11(21): 10372.     CrossRef
  • The new perspective of PET/CT for axillary nodal staging in early breast cancer patients according to ACOSOG Z0011 trial PET/CT axillary staging according to Z0011
    Eunjung Kong, Jungeun Choi
    Nuclear Medicine Communications.2021; 42(12): 1369.     CrossRef
  • Clinical Value of Axillary Ultrasonography in Breast Cancer with Lymph Node Metastases
    Jung Ho Park, Hyun Ryung Kim, Sanghwa Kim, Young Ah Lim, Kyoonsoon Jung, Lee Su Kim
    Journal of Surgical Ultrasound.2021; 8(2): 41.     CrossRef
  • Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?
    V. Madekivi, P. Boström, A. Karlsson, R. Aaltonen, E. Salminen
    Acta Oncologica.2020; 59(6): 689.     CrossRef
  • External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients
    Antonio Piñero-Madrona, Francisco Ripoll-Orts, José Ignacio Sánchez-Méndez, Asunción Chaves-Benito, Maximiliano Rodrigo Gómez-de la Bárcena, Ana Calatrava-Fons, Salomón Menjón-Beltrán, Vicente Peg-Cámara
    Breast Cancer Research and Treatment.2020; 181(2): 339.     CrossRef
  • Axillary Nodal Evaluation in Breast Cancer: State of the Art
    Jung Min Chang, Jessica W. T. Leung, Linda Moy, Su Min Ha, Woo Kyung Moon
    Radiology.2020; 295(3): 500.     CrossRef
  • Can We Identify or Exclude Extensive Axillary Nodal Involvement in Breast Cancer Patients Preoperatively?
    Martijn Leenders, Gaëlle Kramer, Kamar Belghazi, Katya Duvivier, Petrousjka van den Tol, Hermien Schreurs
    Journal of Oncology.2019; 2019: 1.     CrossRef
  • Computer-aided prediction model for axillary lymph node metastasis in breast cancer using tumor morphological and textural features on ultrasound
    Woo Kyung Moon, I-Ling Chen, Ann Yi, Min Sun Bae, Sung Ui Shin, Ruey-Feng Chang
    Computer Methods and Programs in Biomedicine.2018; 162: 129.     CrossRef
  • The Evolution of the Current Indications for Sentinel Lymph Node Biopsy in Breast Cancer
    Sofia E Triantafillidou
    Hellenic Journal of Surgery.2018; 90(4): 186.     CrossRef
  • Axillary Lymph Node to Primary Breast Tumor Standardized Uptake Value Ratio from FDG-PET/CT Imaging for Predicting the Necessity for Nodal Dissection in Primary Breast Tumors
    Han-kyul Shin, Min Kyoon Kim, Sung Jun Park, Ju Won Seok, Hee-Chul Shin
    Journal of Breast Disease.2017; 5(2): 76.     CrossRef
  • 10,950 View
  • 356 Download
  • 21 Web of Science
  • 23 Crossref
Close layer
Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study
Se Hyun Kim, Kyung Hae Jung, Tae-Yong Kim, Seock-Ah Im, In Sil Choi, Yee Soo Chae, Sun Kyung Baek, Seok Yun Kang, Sarah Park, In Hae Park, Keun Seok Lee, Yoon Ji Choi, Soohyeon Lee, Joo Hyuk Sohn, Yeon-Hee Park, Young-Hyuck Im, Jin-Hee Ahn, Sung-Bae Kim, Jee Hyun Kim
Cancer Res Treat. 2016;48(4):1373-1381.   Published online March 23, 2016
DOI: https://doi.org/10.4143/crt.2015.475
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The purpose of this study is to investigate the prognostic value of lymph node (LN) ratio (LNR) in patients with breast cancer after neoadjuvant chemotherapy.
Materials and Methods
This retrospective analysis is based on the data of 814 patientswith stage II/III breast cancer treated with four cycles of doxorubicin/cyclophosphamide followed by four cycles of docetaxel before surgery. We evaluated the clinical significance of LNR (3 categories: low 0-0.20 vs. intermediate 0.21-0.65 vs. high 0.66-1.00) using a Cox proportional regression model.
Results
A total of 799 patients underwent breast surgery. Pathologic complete response (pCR, ypT0/isN0) was achieved in 129 patients (16.1%) (hormone receptor [HR] +/human epidermal growth factor receptor 2 [HER2] –, 34/373 [9.1%]; HER2+, 45/210 [21.4%]; triple negative breast cancer, 50/216 [23.1%]). The mean numbers of involved LN and retrieved LN were 2.70 (range, 0 to 42) and 13.98 (range, 1 to 64), respectively. The mean LNR was 0.17 (low, 574 [71.8%]; intermediate, 170 [21.3%]; high, 55 [6.9%]). In univariate analysis, LNR showed significant association with a worse relapse-free survival (3-year relapse-free survival rate 84.8% in low vs. 66.2% in intermediate vs. 54.3% in high; p < 0.001, log-rank test). In multivariate analysis, LNR did not show significant association with recurrence after adjusting for other clinical factors (age, histologic grade, subtype, ypT stage, ypN stage, lymphatic or vascular invasion, and pCR). In subgroup analysis, the LNR system had good prognostic value in HR+/HER2– subtype.
Conclusion
LNR is not superior to ypN stage in predicting clinical outcome of breast cancer after neoadjuvant chemotherapy. However, the prognostic value of the LNR system in HR+/HER2– patients is notable and worthy of further investigation.

Citations

Citations to this article as recorded by  
  • Breast Cancer Patients With Positive Apical or Infraclavicular/Ipsilateral Supraclavicular Lymph Nodes Should Be Excluded in the Application of the Lymph Node Ratio System
    Zhe Wang, Wei Chong, Huikun Zhang, Xiaoli Liu, Yawen Zhao, Zhifang Guo, Li Fu, Yongjie Ma, Feng Gu
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • The prognostic role of lymph node ratio in breast cancer patients received neoadjuvant chemotherapy: A dose-response meta-analysis
    Jinzhao Liu, Yifei Li, Weifang Zhang, Chenhui Yang, Chao Yang, Liang Chen, Mingjian Ding, Liang Zhang, Xiaojun Liu, Guozhong Cui, Yunjiang Liu
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
    Yul Ri Chung, Ji Won Woo, Soomin Ahn, Eunyoung Kang, Eun-Kyu Kim, Mijung Jang, Sun Mi Kim, Se Hyun Kim, Jee Hyun Kim, So Yeon Park
    Scientific Reports.2021;[Epub]     CrossRef
  • Using a novel T-lymph node ratio model to evaluate the prognosis of nonmetastatic breast cancer patients who received preoperative radiotherapy followed by mastectomy
    Yang Wang, Yuanyuan Zhao, Song Liu, Weifang Tang, Hong Gao, Xucai Zheng, Shikai Hong, Shengying Wang
    Medicine.2017; 96(42): e8203.     CrossRef
  • The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes
    Xiang Li, Ruishan Zhang, Zhuangkai Liu, Shuang Li, Hong Xu
    Oncotarget.2017; 8(12): 20252.     CrossRef
  • Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy
    Ji Hyun Chang, Wan Jeon, Kyubo Kim, Kyung Hwan Shin, Wonshik Han, Dong-Young Noh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang
    Journal of Breast Cancer.2016; 19(4): 394.     CrossRef
  • 12,034 View
  • 163 Download
  • 7 Web of Science
  • 6 Crossref
Close layer
The Expression of Carbonic Anhydrase (CA) IX/XII and Lymph Node Metastasis in Early Breast Cancer
Keun-Yong Eom, Min Hye Jang, So Yeon Park, Eun Young Kang, Sung Won Kim, Jee Hyun Kim, Jae-Sung Kim, In Ah Kim
Cancer Res Treat. 2016;48(1):125-132.   Published online March 3, 2015
DOI: https://doi.org/10.4143/crt.2014.243
AbstractAbstract PDFPubReaderePub
Purpose
The aim of study was to test by immunohistochemical (IHC) staining whether carbonic anhydrase (CA) 9 and 12 have an effect on sentinel lymph node (SLN) metastasis in early breast cancer and to find clinicopathologic factors associated with SLN metastasis.
Materials and Methods
Between June 2003 and June 2011, medical records of 470 patients diagnosedwith breast cancer with pT1-2, pN0-2, and M0 were reviewed. Of these 470, 314 patients who underwent SLN biopsy±axillary dissection were subjects of this study. Using tissue microarray, IHC staining for CA9 and CA12 was performed. Clinicopathologic factors such as patient age, tumour size, lymphatic invasion, hormone receptor status, and the Ki-67 labeling index were analysed together.
Results
The mean age of all patients was 51.7 years. The mean number of harvested SLN was 3.62, and 212 patients (67.5%) had negative SLN. Lymphatic invasion, the Ki-67 labelling index of primary tumours, and CA9 staining of stromal cells, were independent risk factors for SLN metastasis in the multivariate analysis. In 33 patients (10.5%) without the three risk factors, no patient had SLN metastasis. In 80 patients without lymphatic invasion of primary tumours or CA9 staining of stromal cells, only four patients (5%) had positive SLN.
Conclusion
CA9 staining of stromal cells is an independent risk factor for SLN metastasis as well as lymphatic invasion and a low Ki-67 labelling index of primary tumours in patients with early breast cancer. IHC staining of primary tumours for CA12was not associatedwith SLN metastasis.

Citations

Citations to this article as recorded by  
  • The Diagnostic Role of TFF1, TFF3, FOXA1, CA XII and TRPS1 in Serous Effusions
    Ben Davidson, Arild Holth, Jeremias Wohlschlaeger, Maurizio Pinamonti, Binnur Önal
    Cytopathology.2025;[Epub]     CrossRef
  • Impact of CA9 expression in the diagnosis of lymph-node metastases in non-small cell lung cancer based on [18F]FDG PET/CT
    Satoshi Suzuki, Masakazu Yashiro, Nobuhiro Izumi, Takuma Tsukioka, Hidetoshi Inoue, Kantaro Hara, Ryuichi Ito, Takuya Tanimura, Noritoshi Nishiyama, Domenico Albano
    PLOS ONE.2024; 19(10): e0312846.     CrossRef
  • Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling
    Daniele Vergara, Sara Ravaioli, Eugenio Fonzi, Loredaria Adamo, Marina Damato, Sara Bravaccini, Francesca Pirini, Antonio Gaballo, Raffaela Barbano, Barbara Pasculli, Julien Franck, Isabelle Fournier, Michel Salzet, Michele Maffia
    International Journal of Molecular Sciences.2020; 21(3): 715.     CrossRef
  • The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer
    Khalid O. Alfarouk, Samrein B. M. Ahmed, Ahmed Ahmed, Robert L. Elliott, Muntaser E. Ibrahim, Heyam S. Ali, Christian C. Wales, Ibrahim Nourwali, Ahmed N. Aljarbou, Adil H. H. Bashir, Sari T. S. Alhoufie, Saad Saeed Alqahtani, Rosa A. Cardone, Stefano Fai
    Cancers.2020; 12(4): 898.     CrossRef
  • Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer
    Shaoquan Zheng, Yutian Zou, Jie‐ying Liang, Weikai Xiao, Anli Yang, Tiebao Meng, Shilin Lu, Zhongbing Luo, Xiaoming Xie
    Molecular Oncology.2020; 14(11): 2814.     CrossRef
  • The roles of carbonic anhydrases IX and XII in cancer cell adhesion, migration, invasion and metastasis
    Simonas Daunys, Vilma Petrikaitė
    Biology of the Cell.2020; 112(12): 383.     CrossRef
  • Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer
    Min-Sun Jin, Hyebin Lee, In Ae Park, Yul Ri Chung, Seock-Ah Im, Kyung-Hun Lee, Hyeong-Gon Moon, Wonshik Han, Kyubo Kim, Tae-Yong Kim, Dong-Young Noh, Han Suk Ryu
    Virchows Archiv.2016; 469(2): 183.     CrossRef
  • Transcriptome sequencing of HER2-positive breast cancer stem cells identifies potential prognostic marker
    Bo Lei, Xian-yu Zhang, Jia-peng Zhou, Guan-nan Mu, Yi-wen Li, You-xue Zhang, Da Pang
    Tumor Biology.2016; 37(11): 14757.     CrossRef
  • Three-Dimensional Breast Cancer Models Mimic Hallmarks of Size-Induced Tumor Progression
    Manjulata Singh, Shilpaa Mukundan, Maria Jaramillo, Steffi Oesterreich, Shilpa Sant
    Cancer Research.2016; 76(13): 3732.     CrossRef
  • 14,471 View
  • 123 Download
  • 11 Web of Science
  • 9 Crossref
Close layer
Correspondences
Close layer
Commentary on “Clinical Characteristics and Adequate Treatment of Familial Adenomatous Polyposis Combined with Desmoid Tumors”
Edoardo Virgilio, Francesca Di Gregorio, Genoveffa Balducci
Cancer Res Treat. 2015;47(2):339-340.   Published online February 26, 2015
DOI: https://doi.org/10.4143/crt.2015.038
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Benzodiazepines for agitation in patients with delirium
    David Hui
    Current Opinion in Supportive and Palliative Care.2018; 12(4): 489.     CrossRef
  • Reply to Commentary on “Clinical Characteristics and Adequate Treatment of Familial Adenomatous Polyposis Combined with Desmoid Tumors”
    Jin Cheon Kim
    Cancer Research and Treatment.2015; 47(2): 341.     CrossRef
  • 10,957 View
  • 64 Download
  • 2 Web of Science
  • 2 Crossref
Close layer
Case Report
A Unique Case of Erdheim-Chester Disease with Axial Skeleton, Lymph Node, and Bone Marrow Involvement
Jin Lim, Ki Hwan Kim, Koung Jin Suh, Kyung Ah Yoh, Jin Young Moon, Ji Eun Kim, Eun Youn Roh, In Sil Choi, Jin-Soo Kim, Jin Hyun Park
Cancer Res Treat. 2016;48(1):415-421.   Published online February 26, 2015
DOI: https://doi.org/10.4143/crt.2014.160
AbstractAbstract PDFPubReaderePub
Erdheim-Chester disease is a rare non-Langerhans–cell histiocytosis with bone and organ involvement. A 76-year-old man presented with low back pain and a history of visits for exertional dyspnea. We diagnosed him with anemia of chronic disease, cytopenia related to chronic illness, chronic renal failure due to hypertension, and hypothyroidism. However, we could not determine a definite cause or explanation for the cytopenia. Multiple osteosclerotic axial skeleton lesions and axillary lymph node enlargement were detected by computed tomography. Bone marrow biopsy revealed histiocytic infiltration, which was CD68-positive and CD1a-negative. This report describes an unusual presentation of Erdheim-Chester disease involving the bone marrow, axial skeleton, and lymph nodes.

Citations

Citations to this article as recorded by  
  • Erdheim Chester Disease Mimicking Lymphoma: A Case Report
    Philipp Moritz Wunschel, Wolfgang Voss, Marc Keberle
    RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.2022; 194(03): 310.     CrossRef
  • Myelopathy Secondary to Isolated Thoracic Spine Involvement Mimicking Metastasis in Erdheim–Chester Disease
    Rajesh Rajavelu, Ajoy P. Shetty, Rishi M. Kanna, S Rajasekaran
    Indian Spine Journal.2021; 4(1): 133.     CrossRef
  • Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 Pandemic
    Georgia Kaiafa, Dimitrios Pilalas, Triantafyllia Koletsa, Stylianos Daios, Georgios Arsos, Adam Hatzidakis, Adonis Protopapas, Kostas Stamatopoulos, Christos Savopoulos
    Medicina.2021; 57(10): 1001.     CrossRef
  • Case of Erdheim–Chester presenting with xanthelasma-like eruption and osteolytic bone lesions: A case report
    Evelyn Alarcon Chinchilla, Marie-Pascale Gourde, Karine Turcotte, Steve Mathieu, Mohamed Amin-Hashem
    SAGE Open Medical Case Reports.2019;[Epub]     CrossRef
  • Erdheim-Chester Disease Involving Lymph Nodes and Liver Clinically Mimicking Lymphoma: A Case Report
    Yeoun Eun Sung, Yoon Seo Lee, Jieun Lee, Kyo Young Lee
    Journal of Pathology and Translational Medicine.2018; 52(3): 183.     CrossRef
  • Resolved heart tamponade and controlled exophthalmos, facial pain and diabetes insipidus due to Erdheim-Chester disease
    Jaume Monmany, Esther Granell, Laura López, Pere Domingo
    BMJ Case Reports.2018; : bcr-2018-225224.     CrossRef
  • 18F-FDG PET/CT in Erdheim–Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker
    Jason R. Young, Geoffrey B. Johnson, Robert C. Murphy, Ronald S. Go, Stephen M. Broski
    Journal of Nuclear Medicine.2018; 59(5): 774.     CrossRef
  • Erdheim-Chester Disease with Emperipolesis: A Unique Case Involving the Heart
    Pengcheng Zhu, Naping Li, Lu Yu, Mariajose Navia Miranda, Guoping Wang, Yaqi Duan
    Cancer Research and Treatment.2017; 49(2): 553.     CrossRef
  • 18,881 View
  • 97 Download
  • 9 Web of Science
  • 8 Crossref
Close layer
Original Articles
Overexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node Metastasis
Yun-Suhk Suh, Jieun Yu, Byung Chul Kim, Boram Choi, Tae-Su Han, Hye Seong Ahn, Seong-Ho Kong, Hyuk-Joon Lee, Woo Ho Kim, Han-Kwang Yang
Cancer Res Treat. 2015;47(4):718-726.   Published online February 2, 2015
DOI: https://doi.org/10.4143/crt.2014.064
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study is to investigate differentially expressed genes using DNA microarray between advanced gastric cancer (AGC) with aggressive lymph node (LN) metastasis and that with a more advanced tumor stage but without LN metastasis.
Materials and Methods
Five sample pairs of gastric cancer tissue and normal gastric mucosa were taken from three patients with T3N3 stage (highN) and two with T4N0 stage (lowN). Data from triplicate DNA microarray experiments were analyzed, and candidate genes were identified using a volcano plot that showed ≥ 2-fold differential expression and were significant by Welch's t test (p < 0.05) between highN and lowN. Those selected genes were validated independently by reverse- transcriptase–polymerase chain reaction (RT-PCR) using five AGC patients, and tissue- microarray (TMA) comprising 47 AGC patients.
Results
CFTR, LAMC2, SERPINE2, F2R, MMP7, FN1, TIMP1, plasminogen activator inhibitor-1 (PAI- 1), ITGB8, SDS, and TMPRSS4 were commonly up-regulated over 2-fold in highN. REG3A, CD24, ITLN1, and WBP5 were commonly down-regulated over 2-fold in lowN. Among these genes, overexpression of PAI-1 was validated by RT-PCR, and TMA showed 16.7% (7/42) PAI-1 expression in T3N3, but none (0/5) in T4N0 (p=0.393).
Conclusion
DNA microarray analysis and validation by RT-PCR and TMA showed that overexpression of PAI-1 is related to aggressive LN metastasis in AGC.

Citations

Citations to this article as recorded by  
  • WBP5 Expression Influences Prognosis and Treatment Response in Head and Neck Squamous Cell Carcinoma
    Eun-jeong Jeong, Eunjeong Kim, Kwang-Yoon Jung, Seung-Kuk Baek, Yeon Soo Kim
    Cancers.2025; 17(4): 587.     CrossRef
  • Expression of Serpin Family E Member 1 (SERPINE1) Is Associated with Poor Prognosis of Gastric Adenocarcinoma
    Jie Lv, Chunyang Yu, Hanhan Tian, Tao Li, Changhua Yu
    Biomedicines.2023; 11(12): 3346.     CrossRef
  • Helicobacter pylori-induced fibroblast-derived Serpin E1 promotes gastric cancer growth and peritoneal dissemination through p38 MAPK/VEGFA-mediated angiogenesis
    Wei Cheng, Yonghui Liao, Yuan Xie, Qinrong Wang, Leilei Li, Yuanjia Chen, Yan Zhao, Jianjiang Zhou
    Cancer Cell International.2023;[Epub]     CrossRef
  • Analysis of CFTR gene expression as an immunological and prognostic biomarker in pan-cancers
    Qi Wang, Shubing Jia, Jie Zheng, Rongwu Xiang, Yong Cui, Jinghai Zhang, Yijia Xu, Mingyi Zhao
    Computers in Biology and Medicine.2022; 146: 105614.     CrossRef
  • Interplay of Helicobacter pylori, fibroblasts, and cancer cells induces fibroblast activation and serpin E1 expression by cancer cells to promote gastric tumorigenesis
    Xueshu Chen, Wei Chen, Yan Zhao, Qinrong Wang, Wenling Wang, Yining Xiang, Hang Yuan, Yuan Xie, Jianjiang Zhou
    Journal of Translational Medicine.2022;[Epub]     CrossRef
  • SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells
    Junjie Zhou, Wenhao Chen, Qianwen He, Dong Chen, Chunguang Li, Congqing Jiang, Zhao Ding, Qun Qian
    PeerJ.2022; 10: e14084.     CrossRef
  • A qualitative transcriptional signature of recurrence risk for stages II–III gastric cancer patients after surgical resection
    Huarong Zhang, Xiangyu Li, Junling Wu, Jiahui Zhang, Haiyan Huang, Yawei Li, Meifeng Li, Shanshan Wang, Jie Xia, Lishuang Qi, Ting Chen, Lu Ao
    Journal of Gastroenterology and Hepatology.2021; 36(9): 2501.     CrossRef
  • Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer
    Qiaoyun Zhao, Jun Xie, Jinliang Xie, Rulin Zhao, Conghua Song, Huan Wang, Jianfang Rong, Lili Yan, Yanping Song, Fangfei Wang, Yong Xie
    Cancer Biomarkers.2021; 31(1): 59.     CrossRef
  • Current therapeutic options for gastric adenocarcinoma
    C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad
    Saudi Journal of Biological Sciences.2021; 28(9): 5371.     CrossRef
  • Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
    Gary Tincknell, Ann-Katrin Piper, Morteza Aghmesheh, Therese Becker, Kara Lea Vine, Daniel Brungs, Marie Ranson
    Cancers.2021; 13(16): 4097.     CrossRef
  • Sustained postoperative plasma elevations of plasminogen activator inhibitor‑1 following minimally invasive colorectal cancer resection
    H.M.C. Kumara, Addison Poppy, Dasuni Gamage, Erica Pettke, Abhinit Shah, Xiaohong Yan, Vesna Cekic, Richard Whelan
    Molecular and Clinical Oncology.2021;[Epub]     CrossRef
  • High WBP5 expression correlates with elevation of HOX genes levels and is associated with inferior survival in patients with acute myeloid leukaemia
    C. Ward, P. Cauchy, P. Garcia, J. Frampton, M. A. Esteban, G. Volpe
    Scientific Reports.2020;[Epub]     CrossRef
  • microRNA‐501‐5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1
    Xiang Ma, Jiaxi Feng, Ming Lu, Wenjuan Tang, Jianbo Han, XiaGang Luo, Qinghong Zhao, Li Yang
    Journal of Cellular Biochemistry.2020; 121(2): 1911.     CrossRef
  • Adipocyte-Derived Leptin Promotes PAI-1-Mediated Breast Cancer Metastasis in a STAT3/miR-34a Dependent Manner
    Si-Jing Li, Xiao-Hui Wei, Xiao-Man Zhan, Jin-Yong He, Yu-Qi Zeng, Xue-Mei Tian, Sheng-Tao Yuan, Li Sun
    Cancers.2020; 12(12): 3864.     CrossRef
  • Global transcriptomic analysis identifiesSERPINE1as a prognostic biomarker associated with epithelial-to-mesenchymal transition in gastric cancer
    Bodong Xu, Zhigang Bai, Jie Yin, Zhongtao Zhang
    PeerJ.2019; 7: e7091.     CrossRef
  • Role of ion channels in gastrointestinal cancer
    Kyle J Anderson, Robert T Cormier, Patricia M Scott
    World Journal of Gastroenterology.2019; 25(38): 5732.     CrossRef
  • Clinicopathological and Prognostic Significance of WW Domain Binding Protein 5 Expression in Papillary Thyroid Carcinoma
    Yangyang Qian, Zongfu Pan, Zhenying Guo, Xinyang Ge, Guowan Zheng, Jun Cao, Ping Huang, Xin Zhu, Xuhang Zhu, Qingliang Wen, Minghua Ge
    BioMed Research International.2019; 2019: 1.     CrossRef
  • Cystic fibrosis transmembrane conductance regulator—emerging regulator of cancer
    Jieting Zhang, Yan Wang, Xiaohua Jiang, Hsiao Chang Chan
    Cellular and Molecular Life Sciences.2018; 75(10): 1737.     CrossRef
  • Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis
    Xinkui Liu, Jiarui Wu, Dan Zhang, Zhitong Bing, Jinhui Tian, Mengwei Ni, Xiaomeng Zhang, Ziqi Meng, Shuyu Liu
    Frontiers in Genetics.2018;[Epub]     CrossRef
  • The Expression and Significance of FAK/PI3K/AKt/mTOR Signaling Pathway Related Proteins in Human Gastric Carcinoma
    波 于
    World Journal of Cancer Research.2018; 08(03): 113.     CrossRef
  • Proteomic analysis of evodiamine-induced cytotoxicity in thyroid cancer cells
    Hui-I Yu, Hsiu-Chuan Chou, Yi-Ching Su, Li-Hsun Lin, Chieh-Hsiang Lu, Hsiang-Hsun Chuang, Yi-Ting Tsai, En-Chi Liao, Yu-Shan Wei, Yi-Ting Yang, Ying-Ray Lee, Hong-Lin Chan
    Journal of Pharmaceutical and Biomedical Analysis.2018; 160: 344.     CrossRef
  • Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis
    Arseniy E. Yuzhalin, Su Yin Lim, Anton G. Kutikhin, Alex N. Gordon-Weeks
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2018; 1870(2): 207.     CrossRef
  • MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells
    Hengchun Zhang, Zhiguo Sun, Yan Li, Dong Fan, Hao Jiang
    Biomedicine & Pharmacotherapy.2017; 88: 285.     CrossRef
  • Methylation Levels of LINE-1 As a Useful Marker for Venous Invasion in Both FFPE and Frozen Tumor Tissues of Gastric Cancer
    Jimin Min, Boram Choi, Tae-Su Han, Hyuk-Joon Lee, Seong-Ho Kong, Yun-Suhk Suh, Tae-Han Kim, Hwi-Nyeong Choe, Woo Ho Kim, Keun Hur, Han-Kwang Yang
    Molecules and Cells.2017; 40(5): 346.     CrossRef
  • WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway
    Ruixiang Tang, Yingying Lei, Bingshuang Hu, Jie Yang, Shun Fang, Qiongyao Wang, Man Li, Linlang Guo
    British Journal of Cancer.2016; 115(2): 243.     CrossRef
  • Gastric cancer from operating theatre to bench in Korea
    H-K Yang
    British Journal of Surgery.2016; 103(10): 1251.     CrossRef
  • The embryonic stress response to in vitro culture: insight from genomic analysis
    Gael Cagnone, Marc-André Sirard
    Reproduction.2016; 152(6): R247.     CrossRef
  • 15,755 View
  • 166 Download
  • 29 Web of Science
  • 27 Crossref
Close layer
Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy
San-Gang Wu, Qun Li, Juan Zhou, Jia-Yuan Sun, Feng-Yan Li, Qin Lin, Huan-Xin Lin, Xun-Xing Gaun, Zhen-Yu He
Cancer Res Treat. 2015;47(4):757-764.   Published online December 8, 2014
DOI: https://doi.org/10.4143/crt.2014.039
AbstractAbstract PDFPubReaderePub
Purpose
This study was conducted to investigate the prognostic value of lymph node ratio (LNR) in stage II/III breast cancer patients who undergo mastectomy after neoadjuvant chemotherapy.
Materials and Methods
Clinical and pathological data describing stage II/III breast cancer patients were included in this retrospective study. The primary outcomes were locoregional recurrence-free survival (LRFS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overall survival (OS).
Results
Among 277 patients, there were 43 ypN0, 64 ypN1, 89 ypN2, and 81 ypN3 cases. Additionally, there were 43, 57, 92 and 85 cases in the LNR 0, 0.01-0.20, 0.21-0.65, and > 0.65 groups, respectively. The median follow-up was 49.5 months. Univariate analysis showed that both ypN stage and LNR were prognostic factors of LRFS, DMFS, DFS, and OS (p < 0.05). Multivariate analysis showed that LNR was an independent prognostic factor of LRFS, DMFS, DFS, and OS (p < 0.05), while ypN stage had no effect on prognosis (p > 0.05).
Conclusion
The integrated use of LNR and ypN may be suitable for evaluation the prognosis of stage II/III breast cancer patients who undergo mastectomy after neoadjuvant chemotherapy.

Citations

Citations to this article as recorded by  
  • Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective study
    Lingfeng Tang, Linshan Jiang, Xiujie Shu, Yudi Jin, Haochen Yu, Shengchun Liu
    Scientific Reports.2024;[Epub]     CrossRef
  • Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database
    Bing Chen, Xiaojuan Zhang, Yi Liu, Chuandong Wang
    Medicine.2023; 102(13): e33416.     CrossRef
  • The Effect of Lymph Node Harvest on Prognosis in Locally Advanced Middle-Low Rectal Cancer After Neoadjuvant Chemoradiotherapy
    Zhuangbin Lin, Xiaobo Li, Jianyuan Song, Rong Zheng, Cheng Chen, Anchuan Li, Benhua Xu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Breast Cancer Patients With Positive Apical or Infraclavicular/Ipsilateral Supraclavicular Lymph Nodes Should Be Excluded in the Application of the Lymph Node Ratio System
    Zhe Wang, Wei Chong, Huikun Zhang, Xiaoli Liu, Yawen Zhao, Zhifang Guo, Li Fu, Yongjie Ma, Feng Gu
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
    Hee Jun Choi, Jai Min Ryu, Jun Ho Lee, Yoonju Bang, Jongwook Oh, Byung-Joo Chae, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Se Kyung Lee, Jonghan Yu
    Journal of Clinical Medicine.2022; 11(21): 6564.     CrossRef
  • A novel nomogram for predicting locoregional recurrence risk in breast cancer patients treated with neoadjuvant chemotherapy and mastectomy
    Zhou Huang, Mei Shi, Wei-Hu Wang, Liang-Fang Shen, Yu Tang, Qing-Lin Rong, Li Zhu, Xiao-Bo Huang, Jian Tie, Jia-Yi Chen, Jun Zhang, Hong-Fen Wu, Jing Cheng, Min Liu, Chang-Ying Ma, Shu-Lian Wang, Ye-Xiong Li
    Radiotherapy and Oncology.2021; 161: 191.     CrossRef
  • Lymph node ratio as best prognostic factor in triple‐negative breast cancer patients with residual disease after neoadjuvant chemotherapy
    Gabriel A. De la Cruz‐Ku, Diego Chambergo‐Michilot, Bryan Valcarcel, Pamela Rebaza, Mecker Möller, Jhajaira M. Araujo, Daniel Enriquez, Zaida Morante, Cesar Razuri, Renato Luque, Antonella Saavedra, Eduardo Eyzaguirre, Maria Lujan, Naysha Noel, Joseph Pin
    The Breast Journal.2020; 26(9): 1659.     CrossRef
  • Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy
    Jianguo Lai, Zihao Pan, Peixian Chen, Guolin Ye, Kai Chen, Fengxi Su
    Japanese Journal of Clinical Oncology.2019; 49(1): 22.     CrossRef
  • Lymph node ratio as an alternative to pN staging for predicting prognosis after neoadjuvant chemotherapy in breast cancer
    Dong Hui Cho, Soo Youn Bae, Ji Young You, Hong Kyu Kim, Young Woo Chang, Yoo Jin Choi, Sang Uk Woo, Gil Soo Son, Jae Bok Lee, Jeoung Won Bae, Seung Pil Jung
    The Kaohsiung Journal of Medical Sciences.2018; 34(6): 341.     CrossRef
  • Ganglio secundario como indicador de linfadenectomía axilar en pacientes afectas de cáncer de mama
    Manel Cremades, Mireia Torres, Montse Solà, Jordi Navinés, Icíar Pascual, Antonio Mariscal, Albert Caballero, Eva Castellà, Miguel Ángel Luna, Joan Francesc Julián
    Cirugía Española.2017; 95(9): 536.     CrossRef
  • Secondary Node Analysis as an Indicator for Axillary Lymphadenectomy in Breast Cancer Patients
    Manel Cremades, Mireia Torres, Montse Solà, Jordi Navinés, Icíar Pascual, Antonio Mariscal, Albert Caballero, Eva Castellà, Miguel Ángel Luna, Joan Francesc Julián
    Cirugía Española (English Edition).2017; 95(9): 536.     CrossRef
  • Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy
    Liang Huang, Sheng Chen, Wentao T. Yang, Zhiming Shao
    Oncotarget.2017; 8(24): 39703.     CrossRef
  • Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer
    Jacqueline Tsai, Danielle Bertoni, Tina Hernandez-Boussard, Melinda L. Telli, Irene L. Wapnir
    Annals of Surgical Oncology.2016; 23(10): 3310.     CrossRef
  • Number of negative lymph nodes as a prognostic factor for ypN0-N1 breast cancer patients undergoing neoadjuvant chemotherapy
    Fei Xin, Yue Yu, Zheng-Jun Yang, Li-Kun Hou, Jie-Fei Mao, Li Xia, Xin Wang, Xu-Chen Cao
    Tumor Biology.2016; 37(6): 8445.     CrossRef
  • 12,268 View
  • 87 Download
  • 18 Web of Science
  • 14 Crossref
Close layer
Prospective Evaluation of the Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Negative Axillary Conversion after Neoadjuvant Chemotherapy
Hy-De Lee, Sung Gwe Ahn, Seung Ah Lee, Hak Min Lee, Joon Jeong
Cancer Res Treat. 2015;47(1):26-33.   Published online August 29, 2014
DOI: https://doi.org/10.4143/crt.2013.208
AbstractAbstract PDFPubReaderePub
Purpose
Tumor response to neoadjuvant chemotherapy (NAC) may adversely affect the identification and accuracy rate of sentinel lymph node biopsy (SLNB). This study was conducted to evaluate the feasibility of SLNB in node-positive breast cancer patients with negative axillary conversion after NAC. Materials and Methods Ninety-six patients with positive nodes at presentation were prospectively enrolled. 18Fluorodeoxyglucose-positron emission tomography (18F-FDG PET) and ultrasonography were performed before and after NAC. A metastatic axillary lymph node was defined as positive if it was positive upon both 18F-FDG PET and ultrasonography, while it was considered negative if it was negative upon both 18F-FDG PET and ultrasonography. Results After NAC, 55 cases (57.3%) became clinically node-negative, while 41 cases (42.7%) remained node-positive. In the entire cohort, the sentinel lymph node (SLN) identification and false-negative rates were 84.3% (81/96) and 18.4% (9/49), respectively. In the negative axillary conversion group, the results of SLNB showed an 85.7% (48/55) identification rate and 16.7% (4/24) false-negative rate. Conclusion For breast cancer patients with clinically positive nodes at presentation, it is difficult to conclude whether the SLN accurately represents the metastatic status of all axillary lymph nodes, even after clinically negative node conversion following NAC.

Citations

Citations to this article as recorded by  
  • Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Axillary Conversion after Neoadjuvant Chemotherapy—A Single-Tertiary Centre Experience and Review of the Literature
    Alexandra Maria Lazar, Mario-Demian Mutuleanu, Paula Monica Spiridon, Cristian Ioan Bordea, Tatiana Lucia Suta, Alexandru Blidaru, Mirela Gherghe
    Diagnostics.2023; 13(18): 3000.     CrossRef
  • AGO-Empfehlungen zur operativen Therapie der Axilla nach neoadjuvanter Chemotherapie: Update 2021
    Michael Friedrich, Thorsten Kühn, Wolfgang Janni, Volkmar Müller, Maggie Banys-Paluchowski, Cornelia Kolberg-Liedtke, Christian Jackisch, David Krug, Ute-Susann Albert, Ingo Bauerfeind, Jens Blohmer, Wilfried Budach, Peter Dall, Eva M. Fallenberg, Peter A
    Senologie - Zeitschrift für Mammadiagnostik und -therapie.2022; 19(01): 56.     CrossRef
  • The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic review
    Juan C. Vázquez, Antonio Piñero, Francisco J. de Castro, Ana Lluch, Miguel Martín, Agustí Barnadas, Emilio Alba, Álvaro Rodríguez-Lescure, Federico Rojo, Julia Giménez, Ivan Solá, Maria J. Quintana, Xavier Bonfill, Gerard Urrutia, Pedro Sánchez-Rovira
    Clinical and Translational Oncology.2022; 25(2): 417.     CrossRef
  • Outcomes of Sentinel Node Biopsy for Women with Breast Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis of Real-World Data
    Shi-Qian Lin, Nguyen-Phong Vo, Yu-Chun Yen, Ka-Wai Tam
    Annals of Surgical Oncology.2022; 29(5): 3038.     CrossRef
  • Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: An up-to-date meta-analysis of 3,578 patients
    Siyang Cao, Xia Liu, Junwei Cui, Xiaoling Liu, Jieyu Zhong, Zijian Yang, Desheng Sun, Wei Wei
    The Breast.2021; 59: 256.     CrossRef
  • AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update
    Michael Friedrich, Thorsten Kühn, Wolfgang Janni, Volkmar Müller, Maggie Banys-Paluchowski, Cornelia Kolberg-Liedtke, Christian Jackisch, David Krug, Ute-Susann Albert, Ingo Bauerfeind, Jens Blohmer, Wilfried Budach, Peter Dall, Eva M. Fallenberg, Peter A
    Geburtshilfe und Frauenheilkunde.2021; 81(10): 1112.     CrossRef
  • Therapiealgorithmen für das Mammakarzinom
    J.-U. Blohmer, A. Schneeweiss, I. Bauerfeind, T. Fehm, V. Müller, C. Thomssen, I. Witzel, A. Wöckel, W. Janni
    Der Onkologe.2021; 27(12): 1165.     CrossRef
  • Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node‐positive, HER2‐positive breast cancer
    Chihwan Cha, Sung Gwe Ahn, Dooreh Kim, Janghee Lee, Soeun Park, Soong June Bae, Jee Ye Kim, Hyung Seok Park, Seho Park, Seung Il Kim, Byeong‐Woo Park, Joon Jeong
    International Journal of Cancer.2021; 149(8): 1585.     CrossRef
  • The Accuracy of Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy in Clinically Node Positive Breast Cancer Patients: A Single Institution Experience
    Hossein Yahyazadeh, Maria Hashemian, Mojtaba Rajabpour, Saina Aminmozaffari, Maryam Zaree, Ahmad R Mafi, Hossein Pourtavakoli, Narges Sistany Allahabadi, Marzieh Beheshti
    International Journal of Cancer Management.2018;[Epub]     CrossRef
  • A survey of current surgical treatment of early stage breast cancer in China
    Xin Zhang, Ying Wang
    Oncoscience.2018; 5(7-8): 239.     CrossRef
  • Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis
    Jai Min Ryu, Se Kyung Lee, Ji Young Kim, Jonghan Yu, Seok Won Kim, Jeong Eon Lee, Se Hwan Han, Yong Sik Jung, Seok Jin Nam
    Clinical Breast Cancer.2017; 17(7): 550.     CrossRef
  • 22,009 View
  • 127 Download
  • 12 Web of Science
  • 11 Crossref
Close layer
A Distribution Weighted Prognostic Scoring Model for Node Status in Advanced Rectal Cancer
Kwang-Hee Yeo, Ho Hyun Kim, Dong-Yi Kim, Young-Jin Kim, Jae-Kyun Ju
Cancer Res Treat. 2014;46(1):41-47.   Published online January 15, 2014
DOI: https://doi.org/10.4143/crt.2014.46.1.41
AbstractAbstract PDFPubReaderePub
PURPOSE
There are various lymph node-based staging systems. Nevertheless, there is debate over the use of parameters such as the number of involved lymph nodes and the lymph node ratio. As a possible option, the distribution of metastatic lymph nodes may have a prognostic significance in rectal cancer. This study is designed to evaluate the impact of distribution-weighted nodal staging on oncologic outcome in rectal cancer.
MATERIALS AND METHODS
From a prospectively maintained colorectal cancer database of our institution, a total of 435 patients who underwent a curative low anterior resection for mid and upper rectal cancer between 1995 and 2004 were enrolled. Patients were divided into 3 groups according to the location of apical metastatic nodes. A location-weighted prognostic score was calculated by a scoring model using a logistic regression test for location based-statistical weight to number of lymph nodes. All cases were categorized in quartiles from lymph node I to lymph node IV using this protocol.
RESULTS
The location of lymph node metastasis was an independent factor that was associated with a poor prognostic outcome (p<0.001). Based on this result, the location-weighted-nodal prognostic scoring model did not show lesser significant results (p<0.0001) in both overall survival and cancer-free survival analyses.
CONCLUSION
The location of apical nodes among the metastatic nodes does not have a lesser significant impact on oncologic result in patients with advanced rectal cancer. A location-weighted prognostic scoring model, which considered the numbers of involved lymph nodes as the rate of significance according to the location, may more precisely predict the survival outcome in patients with lymph node metastasis.

Citations

Citations to this article as recorded by  
  • Prognostic factors for T1-2 colorectal cancer after radical resection: Lymph node distribution is a valuable predictor of its survival
    Xing Huang, Hao Liu, Xiangqi Liao, Zhigang Xiao, Zhongcheng Huang, Guoxin Li
    Asian Journal of Surgery.2021; 44(1): 241.     CrossRef
  • Chemical shift effect predicting lymph node status in rectal cancer using high-resolution MR imaging with node-for-node matched histopathological validation
    Hongmei Zhang, Chongda Zhang, Zhaoxu Zheng, Feng Ye, Yuan Liu, Shuangmei Zou, Chunwu Zhou
    European Radiology.2017; 27(9): 3845.     CrossRef
  • Prognostic impact of lymph node skip metastasis in Stage III colorectal cancer
    F. Bao, L.‐y. Zhao, A. I. Balde, H. Liu, J. Yan, T.‐t. Li, H. Chen, G.‐x. Li
    Colorectal Disease.2016;[Epub]     CrossRef
  • Prognostic Impact of Distribution of Lymph Node Metastases in Stage III Colon Cancer
    Toshiya Nagasaki, Takashi Akiyoshi, Yoshiya Fujimoto, Tsuyoshi Konishi, Satoshi Nagayama, Yosuke Fukunaga, Masami Arai, Masashi Ueno
    World Journal of Surgery.2015; 39(12): 3008.     CrossRef
  • Five-year outcomes of preoperative chemoradiation for rectal carcinoma in Saudi population: single-institutional experience
    Eyad Fawzi AlSaeed, Mutahir Tunio, Ahmad Zubaidi, Omar Al-Obaid, Abdullah Kamal Ahmed, Omar Abdulmohsen Al-Omar, Emad Ahmed Abid, Mohammed Jaber Alsiwat
    Annals of Saudi Medicine.2015; 35(1): 23.     CrossRef
  • 10,727 View
  • 52 Download
  • 5 Web of Science
  • 5 Crossref
Close layer
Case Report
Poorly Differentiated Neuroendocrine Carcinoma in a Perigastric Lymph Node from an Unknown Primary Site
Hee Seung Lee, Hye-Suk Han, Sung-Nam Lim, Hyun-Jung Jeon, Ho-chang Lee, Ok-Jun Lee, Hyo Young Yun, Ki Hyeong Lee, Seung Taik Kim
Cancer Res Treat. 2012;44(4):271-274.   Published online December 31, 2012
DOI: https://doi.org/10.4143/crt.2012.44.4.271
AbstractAbstract PDFPubReaderePub
Neuroendocrine carcinomas from an unknown primary site are uncommon. The authors report on a case of neuroendocrine carcinoma in a perigastric lymph node (LN) with no primary site. A 52-year-old male patient with early gastric adenocarcinoma underwent treatment by endoscopic submucosal dissection, and, six months later, findings on a computed tomographic scan of the abdomen revealed a LN enlargement measuring 2.0 cm in the perigastric region. The patient underwent subtotal gastrectomy and regional LN dissection under a suggestive preoperative diagnosis of gastric adenocarcinoma with LN metastasis. However, microscopically, no residual tumor was found in the stomach, and the perigastric LN showed poorly differentiated neuroendocrine carcinoma (PDNEC). After an extensive workup, no primary site was identified. The patient also received four cycles of etoposide and cisplatin. Despite its extremely rare incidence, this case suggests that PDNEC of an unknown primary site is limited to a single site, and that resection should be considered in combination with chemotherapy.

Citations

Citations to this article as recorded by  
  • A case of laparoscopic lymphadenectomy for adenocarcinoma of unknown primary incidentally detected as a solitary enlarged lymph node along the common hepatic artery
    Tomonori Morimoto, Shigeo Hisamori, Hiromitsu Kinoshita, Yosuke Yamada, Yuki Teramoto, Takashi Sakamoto, Keiko Kasahara, Shintaro Okumura, Tatsuto Nishigori, Shigeru Tsunoda, Kazutaka Obama
    Surgical Case Reports.2024;[Epub]     CrossRef
  • Synchronous Gastric Adenocarcinoma and Perigastric Lymph Node Metastatic Squamous Cell Carcinoma with Unknown Primary: A Case Report
    Bernard K Seshie, Ki Hyun Kim, Hyun Jung Lee, Si Hak Lee, Sun-Hwi Hwang
    The Journal of Minimally Invasive Surgery.2020; 23(2): 99.     CrossRef
  • Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath
    Nicholas Candy, Adam Young, Kieren Allinson, Oliver Carr, Jason McMillen, Rikin Trivedi
    World Neurosurgery.2017; 104: 1047.e1.     CrossRef
  • Submucosal small-cell neuroendocrine carcinoma of the larynx detected using 18F-fluorodeoxyglucose positron emission tomography/computed tomography: A case report and review of the literature
    HONG-FANG YING, YANG-YANG BAO, SHUI-HONG ZHOU, LIANG CHAI, KUI ZHAO, TING-TING WU
    Oncology Letters.2014; 8(3): 1065.     CrossRef
  • 11,491 View
  • 49 Download
  • 4 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP